Amedeo Smart

Free Medical Literature Service


 

Amedeo

Vascular Surgery

  Free Subscription

Articles published in
Catheter Cardiovasc Interv
    March 2024
  1. VELAGALETI RS, Harrell C, Michalski J, Lefevre T, et al
    Impact of preprocedural left ventricular systolic function on the safety and durability of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Mar 5. doi: 10.1002/ccd.30995.
    >> Share

  2. FILHO EM, Araujo GN, Machado GP, Padilla L, et al
    Guide catheter extension use are associated with higher procedural success in chronic total occlusion percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2024 Mar 3. doi: 10.1002/ccd.30987.
    >> Share

  3. DENBY K, Zaczkiewicz M, Banthiya S, Mashayekhi K, et al
    Understanding large vessel perforation requiring treatment with covered stent implantation: A case series.
    Catheter Cardiovasc Interv. 2024;103:570-579.
    >> Share

  4. UZUN F, Guner A, Demirci G, Ciloglu K, et al
    Comparison of long-term outcomes of double kissing crush versus T and minimal protrusion techniques in complex bifurcation lesions: The EVOLUTE-CRUSH II registry.
    Catheter Cardiovasc Interv. 2024;103:511-522.
    >> Share

  5. SCHELLER B
    Drug-coated balloons for complex coronary de novo lesions.
    Catheter Cardiovasc Interv. 2024;103:688-689.
    >> Share

  6. ALEKSANDRIC S, Beleslin B
    Editorial comment: SYNTAX score II 2020 as a tool for decision making on revascularization strategy in high-risk patients with complex coronary artery disease.
    Catheter Cardiovasc Interv. 2024;103:680-681.
    >> Share

  7. POLETTI E, Zivelonghi C, Dens J, Bennett J, et al
    Performance of the minimalistic hybrid approach algorithm versus other conventional algorithms in the percutaneous treatment of chronic total occlusions.
    Catheter Cardiovasc Interv. 2024;103:548-559.
    >> Share

    February 2024
  8. BOUSSOFARA A, Godin M, Canville A, Baala B, et al
    Assessment of the MANTA closure device in real-life transfemoral transcatheter aortic valve replacement: A single-centre observational study.
    Catheter Cardiovasc Interv. 2024 Feb 26. doi: 10.1002/ccd.30969.
    >> Share

  9. CORCIONE N, Biondi-Zoccai G
    ABC as in Arteriopathy, Bleeding, and Coronary disease: Disentangling the prognostic conundrum of patients undergoing percutaneous coronary intervention with concomitant peripheral artery disease.
    Catheter Cardiovasc Interv. 2024 Feb 22. doi: 10.1002/ccd.30982.
    >> Share

  10. KELLEY BP, Glasco S, Sang CJ 3rd, Yoo B, et al
    To flip or not: Case series of coronary angioplasty in patients with right-sided heart.
    Catheter Cardiovasc Interv. 2024 Feb 12. doi: 10.1002/ccd.30973.
    >> Share

  11. SPIRITO A, Cohen R, Sartori S, Vogel B, et al
    Prognostic impact of peripheral artery disease in patients with and without high bleeding risk undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Feb 5. doi: 10.1002/ccd.30960.
    >> Share

  12. JEYAPRAKASH P, Mikhail P, Ford TJ, Pathan F, et al
    Index of Microcirculatory Resistance to predict microvascular obstruction in STEMI: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2024;103:249-259.
    >> Share

  13. JOLLEY MA, Sulentic A, Amin S, Gupta M, et al
    Introduction of transcatheter edge-to-edge repair in patients with congenital heart disease at a children's hospital.
    Catheter Cardiovasc Interv. 2024;103:326-334.
    >> Share

  14. SUZUKA Y, Hirano K, Tokuda T, Diaz JP, et al
    JETWING technique: Combination therapy of JETSTREAM(?) and aggressive wire recanalization in calcified atheroma and dilatation technique for eccentric heavy calcified plaques using WINGMAN for insertion of protection wire.
    Catheter Cardiovasc Interv. 2024;103:335-339.
    >> Share

  15. MOSCARDELLI S, Condos G, Lombardi WL, Azzalini L, et al
    Intracoronary snaring of the retrograde guidewire: A novel method to solve compartment mismatch in complex retrograde CTO PCI.
    Catheter Cardiovasc Interv. 2024;103:435-442.
    >> Share

  16. FUNATSU A, Sato T, Koike J, Mizobuchi M, et al
    Comprehensive clinical outcomes of drug-coated balloon treatment for coronary artery disease. Insights from a single-center experience.
    Catheter Cardiovasc Interv. 2024;103:404-416.
    >> Share

  17. LI M, Liu X, Jiang M, Lei Y, et al
    External validation of the SYNTAX score II 2020 in patients with chronic renal insufficiency.
    Catheter Cardiovasc Interv. 2024;103:391-403.
    >> Share

    January 2024
  18. SINGH K, Niranjan S, Hibbert B, Taramasso M, et al
    A stepwise approach to coronary artery stenting in acute type A aortic dissection.
    Catheter Cardiovasc Interv. 2024 Jan 31. doi: 10.1002/ccd.30964.
    >> Share

  19. VOLET C, Puricel S, Cook ST, di Cicco P, et al
    Proximal optimization technique and percutaneous coronary intervention for left main disease: POTENTIAL-LM.
    Catheter Cardiovasc Interv. 2024 Jan 31. doi: 10.1002/ccd.30961.
    >> Share

  20. CHICHAREON P, Chamnarnphol N, Chandavimol M, Suwannasom P, et al
    Updated CRUSADE score to predict in-hospital bleeding: External validation in the Thai percutaneous coronary intervention registry.
    Catheter Cardiovasc Interv. 2024 Jan 14. doi: 10.1002/ccd.30940.
    >> Share

  21. JONES D, Spirito A, Sartori S, Vogel B, et al
    Prognostic impact of in-stent restenosis in normal weight, overweight, and obese patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2024 Jan 3. doi: 10.1002/ccd.30939.
    >> Share

  22. BIANCHINI F, Lombardi M, Ricchiuto A, Paraggio L, et al
    Combined ultrasound and angiographic guidance to facilitate transradial access procedures.
    Catheter Cardiovasc Interv. 2024 Jan 3. doi: 10.1002/ccd.30947.
    >> Share

  23. FERNANDEZ CM, Shroff AR, Vidovich MI
    Interventional cardiologist perceptions about PCI without surgical backup-Results of an international survey.
    Catheter Cardiovasc Interv. 2024;103:20-29.
    >> Share

  24. KAWAMURA A, Egami Y, Okamoto N, Kawanami S, et al
    Difference between antegrade and retrograde orbital atherectomy system debulking using an artificial pulsatile heart model.
    Catheter Cardiovasc Interv. 2024;103:42-50.
    >> Share

  25. SHEKILADZE N, Sandesara PB, Tai Z, Maisuradze N, et al
    Technical aspects of entrapped coronary guidewire retrieval using rotational atherectomy device: A case series.
    Catheter Cardiovasc Interv. 2024;103:89-96.
    >> Share

  26. GUPTA A, Shrivastava A, Chhikara S, Mamas MA, et al
    Optical Coherence Tomography Predictors of SIde Branch REstenosis after unprotected Left Main bifurcation angioplasty using double kissing crush technique (OP-SIBRE LM Study).
    Catheter Cardiovasc Interv. 2024;103:51-60.
    >> Share

  27. EFFOE VS, Mewissen MW, Bajwa TK, Khitha J, et al
    Effects of atherectomy on major adverse limb events for femoropopliteal interventions: Vascular Quality Initiative registry.
    Catheter Cardiovasc Interv. 2024;103:106-114.
    >> Share

  28. HARAGUCHI T, Kuramitsu S, Tsujimoto M, Kashima Y, et al
    Outcomes of non-flow-limiting spiral dissection after drug-coated balloon angioplasty for de novo femoropopliteal lesions.
    Catheter Cardiovasc Interv. 2024;103:97-105.
    >> Share

  29. UNGUREANU C, Cocoi M, Colletti G, Avran A, et al
    Successful treatment by recross IVUS-guided reentry in coronary total occlusion: STRIVE-CTO.
    Catheter Cardiovasc Interv. 2024;103:68-79.
    >> Share

    December 2023
  30. FISCHER J, Steffen J, Arlart T, Haum M, et al
    Concomitant percutaneous coronary intervention in patients undergoing transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2023 Dec 22. doi: 10.1002/ccd.30927.
    >> Share

  31. HANSON I, Goldstein JA
    Percutaneous coronary intervention: Before, after, or during TAVR?
    Catheter Cardiovasc Interv. 2023 Dec 22. doi: 10.1002/ccd.30941.
    >> Share

  32. AROW Z, Konigstein M, Vaknin-Assa H, Witberg G, et al
    Percutaneous coronary intervention with ridaforolimus eluting-stents in small vessel coronary artery disease.
    Catheter Cardiovasc Interv. 2023 Dec 14. doi: 10.1002/ccd.30924.
    >> Share

  33. NOORI M, Christiansen EH, Raungaard B, Junker A, et al
    Long-term outcomes after coronary intervention with biodegradable polymer stents in patients with acute coronary syndromes.
    Catheter Cardiovasc Interv. 2023 Dec 13. doi: 10.1002/ccd.30937.
    >> Share

  34. BARBASH IM, Wasserstrum Y, Erlebach M, Guetta V, et al
    Comparison of MANTA versus Perclose Prostyle large-bore vascular closure devices during transcatheter aortic valve implantation.
    Catheter Cardiovasc Interv. 2023 Dec 7. doi: 10.1002/ccd.30921.
    >> Share

  35. PIEDIMONTE G, Azzalini L, Ferrarotto L, Mangione R, et al
    Applicability of J-CTO channel score to predict microcatheter tracking during retrograde percutaneous coronary intervention of chronic total occlusions: Insights from the SURFING MICRO registry.
    Catheter Cardiovasc Interv. 2023 Dec 4. doi: 10.1002/ccd.30928.
    >> Share

  36. DE SILVA K, Li Kam Wa ME, Wells T, Mozid A, et al
    The everolimus eluting Synergy Megatron(TM) drug-eluting stent platform: Early outcomes from the European Synergy Megatron(TM) Implanters' Registry.
    Catheter Cardiovasc Interv. 2023;102:1222-1228.
    >> Share

  37. BASAVARAJAIAH S, Kalkat H, Bhatia G, Cortese B, et al
    How to perform a successful drug-coated balloon angioplasty? Tips and tricks.
    Catheter Cardiovasc Interv. 2023;102:1238-1257.
    >> Share

  38. MOVAHED MR
    Movahed coronary bifurcation classification should be the preferred classification for studying true bifurcation lesions as it summarizes true bifurcation lesions in only one simple category called B2 Lesion with limitless optional suffixes.
    Catheter Cardiovasc Interv. 2023;102:1263-1264.
    >> Share

  39. MATHEW RO, Rangaswami J, Abramov D, Mahalwar G, et al
    Proportional troponin changes and risk for outcomes with intervention strategies in non-ST-elevation acute coronary syndrome across kidney function.
    Catheter Cardiovasc Interv. 2023;102:1162-1176.
    >> Share

  40. YAYLAK B, Polat F, Onuk T, Akyuz S, et al
    The relation of polymer structure of stent used in patients with acute coronary syndrome revascularized by stent implantation with long-term cardiovascular events.
    Catheter Cardiovasc Interv. 2023;102:1186-1197.
    >> Share

  41. RAISZADEH M, Khosronejad A, Dianaty S, Yekta BG, et al
    Novel repair of acute Stanford type B aortic dissection using combined endovascular graft and transfemoral replacement of vascular plug.
    Catheter Cardiovasc Interv. 2023;102:1287-1290.
    >> Share

  42. SCHULTE K, Zdoroveac A, Gurke L, Isaak A, et al
    Endovascular maneuvers for contralateral stent graft limb misplacement in endovascular aortic repair.
    Catheter Cardiovasc Interv. 2023;102:1271-1274.
    >> Share

    November 2023
  43. JAVAID AI, Michalek JE, Gruslova AB, Hoskins SA, et al
    Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Nov 23. doi: 10.1002/ccd.30913.
    >> Share

  44. STEINBERG ZL, Rayner SG, Leary PJ
    Balloon pulmonary angioplasty for chronic thromboembolic pulmonary hypertension due to septic emboli.
    Catheter Cardiovasc Interv. 2023 Nov 22. doi: 10.1002/ccd.30919.
    >> Share

  45. GARBO R, Iannaccone M, Bruno F, Arioti M, et al
    Intravascular ultrasound-guided STAR 2.0: A new technique for chronic total occlusion recanalization.
    Catheter Cardiovasc Interv. 2023 Nov 20. doi: 10.1002/ccd.30920.
    >> Share

  46. SIMSEK B, Rempakos A, Kostantinis S, Alexandrou M, et al
    International survey of chronic total occlusion percutaneous coronary intervention operators.
    Catheter Cardiovasc Interv. 2023 Nov 20. doi: 10.1002/ccd.30914.
    >> Share

  47. MAJEED H, Blankenship JC
    Ellis type 4 coronary artery perforation during percutaneous coronary intervention: Case series and review.
    Catheter Cardiovasc Interv. 2023 Nov 10. doi: 10.1002/ccd.30873.
    >> Share

  48. NUMASAWA Y, Sawano M, Ishii H, Kohsaka S, et al
    One-year outcomes of patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy catheter: Insights from the J-PCI OUTCOME registry.
    Catheter Cardiovasc Interv. 2023 Nov 9. doi: 10.1002/ccd.30895.
    >> Share

  49. LIU X, Zhang Y, Xu Y, Tang Z, et al
    Fractional flow reserve versus intravascular imaging to guide decision-making for percutaneous coronary intervention in intermediate lesions: A meta-analysis.
    Catheter Cardiovasc Interv. 2023 Nov 8. doi: 10.1002/ccd.30909.
    >> Share

  50. COZZI O, Maurina M, Cacia M, Bernardini V, et al
    Clinical and procedural outcomes of percutaneous coronary intervention for de novo lesions involving the ostial left circumflex coronary artery.
    Catheter Cardiovasc Interv. 2023 Nov 7. doi: 10.1002/ccd.30903.
    >> Share

  51. ALADIN AI, Wermers JP, Zhang C, Case BC, et al
    Prognostic implication of hemoglobin reduction with and without clinical bleeding after percutaneous coronary intervention in patients with acute coronary syndromes.
    Catheter Cardiovasc Interv. 2023 Nov 5. doi: 10.1002/ccd.30896.
    >> Share

  52. UNGUREANU C, Leone PP, Colletti G, Gasparini GL, et al
    Retrograde balloon hemostasis.
    Catheter Cardiovasc Interv. 2023;102:896-899.
    >> Share

  53. RISSANEN TT, Kleber FX, Scheller B
    Drug-coated balloon angioplasty is a well-established treatment and in everyday use in cathlabs worldwide.
    Catheter Cardiovasc Interv. 2023;102:912-913.
    >> Share

  54. RESTIVO A, Stanzione A, Maffeo D, Buono A, et al
    Ping-pong snaring of a totally dislodged stent across left main ostium: "All is not lost".
    Catheter Cardiovasc Interv. 2023;102:889-891.
    >> Share

  55. FUJISAKI T, Kuno T, Iwagami M, Miyamoto Y, et al
    Net clinical benefit of dual antiplatelet therapy in elderly patients with acute coronary syndrome: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023;102:788-802.
    >> Share

  56. BLACHUTZIK F, Meier S, Weissner M, Schlattner S, et al
    Coronary intravascular lithotripsy and rotational atherectomy for severely calcified stenosis: Results from the ROTA.shock trial.
    Catheter Cardiovasc Interv. 2023;102:823-833.
    >> Share

  57. GALASSI AR, Vadala G, Maniscalco L, Gasparini G, et al
    Wire-based antegrade dissection re-entry technique for coronary chronic total occlusions percutaneous revascularization: Experience from the ERCTO Registry.
    Catheter Cardiovasc Interv. 2023;102:864-877.
    >> Share

  58. EL KHOURY A, Lazar L, Cortese B
    The fate of coronary dissections left after sirolimus-coated balloon angioplasty: A prespecified subanalysis of the EASTBOURNE study.
    Catheter Cardiovasc Interv. 2023;102:979-986.
    >> Share

  59. SANDESARA PB, Elhage Hassan M, Shekiladze N, Turk AA, et al
    Intravascular lithotripsy compared to rotational atherectomy for the treatment of calcified distal left main coronary artery disease: A single center experience.
    Catheter Cardiovasc Interv. 2023;102:997-1003.
    >> Share

  60. HERRON C, Batlivala SP, Shahanavaz S
    Right atrial thrombus removal with use of the ONO retrieval device.
    Catheter Cardiovasc Interv. 2023;102:1105-1108.
    >> Share

  61. UEDA H, Fujiwara Y, Nishida Y, Maenaka M, et al
    Impact of prolonged drug-coated balloon inflation on residual stenosis and clinical outcomes in coronary artery disease patients: A propensity score matched analysis.
    Catheter Cardiovasc Interv. 2023;102:969-978.
    >> Share

  62. JUN EJ, Hong SP, Kim B, Lee JB, et al
    Healing and stent coverage with the new ultrathin sirolimus-eluting stent with abluminal biodegradable polymer.
    Catheter Cardiovasc Interv. 2023;102:1040-1047.
    >> Share

  63. WALLNER K, Kearney KE, Tiwana J, Pristera N, et al
    Increased prescription dose for large vessel intravascular brachytherapy.
    Catheter Cardiovasc Interv. 2023;102:1034-1039.
    >> Share

  64. CRITCHFIELD DR, Chamberlain RC, Turek JW, Fleming GA, et al
    Hybrid approach to pulmonary vein stenting after Fontan palliation.
    Catheter Cardiovasc Interv. 2023;102:1095-1100.
    >> Share

  65. ICHIKAWA M, Matsuoka Y, Hasebe T
    Coronary arterial repair in patients with stable angina pectoris or acute coronary syndrome after ultrathin biodegradable polymer sirolimus-eluting stent implantation at 1-year follow-up by coronary angioscopy.
    Catheter Cardiovasc Interv. 2023;102:1012-1019.
    >> Share

  66. MERINOPOULOS I, Gunawardena T, Corballis N, Tsampasian V, et al
    Cost effectiveness analysis of drug coated balloon only angioplasty for de novo coronary artery disease.
    Catheter Cardiovasc Interv. 2023;102:987-996.
    >> Share

    October 2023
  67. MOHAMED MO, Kinnaird T, Rab ST, Zaman S, et al
    Intracoronary imaging guided percutaneous coronary intervention outcomes among individuals with cardiogenic shock.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30859.
    >> Share

  68. CORTESE B, Kalkat H, Bathia G, Basavarajaiah S, et al
    The evolution and revolution of drug coated balloons in coronary angioplasty: An up-to-date review of literature data.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30891.
    >> Share

  69. LU H, Hu Y, Ma Y, Zhou Y, et al
    Exploring indicators of success in chronic total occlusion percutaneous coronary intervention with Stingray system-based antegrade dissection re-entry: Insights from retrospective analysis.
    Catheter Cardiovasc Interv. 2023 Oct 23. doi: 10.1002/ccd.30889.
    >> Share

  70. HIGASHINO N, Iida O, Ishihara T, Hata Y, et al
    Angiographic patterns of restenosis after drug-coated balloon angioplasty for femoropopliteal lesions and 1-year prognosis after repeat endovascular therapy.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30856.
    >> Share

  71. AL MAWED M, Vlachojannis M, Pula A, Gielen S, et al
    Delayed coronary perforation four days after percutaneous coronary intervention with subsequent cardiac tamponade: A case report.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30861.
    >> Share

  72. MITSUI K, Takagi K, Kakuta T, Noguchi T, et al
    Novel percutaneous intervention technique for obstructed coronary artery after valve-in-valve transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30865.
    >> Share

  73. MAURINA M, Chiarito M, Leone PP, Testa L, et al
    Randomized clinical trial of abluminus DES+ sirolimus-eluting stent versus everolimus-eluting DES for percutaneous coronary intervention in patients with diabetes mellitus: An optical coherence tomography study.
    Catheter Cardiovasc Interv. 2023 Oct 19. doi: 10.1002/ccd.30853.
    >> Share

  74. PAOLUCCI L, De Micco F, Bezzeccheri A, Scarpelli M, et al
    Contrast media volume reduction with the DyeVert(TM) system to prevent acute kidney injury in stable patients undergoing coronary procedures.
    Catheter Cardiovasc Interv. 2023;102:655-662.
    >> Share

  75. TENG L, Zhang Y, Fang J, Liu X, et al
    A Bayesian network meta-analysis for acute thrombosis after lower extremity artery endovascular treatment.
    Catheter Cardiovasc Interv. 2023;102:731-742.
    >> Share

  76. GRESSLER LE, Ramkumar N, Marinac-Dabic D, dosReis S, et al
    The association of major adverse limb events and combination stent and atherectomy in patients undergoing revascularization for lower extremity peripheral artery disease.
    Catheter Cardiovasc Interv. 2023;102:688-700.
    >> Share

  77. HIRAI T
    "Crossing the invisible".
    Catheter Cardiovasc Interv. 2023;102:774-775.
    >> Share

  78. KLEBER FX
    Commentary: Dissection still a sticking point in the widespread use of DCB in PCI.
    Catheter Cardiovasc Interv. 2023;102:772-773.
    >> Share

  79. SCHLEIGER A, Al Darwish N, Meyer M, Kramer P, et al
    Long-term follow-up after endovascular treatment of aortic coarctation with bare and covered Cheatham platinum stents.
    Catheter Cardiovasc Interv. 2023;102:672-682.
    >> Share

    September 2023
  80. SHAMKHANI W, Moledina S, Rashid M, Mamas MA, et al
    Complex high-risk percutaneous coronary intervention types, trends, and outcomes according to vascular access site.
    Catheter Cardiovasc Interv. 2023 Sep 26. doi: 10.1002/ccd.30846.
    >> Share

  81. DI MAIO M, Esposito L, Silverio A, Bellino M, et al
    Prognostic significance of the SYNTAX score and SYNTAX score II in patients with myocardial infarction treated with percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Sep 13. doi: 10.1002/ccd.30842.
    >> Share

  82. ULLAH W, Sarvepalli D, Kumar A, Zahid S, et al
    Trends and outcomes of combined percutaneous (TAVI+PCI) and surgical approach (SAVR+CABG) for patients with aortic valve and coronary artery disease: A National Readmission Database (NRD) analysis.
    Catheter Cardiovasc Interv. 2023 Sep 12. doi: 10.1002/ccd.30832.
    >> Share

  83. AHN J, Yu H, Rha SW, Choi BG, et al
    Long-term clinical outcomes following successful percutaneous coronary intervention in patients with extremely long coronary chronic total occlusion lesions.
    Catheter Cardiovasc Interv. 2023 Sep 8. doi: 10.1002/ccd.30829.
    >> Share

  84. REMPAKOS A, Kostantinis S, Simsek B, Karacsonyi J, et al
    Impact of preprocedural anemia on in-hospital and follow-up outcomes of chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Sep 8. doi: 10.1002/ccd.30810.
    >> Share

  85. HIRAI T, Grantham JA, Kandzari DE, Ballard W, et al
    Percutaneous ventricular assist device for higher-risk percutaneous coronary intervention in surgically ineligible patients: Indications and outcomes from the OPTIMUM study.
    Catheter Cardiovasc Interv. 2023 Sep 7. doi: 10.1002/ccd.30834.
    >> Share

  86. ALEXANDROU M, Rempakos A, Al Ogaili A, Choi JW, et al
    Balloon-assisted subintimal entry (BASE) in chronic total occlusion percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2023 Sep 7. doi: 10.1002/ccd.30830.
    >> Share

  87. SOMSEN YBO, de Winter RW, Giunta R, Schumacher SP, et al
    Collateral grading systems in retrograde percutaneous coronary intervention of chronic total occlusions.
    Catheter Cardiovasc Interv. 2023 Sep 6. doi: 10.1002/ccd.30812.
    >> Share

  88. BRUNO F, Kang J, Elia E, Han JK, et al
    Impact of diabetes on long-term outcomes of bifurcation percutaneous coronary intervention. An analysis from the BIFURCAT registry.
    Catheter Cardiovasc Interv. 2023 Sep 5. doi: 10.1002/ccd.30802.
    >> Share

  89. SCARPARO P, Schermers T, Improta R, Kardys I, et al
    Stent expansion in calcified coronary chronic total occlusions: The impact of different stent platforms.
    Catheter Cardiovasc Interv. 2023;102:451-463.
    >> Share

  90. VAZQUEZ DJL, Lopez GA, Guzman MQ, Cancelo AV, et al
    Prognostic impact of coronary lesions and its revascularization in a 5-year follow-up after the TAVI procedure.
    Catheter Cardiovasc Interv. 2023;102:513-520.
    >> Share

  91. KIM SE, Choi KH, Song YB
    An unusual no-reflow phenomenon due to neointimal tissue embolization during drug eluting balloon intervention in stent restenosis: A case report.
    Catheter Cardiovasc Interv. 2023;102:481-485.
    >> Share

  92. DOOLUB G, Iannaccone M, Rab T, Routledge H, et al
    Sex-based treatment and outcomes for coronary bifurcation stenting: A report from the e-ULTIMASTER registry.
    Catheter Cardiovasc Interv. 2023;102:430-439.
    >> Share

  93. VELLA C, Preda A, Ferri L, Montorfano M, et al
    Intravascular coronary lithotripsy for the treatment of iatrogenic calcium embolization: The "block and crack" technique.
    Catheter Cardiovasc Interv. 2023;102:486-488.
    >> Share

    August 2023
  94. SUZUKI N
    Prediction of residual ischemia after coronary stenting by quantitative flow ratio modulated by optical coherence tomography: Where we are now and our future perspectives.
    Catheter Cardiovasc Interv. 2023;102:392-393.
    >> Share

  95. CHAUS A, Uretsky BF
    "CHIP-ping" away at the definition of PCI "complexity" and "risk".
    Catheter Cardiovasc Interv. 2023;102:396-397.
    >> Share

  96. SHROFF GR, Garcia S, Schmidt C, Okeson B, et al
    Renal impairment and mortality in patients with STEMI and cardiogenic shock/cardiac arrest.
    Catheter Cardiovasc Interv. 2023;102:179-190.
    >> Share

  97. YASSIN I, Mosaad MA, Hassan AM, Abdelghani M, et al
    Fix and pull technique for retrieval of intracoronary unexpanded-stent entrapment.
    Catheter Cardiovasc Interv. 2023;102:247-248.
    >> Share

    July 2023
  98. SUN ML, Zhu YJ, Zhou YP, Zhu XJ, et al
    Percutaneous transluminal pulmonary angioplasty for Takayasu arteritis-associated pulmonary hypertension: A single-arm meta-analysis.
    Catheter Cardiovasc Interv. 2023 Jul 31. doi: 10.1002/ccd.30773.
    >> Share

  99. KANDZARI DE, Garcia-Garcia HM, Stoler RC, Wang J, et al
    Ultrathin bioresorbable polymer sirolimus-eluting stents in US patients undergoing coronary revascularization: 1-Year outcomes from the BIOFLOW VII trial.
    Catheter Cardiovasc Interv. 2023 Jul 26. doi: 10.1002/ccd.30783.
    >> Share

  100. GINETE WL, Groth NA, Rudeck MN, Renier CM, et al
    Outcomes of same-day discharge following percutaneous coronary intervention in a rural population.
    Catheter Cardiovasc Interv. 2023 Jul 22. doi: 10.1002/ccd.30762.
    >> Share

  101. PARK DY, An S, Jolly N, Attanasio S, et al
    Comparison of intravascular ultrasound, optical coherence tomography, and conventional angiography-guided percutaneous coronary interventions: A systematic review, network meta-analysis, and meta-regression.
    Catheter Cardiovasc Interv. 2023 Jul 22. doi: 10.1002/ccd.30784.
    >> Share

  102. SONODA S, Node K
    Fighting calcification with optical coherence tomography-guided percutaneous coronary intervention. Commentary on the optical coherence tomography-derived predictors of stent expansion in calcified lesions.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30776.
    >> Share

  103. AIJAZ B, Glorioso TJ, Butala N, Waldo SW, et al
    Temporal trends and hospital variation in the use of P2Y12 inhibitors among patients undergoing percutaneous coronary intervention: Insights from the VA CART program.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30782.
    >> Share

  104. MAZNYCZKA A, Arunothayaraj S, Egred M, Banning A, et al
    Bifurcation left main stenting with or without intracoronary imaging: Outcomes from the EBC MAIN trial.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30785.
    >> Share

  105. KANE J, Kearney KE, Lombardi WL, Azzalini L, et al
    Electrocautery-assisted re-entry to resolve bilateral aorto-ostial chronic total occlusions due to leaflet obstruction following transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2023 Jul 20. doi: 10.1002/ccd.30781.
    >> Share

  106. MITSUI K, Lee T, Miyazaki R, Hara N, et al
    Drug-coated balloon strategy following orbital atherectomy for calcified coronary artery compared with drug-eluting stent: One-year outcomes and optical coherence tomography assessment.
    Catheter Cardiovasc Interv. 2023;102:11-17.
    >> Share

  107. ZIEDSES DES PLANTES AC, Scoccia A, Neleman T, Groenland FTW, et al
    Optical coherence tomography-derived predictors of stent expansion in calcified lesions.
    Catheter Cardiovasc Interv. 2023;102:25-35.
    >> Share

  108. WERNER GS, Lorenz S, Dimitriadis Z, Krueger B, et al
    Anemia and periprocedural complications determine contrast-associated acute kidney injury after recanalization of chronic coronary occlusions in chronic kidney disease.
    Catheter Cardiovasc Interv. 2023;102:101-110.
    >> Share

    June 2023
  109. GEWEHR DM, Carvalho PEP, Dagostin CS, Cardoso R, et al
    Pretreatment with P2Y12 inhibitors in ST-elevation myocardial infarction: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Jun 23. doi: 10.1002/ccd.30750.
    >> Share

  110. PICCOLO R, Leone A, Simonetti F, Avvedimento M, et al
    Periprocedural myocardial infarction in patients undergoing complex versus noncomplex percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Jun 19. doi: 10.1002/ccd.30749.
    >> Share

  111. LOPEZ-MINGUEZ JR, Martin de Francisco AL, Soler MJ, Hernandez F, et al
    Cost-effectiveness analysis of dyevert Power XT in patients with chronic kidney disease undergoing percutaneous coronary intervention procedures in Spain.
    Catheter Cardiovasc Interv. 2023 Jun 10. doi: 10.1002/ccd.30744.
    >> Share

  112. MILEVA N, Ohashi H, Paolisso P, Leipsic J, et al
    Relationship between coronary volume, myocardial mass, and post-PCI fractional flow reserve.
    Catheter Cardiovasc Interv. 2023;101:1182-1192.
    >> Share

  113. PERSHAD A
    CTO revascularization in TAVR patients-The jury is still out.
    Catheter Cardiovasc Interv. 2023;101:1229.
    >> Share

  114. ZONI CR, Mukherjee D, Gulati M
    Proposed new classification for acute coronary syndrome: Acute coronary syndrome requiring immediate reperfusion.
    Catheter Cardiovasc Interv. 2023;101:1177-1181.
    >> Share

    May 2023
  115. GROENLAND FTW, Ziedses des Plantes AC, Neleman T, Scoccia A, et al
    Culprit lesion plaque characterization and thrombus grading by high-definition intravascular ultrasound in patients with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2023 May 26. doi: 10.1002/ccd.30699.
    >> Share

  116. DE FILIPPO O, Bruno F, Pinxterhuis TH, Gasior M, et al
    Predictors of target lesion failure after treatment of left main, bifurcation, or chronic total occlusion lesions with ultrathin-strut drug-eluting coronary stents in the ULTRA registry.
    Catheter Cardiovasc Interv. 2023 May 26. doi: 10.1002/ccd.30696.
    >> Share

  117. RJOOB K, McGilligan V, McAllister R, Bond R, et al
    What do we mean by complex percutaneous coronary intervention? An assessment of agreement amongst interventional cardiologists for defining complexity.
    Catheter Cardiovasc Interv. 2023 May 20. doi: 10.1002/ccd.30684.
    >> Share

  118. BENEDETTI A, Castaldi G, Poletti E, Moroni A, et al
    Percutaneous treatment of left circumflex coronary artery injury related to mitral valve surgery: Case series and systematic review of the literature.
    Catheter Cardiovasc Interv. 2023 May 20. doi: 10.1002/ccd.30693.
    >> Share

  119. OKSNES A, Skaar E, Engan B, Bleie O, et al
    Effectiveness, safety, and patient reported outcomes of a planned investment procedure in higher-risk chronic total occlusion percutaneous coronary intervention: Rationale and design of the invest-CTO study.
    Catheter Cardiovasc Interv. 2023 May 17. doi: 10.1002/ccd.30692.
    >> Share

  120. DING D, Tu S, Li Y, Li C, et al
    Quantitative flow ratio modulated by intracoronary optical coherence tomography for predicting physiological efficacy of percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30681.
    >> Share

  121. GHETTI G, Bendandi F, Donati F, Ciurlanti L, et al
    Predictors of bail-out stenting in patients with small vessel disease treated with drug-coated balloon percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30688.
    >> Share

  122. KOSTANTINIS S, Rempakos A, Simsek B, Karacsonyi J, et al
    Aortocoronary dissection during percutaneous coronary interventions for chronic total occlusion: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2023 May 12. doi: 10.1002/ccd.30680.
    >> Share

  123. ZHANG YJ, Ma WR, Xu B, Huang ZH, et al
    Retrograde percutaneous coronary intervention of chronic total occlusion via discontinuous septal channels.
    Catheter Cardiovasc Interv. 2023 May 10. doi: 10.1002/ccd.30678.
    >> Share

  124. CADER A, Alasnag M
    Is there a woman paradox? Commentary on the Gender differences in percutaneous coronary intervention for chronic total occlusions from the ERCTO study.
    Catheter Cardiovasc Interv. 2023 May 8. doi: 10.1002/ccd.30672.
    >> Share

  125. ABRAHAM B, Farina JM, Fath A, Abdou M, et al
    The impact of moderate aortic stenosis in acute myocardial infarction: A multicenter retrospective study.
    Catheter Cardiovasc Interv. 2023 May 5. doi: 10.1002/ccd.30676.
    >> Share

  126. MINICI R, Serra R, De Rosi N, Ciranni S, et al
    Endovascular treatment of femoro-popliteal occlusions with retrograde tibial access after failure of the antegrade approach.
    Catheter Cardiovasc Interv. 2023;101:1108-1119.
    >> Share

  127. RIGATTIERI S, Casenghi M
    Lowering air kerma to improve the CTO operator's karma.
    Catheter Cardiovasc Interv. 2023;101:1172-1173.
    >> Share

  128. MORONI A, Marin F, Venturi G, Scarsini R, et al
    Management of failed stenting of the unprotected left main coronary artery.
    Catheter Cardiovasc Interv. 2023;101:1001-1013.
    >> Share

  129. MASSUSSI M, Adamo M, Rosati F, Chizzola G, et al
    Coronary artery disease and TAVI: Current evidence on a recurrent issue.
    Catheter Cardiovasc Interv. 2023;101:1154-1160.
    >> Share

  130. BUYUKGOZ C, Sandhu H, Shah S, Rower K, et al
    Strategies and techniques for percutaneous Veno-Arterial ECMO cannulation and decannulation in children.
    Catheter Cardiovasc Interv. 2023;101:1088-1097.
    >> Share

  131. MORETTI F, Rondi M, Ottani F
    Zero-contrast IVUS-guided complex PCI in a patient with NSTE-ACS and severe renal impairment.
    Catheter Cardiovasc Interv. 2023;101:1074-1080.
    >> Share

  132. YIN J, Wang R, Chen H, Lu H, et al
    In vivo evaluation of intravascular lithotripsy in a healthy porcine coronary model.
    Catheter Cardiovasc Interv. 2023;101:1062-1070.
    >> Share

  133. NICKELL A, Sergev O, Alberto N, Bande D, et al
    Effectiveness of the vacuum assisted aspiration AngioVac system in the removal of intravascular masses.
    Catheter Cardiovasc Interv. 2023;101:1161-1165.
    >> Share

  134. SETO AH
    Cut, score, press, shock, or ablate?
    Catheter Cardiovasc Interv. 2023;101:975-977.
    >> Share

  135. EL HAJJ M, Krajcer Z
    Bioresorbable stents: We have more work to do.
    Catheter Cardiovasc Interv. 2023;101:978-979.
    >> Share

  136. WANG X, Li Y, Fu G, Xu B, et al
    Three-year clinical outcomes of the novel sirolimus-eluting bioresorbable scaffold for the treatment of de novo coronary artery disease: A prospective patient-level pooled analysis of NeoVas trials.
    Catheter Cardiovasc Interv. 2023;101:967-972.
    >> Share

    April 2023
  137. TARANTINI G, Cardaioli F
    Looking but not seeing the cap: The case for PROGRESS-CTO.
    Catheter Cardiovasc Interv. 2023;101:955-956.
    >> Share

  138. GRINES CL, Tummala PE
    Calcified coronary nodule: Tip of the iceberg on a road full of thorns.
    Catheter Cardiovasc Interv. 2023;101:959-960.
    >> Share

  139. RAMKUMAR N, Suckow BD, Behrendt CA, Mackenzie TA, et al
    Association between sex and long-term outcomes of endovascular treatment for peripheral artery disease.
    Catheter Cardiovasc Interv. 2023;101:877-887.
    >> Share

  140. LONG Y, He B, Tsao N, Liu H, et al
    Combined ascending aortobiiliac bypass and endovascular obliteration in the Bentall procedure for dual aortic aneurysms.
    Catheter Cardiovasc Interv. 2023;101:943-946.
    >> Share

  141. YILDIZ M, Henry TD
    Unprotected left main occlusion: Rare but deadly.
    Catheter Cardiovasc Interv. 2023;101:953-954.
    >> Share

  142. ANDREA E, Danilo M, Nicola GA, Pierluigi CA, et al
    Adjunctive techniques in endovascular repair of postcarotid endarterectomy pseudoaneurysm: Case report and literature review.
    Catheter Cardiovasc Interv. 2023;101:900-906.
    >> Share

  143. JIA H, Xi Y, Yuan P, Guo W, et al
    Coil embolization of asymptomatic left gastric artery aneurysm: Case report and literature review.
    Catheter Cardiovasc Interv. 2023;101:907-910.
    >> Share

  144. MUSUMECI G, Annibali G
    Keep it simple.
    Catheter Cardiovasc Interv. 2023;101:947-948.
    >> Share

  145. MORI S, Takahara M, Nakama T, Tobita K, et al
    Impact of calcification on clinical outcomes after drug-coated balloon angioplasty for superficial femoral artery disease: Assessment using the peripheral artery calcification scoring system.
    Catheter Cardiovasc Interv. 2023;101:892-899.
    >> Share

  146. ZACA S, Patruno I, Pulli R, Angiletta D, et al
    Endovascular repair using parallel grafts to treat a suprarenal pancreatitis-related abdominal aortic pseudoaneurysm.
    Catheter Cardiovasc Interv. 2023;101:888-891.
    >> Share

  147. HADDAD RN, Dautry R, Bonnet D, Malekzadeh-Milani S, et al
    Transvenous retrograde thoracic duct embolization for effective treatment of recurrent plastic bronchitis after fontan palliation.
    Catheter Cardiovasc Interv. 2023;101:863-869.
    >> Share

  148. BACCI E, Chiarito M, Sanz-Sanchez J, Leone PP, et al
    Safety and efficacy of an ultra low dose fluoroscopic protocol for chronic total occlusion recanalization.
    Catheter Cardiovasc Interv. 2023;101:911-917.
    >> Share

  149. HANNAN EL, Zhong Y, Cozzens K, Osinaga A, et al
    Impact of COVID-19 on percutaneous coronary intervention utilization and mortality in New York.
    Catheter Cardiovasc Interv. 2023 Apr 1. doi: 10.1002/ccd.30648.
    >> Share

    March 2023
  150. TORABI AJ, Von der Lohe E, Kovacs RJ, Frick KA, et al
    Measures of social deprivation and outcomes after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Mar 30. doi: 10.1002/ccd.30642.
    >> Share

  151. SIMSEK B, Khatri J, Young L, Kostantinis S, et al
    Same day discharge versus overnight observation following chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2023 Mar 24. doi: 10.1002/ccd.30644.
    >> Share

  152. MORI H, Kurita T, Takasaki A, Dohi K, et al
    Plaque characterization of a saphenous vein graft by near-infrared spectroscopy and histopathology in a patient with a percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Mar 23. doi: 10.1002/ccd.30641.
    >> Share

  153. RYAN N, Alasnag M
    Commentary on "Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry".
    Catheter Cardiovasc Interv. 2023 Mar 21. doi: 10.1002/ccd.30643.
    >> Share

  154. ALLANA SS, Brilakis ES
    What is the role of drug-coated balloons in chronic total occlusion percutaneous coronary intervention?
    Catheter Cardiovasc Interv. 2023 Mar 15. doi: 10.1002/ccd.30632.
    >> Share

  155. DAI N, Tang X, Chen Z, Huang D, et al
    Pre-stenting angiography-FFR based physiological map provides virtual intervention and predicts physiological and clinical outcomes.
    Catheter Cardiovasc Interv. 2023 Mar 15. doi: 10.1002/ccd.30635.
    >> Share

  156. KIM YH, Her AY, Rha SW, Choi CU, et al
    Effects of delayed hospitalization on the 3-year clinical outcomes of patients with or without diabetes who had non-ST-segment-elevation myocardial infarction and underwent new-generation drug-eluting stent implantation.
    Catheter Cardiovasc Interv. 2023 Mar 15. doi: 10.1002/ccd.30630.
    >> Share

  157. AVRAN A, Zuffi A, Gobbi C, Gasperetti A, et al
    Gender differences in percutaneous coronary intervention for chronic total occlusions from the ERCTO study.
    Catheter Cardiovasc Interv. 2023 Mar 8. doi: 10.1002/ccd.30616.
    >> Share

  158. POSTALIAN A, Krajcer Z
    The relationship between chronic kidney disease and "complex" percutaneous coronary intervention: Uncovering the details.
    Catheter Cardiovasc Interv. 2023 Mar 8. doi: 10.1002/ccd.30612.
    >> Share

  159. TOKUDA T, Oba Y, Kagase A, Matsuda H, et al
    Feasibility and impact of extra-vascular ultrasound-guided endovascular treatment for infrapopliteal artery occlusive disease.
    Catheter Cardiovasc Interv. 2023 Mar 6. doi: 10.1002/ccd.30615.
    >> Share

  160. LEE A, Gilchrist IC
    A tale of two registries: Trends and outcomes of percutaneous coronary intervention in two transatlantic populations.
    Catheter Cardiovasc Interv. 2023 Mar 2. doi: 10.1002/ccd.30608.
    >> Share

  161. HEUSER RR
    Regulators can we get DCB balloons approved for use in the United States?
    Catheter Cardiovasc Interv. 2023;101:834-835.
    >> Share

  162. SETO AH, Tehrani DM
    Better together? Maybe not with CTO-PCI.
    Catheter Cardiovasc Interv. 2023;101:828-829.
    >> Share

  163. MANGIERI A, Nerla R, Castriota F, Reimers B, et al
    Cutting balloon to optimize predilation for stent implantation: The COPS randomized trial.
    Catheter Cardiovasc Interv. 2023;101:798-805.
    >> Share

  164. MATSUHIRO Y, Nakamura D, Dohi T, Ishihara T, et al
    Impact of calcified nodule on target lesion failure after stent implantation in hemodialysis patients.
    Catheter Cardiovasc Interv. 2023;101:701-712.
    >> Share

  165. FEGHALY J, Chen K, Blanco A, Pineda AM, et al
    Distal versus conventional radial artery access for coronary catheterization: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023;101:722-736.
    >> Share

  166. TERASHITA K, Shimada Y, Yamanaka Y, Motohashi Y, et al
    Intraplaque wiring enables drug-coated balloons to be utilized for percutaneous recanalization of chronically occluded coronary arteries.
    Catheter Cardiovasc Interv. 2023;101:764-772.
    >> Share

  167. DURIG M, Arroyo D, Bedossa M, Commeau P, et al
    Clinical outcomes after unprotected left main coronary artery occlusion: A retrospective multicentre cohort analysis.
    Catheter Cardiovasc Interv. 2023;101:679-686.
    >> Share

  168. LI WD, Keyoumu R, Wang C, Liu Z, et al
    3D Printing-guided endovascular repair of enormous twisted thoracoabdominal aortic aneurysm with branch stenosis and occlusion.
    Catheter Cardiovasc Interv. 2023;101:813-816.
    >> Share

  169. ANDREASEN LN, Balleby IR, Barkholt TO, Hebsgaard L, et al
    Early healing after treatment of coronary lesions by thin strut everolimus, or thicker strut biolimus eluting bioabsorbable polymer stents: The SORT-OUT VIII OCT study.
    Catheter Cardiovasc Interv. 2023;101:787-797.
    >> Share

    February 2023
  170. UENO K, Morita N, Kojima Y, Takahashi H, et al
    Serial quantitative angiographic study of target lumen enlargement after drug-coated balloon angioplasty for native coronary artery disease.
    Catheter Cardiovasc Interv. 2023 Feb 25. doi: 10.1002/ccd.30598.
    >> Share

  171. IGLESIAS JF, Muller O, Losdat S, Roffi M, et al
    Complex primary percutaneous coronary intervention with ultrathin-strut biodegradable versus thin-strut durable polymer drug-eluting stents in patients with ST-segment elevation myocardial infarction: A subgroup analysis from the BIOSTEMI randomized t
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30600.
    >> Share

  172. HEATON J, Singh S, Nanavaty D, Okoh AK, et al
    Impact of frailty on outcomes in acute ST-elevated myocardial infarctions undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30595.
    >> Share

  173. WILL M, Schwarz K, Weiss T, Leibundgut G, et al
    The impact of chronic total occlusions in patients undergoing transcatheter aortic valve replacement: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2023 Feb 19. doi: 10.1002/ccd.30601.
    >> Share

  174. REMPAKOS A, Simsek B, Kostantinis S, Karacsonyi J, et al
    Impact of lesion length on the outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2023 Feb 5. doi: 10.1002/ccd.30581.
    >> Share

  175. KOSTANTINIS S, Simsek B, Karacsonyi J, Rempakos A, et al
    Impact of proximal cap ambiguity on the procedural techniques and outcomes of chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO Registry.
    Catheter Cardiovasc Interv. 2023 Feb 5. doi: 10.1002/ccd.30580.
    >> Share

  176. WANAMAKER BL, Shoaib A, Seth M, Sukul D, et al
    Comparative analysis of percutaneous revascularization practice in the United States and the United Kingdom: Insights from the BMC2 and BCIS databases.
    Catheter Cardiovasc Interv. 2023;101:495-504.
    >> Share

  177. ARUNOTHAYARAJ S, Lassen JF, Clesham GJ, Spence MS, et al
    Impact of technique on bifurcation stent outcomes in the European Bifurcation Club Left Main Coronary Trial.
    Catheter Cardiovasc Interv. 2023;101:553-562.
    >> Share

  178. AZZALINI L, Hirai T, Salisbury A, Gosch K, et al
    Validation of the new PROGRESS-CTO complication risk scores in the OPEN-CTO registry.
    Catheter Cardiovasc Interv. 2023;101:536-542.
    >> Share

  179. VAN HEMERT ND, Voskuil M, Rozemeijer R, Kraaijeveld AO, et al
    Long-term follow-up of contemporary drug-eluting stent implantation in diabetic patients: Subanalysis of a randomized controlled trial.
    Catheter Cardiovasc Interv. 2023;101:505-510.
    >> Share

    January 2023
  180. KARACSONYI J, Alaswad K, Krestyaninov O, Karmpaliotis D, et al
    Single vs. multiple operators for chronic total occlusion percutaneous coronary interventions: From the PROGRESS-CTO Registry.
    Catheter Cardiovasc Interv. 2023 Jan 25. doi: 10.1002/ccd.30564.
    >> Share

  181. KAWAMURA Y, Yoshimachi F, Kasai S, Ikari Y, et al
    Novel dual guiding catheter technique for kissing balloon inflation in percutaneous coronary intervention for bifurcated chronic total occlusive lesion.
    Catheter Cardiovasc Interv. 2023 Jan 24. doi: 10.1002/ccd.30568.
    >> Share

  182. CHEN H, Spirito A, Sartori S, Nicolas J, et al
    Impact of complex percutaneous coronary intervention features on clinical outcomes in patients with or without chronic kidney disease.
    Catheter Cardiovasc Interv. 2023 Jan 24. doi: 10.1002/ccd.30569.
    >> Share

  183. RASANEN A, Karkkainen JM, Eranti A, Eranen J, et al
    Percutaneous coronary intervention with drug-coated balloon-only strategy combined with single antiplatelet treatment in patients at high bleeding risk: Single center experience of a novel concept.
    Catheter Cardiovasc Interv. 2023 Jan 22. doi: 10.1002/ccd.30558.
    >> Share

  184. AZZALINI L, Boudou N, Avran A, Kane J, et al
    Role of the retrograde Carlino technique for chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2023 Jan 22. doi: 10.1002/ccd.30565.
    >> Share

  185. DAVIS MG, Blankenship JC
    PCI for late STEMI: Better late than never?
    Catheter Cardiovasc Interv. 2023;101:11-12.
    >> Share

  186. CHAUS A, Uretsky BF
    Bifurcation stenting: If the shoe doesn't fit.
    Catheter Cardiovasc Interv. 2023;101:58-59.
    >> Share

  187. SAQIB N, Pir MS, Rajagopalan S, Patel TM, et al
    Comparison of radiation exposure associated with transradial and transfemoral access: An updated meta-analysis.
    Catheter Cardiovasc Interv. 2023;101:87-96.
    >> Share

  188. PETKOSKA D, Zafirovska B, Vasilev I, Novotni G, et al
    Radial and ulnar approach for carotid artery stenting with Roadsaver double layer micromesh stent: Early and long-term follow-up.
    Catheter Cardiovasc Interv. 2023;101:154-163.
    >> Share

  189. INCI EK, Khandhar S, Toma C, Licitra G, et al
    Mechanical thrombectomy versus catheter directed thrombolysis in patients with pulmonary embolism: A multicenter experience.
    Catheter Cardiovasc Interv. 2023;101:140-146.
    >> Share

  190. GRIFFIN ACG, Yildiz M, Bradley S, Smith JE, et al
    Frequency and outcomes of STEMI patients presenting between 12 and 24 h after symptom onset: Late-presenting STEMI.
    Catheter Cardiovasc Interv. 2023;101:1-10.
    >> Share

  191. PRICE J, Okyere R, Al-Kindi S, Gupta A, et al
    Management of a right coronary artery mycotic coronary aneurysm with percutaneous intervention with covered stents.
    Catheter Cardiovasc Interv. 2023;101:108-112.
    >> Share

  192. JAKOBSEN L, Christiansen EH, Freeman P, Kahlert J, et al
    Impact of acute coronary syndrome on clinical outcomes after revascularization with the dual-therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent.
    Catheter Cardiovasc Interv. 2023;101:13-21.
    >> Share

  193. GAROT P, Brunel P, Dibie A, Morelle JF, et al
    Comparison of outcomes in patients with or without ARC-HBR criteria undergoing PCI with polymer-free biolimus coated stents: The BioFreedom France study.
    Catheter Cardiovasc Interv. 2023;101:60-71.
    >> Share

  194. ACHIM A, Krivoshei L, Leibundgut G
    Unrecoverable stent deformation in the left main: Crush it or remove it?
    Catheter Cardiovasc Interv. 2023;101:113-120.
    >> Share

  195. CHIANG M, Villablanca PA, O'Neill WW, Frisoli T, et al
    Trans-caval aspiration artherectomy/thrombectomy of large mobile plaques and thrombi in aortic arch and descending aorta.
    Catheter Cardiovasc Interv. 2023;101:164-169.
    >> Share

    December 2022
  196. QIAN J, Wu Y, Li C, Yin J, et al
    Drug-coated balloon for the treatment of small vessel disease: 9 months of angiographic results and 12 months of clinical outcomes of the PEPCAD China SVD study.
    Catheter Cardiovasc Interv. 2022 Dec 8. doi: 10.1002/ccd.30472.
    >> Share

  197. TEHRANI DM, Seto AH
    The future of angiography: Estimates of FFR pre- and post-PCI.
    Catheter Cardiovasc Interv. 2022;100:1218-1219.
    >> Share

  198. FARIA D, Mejia-Renteria H, Lee JM, Lee SH, et al
    Age-related changes in the coronary microcirculation influencing the diagnostic performance of invasive pressure-based indices and long-term patient prognosis.
    Catheter Cardiovasc Interv. 2022;100:1195-1205.
    >> Share

  199. THALER C, Witt DR, Henry TD, Grey EZ, et al
    Revascularization and long-term outcomes in high-acuity spontaneous coronary artery dissection.
    Catheter Cardiovasc Interv. 2022;100:1229-1241.
    >> Share

  200. WINSCOTT JG, Hillegass WB
    Drug-coated balloon treatment of complex femoropopliteal disease yields favorable and durable outcomes at 5 years.
    Catheter Cardiovasc Interv. 2022;100:1284-1285.
    >> Share

  201. KO YG, Choi D, Rha SW, Won JH, et al
    Long-term outcomes after paclitaxel-coated balloon angioplasty of femoropopliteal arteries in Asian patients of the IN.PACT Global Study.
    Catheter Cardiovasc Interv. 2022;100:1273-1283.
    >> Share

    November 2022
  202. NG JCK, Ang H, Zhong L, Hakim D, et al
    Multimodality imaging results of TAP versus novel modified TAP stenting in coronary bifurcation: From bench testing to first-in-man investigation.
    Catheter Cardiovasc Interv. 2022 Nov 20. doi: 10.1002/ccd.30496.
    >> Share

  203. AZZALINI L, Moroni F, Dawson KL, Kearney KE, et al
    Chronic total occlusion percutaneous coronary intervention in heart transplant patients.
    Catheter Cardiovasc Interv. 2022 Nov 15. doi: 10.1002/ccd.30476.
    >> Share

  204. NAGRAJ S, Tzoumas A, Kakargias F, Giannopoulos S, et al
    Hybrid coronary revascularization (HCR) versus coronary artery bypass grafting (CABG) in multivessel coronary artery disease (MVCAD): A meta-analysis of 14 studies comprising 4226 patients.
    Catheter Cardiovasc Interv. 2022 Nov 6. doi: 10.1002/ccd.30446.
    >> Share

  205. SELVARAJ V, Chatterjee S, Hirai T, Abbott JD, et al
    Three versus 12-month dual antiplatelet therapy duration in patients with acute coronary syndrome undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2022 Nov 3. doi: 10.1002/ccd.30467.
    >> Share

  206. SCOCCIA A, Scarparo P, Neleman T, Kakar H, et al
    Diagnostic accuracy of angiography-based vessel fractional flow reserve after chronic coronary total occlusion recanalization.
    Catheter Cardiovasc Interv. 2022 Nov 2. doi: 10.1002/ccd.30439.
    >> Share

  207. LEE HJ, Mejia-Renteria H, Escaned J, Doh JH, et al
    Prediction of functional results of percutaneous coronary interventions with virtual stenting and quantitative flow ratio.
    Catheter Cardiovasc Interv. 2022 Nov 2. doi: 10.1002/ccd.30451.
    >> Share

  208. TARANTINI G, Cardaioli F
    CHIP-PCI: Ready for a prime time?
    Catheter Cardiovasc Interv. 2022;100:721-722.
    >> Share

  209. ALLANA SS, Brilakis ES
    How good is intravascular brachytherapy for treating in-stent restenosis?
    Catheter Cardiovasc Interv. 2022;100:763-764.
    >> Share

  210. CILINGIROGLU M, Halil Inanc I
    Local or general anesthesia for EVAR in patients with ruptured AAA?
    Catheter Cardiovasc Interv. 2022;100:938.
    >> Share

  211. COLOPI M, Musumeci G
    Intravascular lithotripsy pretreatment of coronary chronic total occlusions: Current PROGRESS and the Next Frontier.
    Catheter Cardiovasc Interv. 2022;100:939-940.
    >> Share

  212. WINSCOTT JG, Hillegass WB
    Percutaneous coronary intervention in the polyvascular patient remains a high-risk procedure.
    Catheter Cardiovasc Interv. 2022;100:747-748.
    >> Share

  213. TOPAZ O
    The premise and performance of transcatheter vacuum-assisted extraction of left side cardiac thrombotic masses.
    Catheter Cardiovasc Interv. 2022;100:931-932.
    >> Share

  214. ALLANA SS, Brilakis ES
    Dual guidewire balloon for antegrade fenestration re-entry: A welcome addition to the CTO operators' armamentarium.
    Catheter Cardiovasc Interv. 2022;100:933-935.
    >> Share

  215. JONES EL, Blankenship JC
    Women deserve the best care.
    Catheter Cardiovasc Interv. 2022;100:936-937.
    >> Share

  216. KUKAR A, Dangas GD
    Peripheral studies deserve center stage!
    Catheter Cardiovasc Interv. 2022;100:927-928.
    >> Share

  217. SIMSEK B, Kostantinis S, Karacsonyi J, Allana S, et al
    Outcomes and challenges of the provisional stenting technique: Insights from the PROGRESS-BIFURCATION registry.
    Catheter Cardiovasc Interv. 2022;100:749-755.
    >> Share

  218. WALLNER K, Kearney KE, Kim M, Tiwana J, et al
    Failure patterns after intravascular brachytherapy for in-stent coronary restenosis.
    Catheter Cardiovasc Interv. 2022;100:759-762.
    >> Share

  219. CHAMI T, Mahowald MK, Brilakis E
    Retrograde approach for rewiring a jailed side branch during double kissing crush stenting.
    Catheter Cardiovasc Interv. 2022;100:756-758.
    >> Share

  220. TARGONSKI R, Gasecka A, Luis MS, Jagielak D, et al
    Harnessing the parallax for better spatial awareness.
    Catheter Cardiovasc Interv. 2022;100:915-922.
    >> Share

  221. YEN YT, Chen YY, Kao PH, Lin CH, et al
    Zone 0 thoracic endovascular aortic repair in high risk patients: A retrospective case series.
    Catheter Cardiovasc Interv. 2022;100:787-794.
    >> Share

  222. TARANTINI G, Fabris T
    Single-access technique for Impella-assisted PCI: How to take hold of Impella by the smooth handle.
    Catheter Cardiovasc Interv. 2022;100:1043-1044.
    >> Share

  223. PICCOLO R, Esposito G
    Peripheral arterial disease and multisite atherosclerosis in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022;100:1146-1147.
    >> Share

  224. SETH A, Ezhumalai B
    Percutaneous Coronary Intervention of bifurcation lesions: The proof is in the pudding!
    Catheter Cardiovasc Interv. 2022;100:1148-1149.
    >> Share

  225. SALAETS T, Cools B, De Meester P, Heying R, et al
    Stent expansion of restrictive Fontan conduits to nominal diameter and beyond.
    Catheter Cardiovasc Interv. 2022;100:1059-1066.
    >> Share

  226. ALLALI A, Toelg R, Abdel-Wahab M, Hemetsberger R, et al
    Combined rotational atherectomy and cutting balloon angioplasty prior to drug-eluting stent implantation in severely calcified coronary lesions: The PREPARE-CALC-COMBO study.
    Catheter Cardiovasc Interv. 2022;100:979-989.
    >> Share

  227. GILLMORE T, Jung RG, Moreland R, Di Santo P, et al
    Impact of intracoronary assessments on revascularization decisions: A contemporary evaluation.
    Catheter Cardiovasc Interv. 2022;100:955-963.
    >> Share

  228. MASUDA H, Kuramitsu S, Ito T, Morofuji T, et al
    Outcomes of paclitaxel-coated balloon angioplasty for in-stent calcified nodule: An optical coherence tomography study.
    Catheter Cardiovasc Interv. 2022;100:990-999.
    >> Share

  229. ROLA P, Wlodarczak S, Doroszko A, Lesiak M, et al
    The bioresorbable magnesium scaffold (Magmaris)-State of the art: From basic concept to clinical application.
    Catheter Cardiovasc Interv. 2022;100:1051-1058.
    >> Share

  230. LANGHOFF R, Petrov I, Kedev S, Milosevic Z, et al
    PERFORMANCE 1 study: Novel carotid stent system with integrated post-dilation balloon and embolic protection device.
    Catheter Cardiovasc Interv. 2022;100:1090-1099.
    >> Share

  231. DEL VAL D, Cuesta J, Roquero P, Alfonso F, et al
    Lithotripsy for calcified in-stent restenosis. The "rock strata peeling pattern": A novel fracture pattern detected by optical coherence tomography.
    Catheter Cardiovasc Interv. 2022;100:1036-1038.
    >> Share

  232. PARFREY S, Mozid A
    Feasibility of facilitated antegrade dissection with Stingray-based re-entry for coronary chronic total occlusions with previously stented graft-to-native-vessel anastomoses.
    Catheter Cardiovasc Interv. 2022;100:1030-1035.
    >> Share

  233. MORETTI F, Bernelli C, Pellegrini D, Boccuzzi G, et al
    Determinants and long-term outcomes of largely uncovered struts in thin-struts drug-eluting stents assessed by optical coherence tomography.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S25-S35.
    >> Share

  234. BUCCOLA J, Meinen J, Spinelli J, Hammerstone M, et al
    Investigating real-world impact of optical coherence tomography workflow-guided coronary interventions: Design and rationale of the LightLab Clinical Initiative.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S1-S6.
    >> Share

  235. SHLOFMITZ E, Croce K, Bezerra H, Sheth T, et al
    The MLD MAX OCT algorithm: An imaging-based workflow for percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S7-S13.
    >> Share

  236. RAJA A, Osborn EA, Bergmark BA, Croce KD, et al
    OCT utilization: Summary statistics from the LightLab clinical initiative.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S36-S43.
    >> Share

  237. KHUDDUS MA, Darki A, Padaliya BB, West NEJ, et al
    Improving efficiency and operator proficiency during percutaneous coronary interventions utilizing a standardized optical coherence tomography workflow.
    Catheter Cardiovasc Interv. 2022;100 Suppl 1:S14-S24.
    >> Share

    October 2022
  238. WATANABE Y, Sakakura K, Taniguchi Y, Yamamoto K, et al
    Impact of intravascular ultrasound-incomplete stent apposition on stent failure.
    Catheter Cardiovasc Interv. 2022 Oct 27. doi: 10.1002/ccd.30424.
    >> Share

  239. NAIMI I, Morray B, Portman MA, Steinberg ZL, et al
    Use of the PK Papyrus covered coronary stent in the treatment of Kawasaki disease-associated giant coronary artery aneurysms.
    Catheter Cardiovasc Interv. 2022 Oct 26. doi: 10.1002/ccd.30458.
    >> Share

  240. KOSTANTINIS S, Simsek B, Karacsonyi J, Alaswad K, et al
    Gender differences in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Oct 25. doi: 10.1002/ccd.30425.
    >> Share

  241. CORTESE B, Piraino D, Gentile D, Onea HL, et al
    Intravascular imaging for left main stem assessment: An update on the most recent clinical data.
    Catheter Cardiovasc Interv. 2022 Oct 23. doi: 10.1002/ccd.30440.
    >> Share

  242. ZHENG WC, Noaman S, Batchelor RJ, Hanson L, et al
    Evaluation of factors associated with selection for coronary angiography and in-hospital mortality among patients presenting with out-of-hospital cardiac arrest without ST-segment elevation.
    Catheter Cardiovasc Interv. 2022 Oct 23. doi: 10.1002/ccd.30442.
    >> Share

  243. GRINES CL, Tummala P
    Will the TRANSFORM II trial transform our management of small vessel coronary disease?
    Catheter Cardiovasc Interv. 2022 Oct 18. doi: 10.1002/ccd.30429.
    >> Share

  244. ASLLANAJ B, Urzua A, Dota A, Levisman J, et al
    Non-surgical extirpation of a non-infectious expanding tricuspid valve mass by percutaneous aspiration thrombectomy.
    Catheter Cardiovasc Interv. 2022 Oct 18. doi: 10.1002/ccd.30428.
    >> Share

  245. SIDDIQI TJ, Khan MS, Karimi Galougahi K, Shlofmitz E, et al
    Optical coherence tomography versus angiography and intravascular ultrasound to guide coronary stent implantation: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Oct 17. doi: 10.1002/ccd.30416.
    >> Share

  246. VERREAULT-JULIEN L, Shekiladze N, Wollmuth J, Rinfret S, et al
    Single-access for Impella-supported percutaneous coronary intervention using a sheathless technique with an 8 Fr guide.
    Catheter Cardiovasc Interv. 2022 Oct 13. doi: 10.1002/ccd.30427.
    >> Share

  247. MATHEWS SJ, Brown CL, Kolski BC, Marques VM, et al
    Initial experience with a continuous mechanical aspiration system for thrombus removal before percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Oct 2. doi: 10.1002/ccd.30389.
    >> Share

  248. EARLE W, Abdallah G, Meagher S, Shen K, et al
    Reducing use of triple therapy after percutaneous coronary intervention: Results from a hospital-wide quality improvement initiative.
    Catheter Cardiovasc Interv. 2022 Oct 2. doi: 10.1002/ccd.30412.
    >> Share

  249. KONG M, Ni M, Zhu X, Qian J, et al
    False lumen patency status and outcomes after endovascular repair of uncomplicated chronic type B dissection.
    Catheter Cardiovasc Interv. 2022;100:696-704.
    >> Share

  250. OSMAN M, Syed M, Simpson TF, Bhardwaj B, et al
    Incidence and outcomes of cardiogenic shock among women with spontaneous coronary artery dissection.
    Catheter Cardiovasc Interv. 2022;100:530-534.
    >> Share

  251. SHEKHAR S, Ajay A, Agrawal A, Kumar A, et al
    Radiation reduction in a modern catheterization laboratory: A single-center experience.
    Catheter Cardiovasc Interv. 2022;100:575-584.
    >> Share

  252. GRECO A, Sciahbasi A, Abizaid A, Mehran R, et al
    Sirolimus-coated balloon versus everolimus-eluting stent in de novo coronary artery disease: Rationale and design of the TRANSFORM II randomized clinical trial.
    Catheter Cardiovasc Interv. 2022;100:544-552.
    >> Share

  253. WANG HY, Mo R, Guan CD, Wang Y, et al
    Establishing the optimal duration of DAPT following PCI in high-risk TWILIGHT-like patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2022;100:593-595.
    >> Share

  254. CHAMBERS JW, Martinsen BJ, Sturm RC, Mandair D, et al
    Orbital atherectomy of calcified coronary ostial lesions.
    Catheter Cardiovasc Interv. 2022;100:553-559.
    >> Share

  255. QINTAR M, Wang DD, Lee J, Villablanca P, et al
    Transcatheter vacuum-assisted left-sided mass extraction with the AngioVac system.
    Catheter Cardiovasc Interv. 2022;100:628-635.
    >> Share

  256. WILGENHOF A, Vescovo GM, Bezzeccheri A, Scott B, et al
    Minimalistic hybrid approach for the percutaneous treatment of chronic coronary total occlusions: An in-depth analysis of the whole algorithm.
    Catheter Cardiovasc Interv. 2022;100:502-511.
    >> Share

  257. LEI J, Pu H, Wu Z, Huang Q, et al
    Local versus general anesthesia for endovascular aneurysm repair in ruptured abdominal aortic aneurysm: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022;100:679-686.
    >> Share

  258. PATEL M, Mujer M, John A, Darki A, et al
    VA-ECMO-assisted aspiration thrombectomy in a patient presenting with acute massive PE with absolute contraindications to thrombolytics.
    Catheter Cardiovasc Interv. 2022;100:705-709.
    >> Share

    September 2022
  259. MEGALY M, Buda K, Karacsonyi J, Kostantinis S, et al
    Extraplaque versus intraplaque tracking in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Sep 28. doi: 10.1002/ccd.30403.
    >> Share

  260. BASHAR H, Matetic A, Curzen N, Mamas MA, et al
    Impact of extracardiac vascular disease on outcomes of 1.4 million patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Sep 21. doi: 10.1002/ccd.30404.
    >> Share

  261. CARANDE EJ, Protty MB, Verhemel S, Hussein MH, et al
    Predictors of 30-day and 12-month mortality in left main stem percutaneous coronary intervention 2016-2020: A study from two UK centers.
    Catheter Cardiovasc Interv. 2022 Sep 14. doi: 10.1002/ccd.30400.
    >> Share

  262. AHLERS MJ, Srivastava PK, Basir MB, O'Neill WW, et al
    Characteristics and outcomes of patients presenting with acute myocardial infarction and cardiogenic shock during COVID-19.
    Catheter Cardiovasc Interv. 2022 Sep 7. doi: 10.1002/ccd.30390.
    >> Share

  263. SHAMKHANI W, Rashid M, Mamas M
    Complex, high-risk percutaneous coronary intervention types, trends, and in-hospital outcomes among different age groups: An insight from a national registry.
    Catheter Cardiovasc Interv. 2022 Sep 2. doi: 10.1002/ccd.30366.
    >> Share

  264. GRINES CL, Dupont A
    Turndown for coronary artery bypass surgery: Never say never to revascularization.
    Catheter Cardiovasc Interv. 2022;100:367-368.
    >> Share

  265. MUSUMECI G, Civera S
    When not to treat could be the best option.
    Catheter Cardiovasc Interv. 2022;100:338-339.
    >> Share

  266. BUTMAN SM
    Variability in healthcare delivery: It is never a good thing.
    Catheter Cardiovasc Interv. 2022;100:317-318.
    >> Share

  267. WHITBECK MG, Chambers JW
    Treatment of cardiac device-related infective endocarditis utilizing the new T20 curve catheter and flow saver with the Inari mechanical aspiration system.
    Catheter Cardiovasc Interv. 2022;100:476-479.
    >> Share

  268. PATEL P, Sethi N, Patel GA, Kalisetti D, et al
    Evaluation of the incidence of radial artery occlusion using different introducer sheaths and hemostasis techniques.
    Catheter Cardiovasc Interv. 2022;100:387-391.
    >> Share

  269. HONDA Y, Yamawaki M, Mori S, Tsutsumi M, et al
    Predictive performance of J-Calc-CTO score for guidewire crossing through chronic total occlusion lesions within 30 minutes: J-CTO score modified by computed tomography coronary angiography.
    Catheter Cardiovasc Interv. 2022 Sep 1. doi: 10.1002/ccd.30384.
    >> Share

    August 2022
  270. SAGER R, Keller LS, Stehli J, Jakob P, et al
    Association of N-terminal pro-B-type natriuretic peptide with mortality in elderly (>/=80 years) patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Aug 30. doi: 10.1002/ccd.30365.
    >> Share

  271. SAVAGE ML, Hay K, Murdoch DJ, Walters DL, et al
    Sex differences in time to primary percutaneous coronary intervention and outcomes in patients presenting with ST-segment elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2022 Aug 16. doi: 10.1002/ccd.30357.
    >> Share

  272. KOSTANTINIS S, Simsek B, Karacsonyi J, Davies RE, et al
    Intravascular lithotripsy in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Aug 2. doi: 10.1002/ccd.30354.
    >> Share

  273. VETROVEC GW
    Robotic coronary angiography: Advantages of stepping back.
    Catheter Cardiovasc Interv. 2022;100:214-215.
    >> Share

  274. DI MARIO C, Kucukseymen S
    Second generation drug eluting stent: The longer, the better?
    Catheter Cardiovasc Interv. 2022;100:188-189.
    >> Share

  275. MOUSLY H, Hajjari J, Chami T, Hammad T, et al
    Percutaneous mechanical thrombectomy and extracorporeal membranous oxygenation: A case series.
    Catheter Cardiovasc Interv. 2022;100:274-278.
    >> Share

  276. GAUTIER A, Hovasse T, Arroyo D, Unterseeh T, et al
    Safety and efficacy of 48 mm Xience Xpedition everolimus-eluting stent for the treatment of long coronary lesions.
    Catheter Cardiovasc Interv. 2022;100:179-187.
    >> Share

    July 2022
  277. FREUND A, van Royen N, Kern KB, Jobs A, et al
    Early coronary angiography in patients after out-of-hospital cardiac arrest without ST-segment elevation: Meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2022 Jul 28. doi: 10.1002/ccd.30355.
    >> Share

  278. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Antegrade dissection and re-entry versus parallel wiring in chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Jul 28. doi: 10.1002/ccd.30346.
    >> Share

  279. MUSTO C, Scappaticci M, Biondi-Zoccai G, De Felice F, et al
    Instantaneous wave-free ratio-guided revascularization of nonculprit lesions in STEMI patients with multivessel coronary disease: The WAVE registry.
    Catheter Cardiovasc Interv. 2022 Jul 23. doi: 10.1002/ccd.30342.
    >> Share

  280. SIMSEK B, Gorgulu S, Kostantinis S, Karacsonyi J, et al
    Radial access for chronic total occlusion percutaneous coronary intervention: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2022 Jul 23. doi: 10.1002/ccd.30347.
    >> Share

  281. BABAEV A, Halista M, Bakirova Z, Avtushka V, et al
    Directional versus orbital atherectomy of femoropopliteal artery lesions: Angiographic and intravascular ultrasound outcomes.
    Catheter Cardiovasc Interv. 2022 Jul 16. doi: 10.1002/ccd.30339.
    >> Share

  282. GALASSI AR, Vadala G, Testa G, Puglisi S, et al
    Dual guidewire balloon antegrade fenestration and re-entry technique for coronary chronic total occlusions percutaneous coronary interventions.
    Catheter Cardiovasc Interv. 2022 Jul 12. doi: 10.1002/ccd.30324.
    >> Share

  283. OKUYA Y, Gohil K, Moussa ID
    Angiography versus FFR guided complete revascularization versus culprit-only revascularization for patients presenting with STEMI: Network meta-analysis.
    Catheter Cardiovasc Interv. 2022 Jul 5. doi: 10.1002/ccd.30304.
    >> Share

  284. SHELDON M, Blankenship JC
    STEMI in nonagenarians: Never too old.
    Catheter Cardiovasc Interv. 2022;100:17-18.
    >> Share

  285. ASHLEY KE, Hillegass WB
    Ticagrelor monotherapy after coronary stenting in patients requiring proton pump inhibitor and prolonged antiplatelet therapy.
    Catheter Cardiovasc Interv. 2022;100:83-84.
    >> Share

  286. DI SERAFINO L, Esposito G
    May FFR-guided PCI save lives?: Commentary on: "Clinical impact of FFR-guided PCI compared to angio-guided PCI from the France PCI registry".
    Catheter Cardiovasc Interv. 2022;100:49-50.
    >> Share

  287. KALYANASUNDARAM A, Seth A
    Retrograde CTO PCI-the final frontier-challenges and outcomes.
    Catheter Cardiovasc Interv. 2022;100:28-29.
    >> Share

  288. GRINES CL, Marshall JJ
    Directional coronary atherectomy revisited.
    Catheter Cardiovasc Interv. 2022;100:59-60.
    >> Share

  289. ADJEDJ J, Morelle JF, Saint Etienne C, Fichaux O, et al
    Clinical impact of FFR-guided PCI compared to angio-guided PCI from the France PCI registry.
    Catheter Cardiovasc Interv. 2022;100:40-48.
    >> Share

  290. LIANG B, Gu N
    High-speed rotational atherectomy in coronary artery calcification: The randomized ROTAXUS and PREPARE-CALC trials.
    Catheter Cardiovasc Interv. 2022;100:61-71.
    >> Share

  291. FARAG M, Al-Atta A, Abdalazeem I, Salim T, et al
    Clinical outcomes of percutaneous coronary intervention in high-risk patients turned down for surgical revascularization.
    Catheter Cardiovasc Interv. 2022 Jul 1. doi: 10.1002/ccd.30318.
    >> Share

    June 2022
  292. RASHID M, Kinnaird T, Ludman P, Keeble TR, et al
    Variation in practice for out-of-hospital cardiac arrest treated with percutaneous coronary intervention in England and Wales.
    Catheter Cardiovasc Interv. 2022 Jun 29. doi: 10.1002/ccd.30316.
    >> Share

  293. PAVANI M, Cerrato E, Franze A, Colombo F, et al
    Grade 3 coronary artery perforations in chronic total occlusion-percutaneous coronary intervention: Mechanisms, locations, and outcomes from the G3CAP Registry.
    Catheter Cardiovasc Interv. 2022 Jun 10. doi: 10.1002/ccd.30293.
    >> Share

  294. SIMSEK B, Brilakis ES
    Why double-kissing crush should be preferred over culotte for two-stent bifurcation stenting.
    Catheter Cardiovasc Interv. 2022;99:2006-2007.
    >> Share

  295. SETO AH
    Closing the loop in cath lab communication: Avoiding the tower of babble.
    Catheter Cardiovasc Interv. 2022;99:1963-1964.
    >> Share

  296. KARACSONYI J, Brilakis ES, Chandwaney RH
    Guide-Extension Carlino: A novel technique for crossing a microcatheter uncrossable proximal cap during chronic total occlusion interventions.
    Catheter Cardiovasc Interv. 2022;99:2038-2042.
    >> Share

  297. JAKOBSEN L, Christiansen EH, Freeman P, Kahlert J, et al
    Impact of diabetes on clinical outcomes after revascularization with the dual therapy CD34 antibody-covered sirolimus-eluting Combo stent and the sirolimus-eluting Orsiro stent.
    Catheter Cardiovasc Interv. 2022;99:1965-1975.
    >> Share

  298. KOBAYASHI N, Ito Y, Kishi K, Muramatsu T, et al
    Procedural results and in-hospital outcomes of percutaneous coronary intervention for chronic total occlusion in patients with reduced left ventricular ejection fraction: Sub-analysis of the Japanese CTO-PCI Expert Registry.
    Catheter Cardiovasc Interv. 2022 Jun 1. doi: 10.1002/ccd.30231.
    >> Share

    May 2022
  299. JOSEPH T, VanOosterhout S, Negash A, VanLoo L, et al
    Robotically performed diagnostic coronary angiography.
    Catheter Cardiovasc Interv. 2022 May 27. doi: 10.1002/ccd.30250.
    >> Share

  300. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Predictors of success in primary retrograde strategy in chronic total occlusion percutaneous coronary intervention: insights from the PROGRESS-chronic total occlusion registry.
    Catheter Cardiovasc Interv. 2022 May 26. doi: 10.1002/ccd.30228.
    >> Share

  301. NUMASAWA Y, Inohara T, Ishii H, Yamaji K, et al
    Overview of in-hospital outcomes in patients undergoing percutaneous coronary intervention with the revived directional coronary atherectomy.
    Catheter Cardiovasc Interv. 2022 May 20. doi: 10.1002/ccd.30233.
    >> Share

  302. ISMAYL M, Machanahalli Balakrishna A, Walters RW, Pajjuru VS, et al
    In-hospital mortality and readmission after ST-elevation myocardial infarction in nonagenarians: A nationwide analysis from the United States.
    Catheter Cardiovasc Interv. 2022 May 14. doi: 10.1002/ccd.30227.
    >> Share

  303. VAN HATTEM VAE, Otterspoor LC, Lipsic E, Vlaar PJJ, et al
    Right ventricular hematoma: A rare but potentially fatal complication of percutaneous coronary artery intervention.
    Catheter Cardiovasc Interv. 2022 May 12. doi: 10.1002/ccd.30226.
    >> Share

  304. ONO M, Onuma Y, Kawashima H, Hara H, et al
    Impact of proton pump inhibitors on efficacy of antiplatelet strategies with ticagrelor or aspirin after percutaneous coronary intervention: Insights from the GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2022 May 2. doi: 10.1002/ccd.30217.
    >> Share

  305. JOVIN IS, Warsavage TJ, Plomondon ME, Grunwald GK, et al
    Iso-osmolar versus low-osmolar contrast media and outcomes after percutaneous coronary intervention: Insights from the VA CART Program.
    Catheter Cardiovasc Interv. 2022 May 2. doi: 10.1002/ccd.30218.
    >> Share

  306. MA W, Wang Q, Wang B, Wang C, et al
    Novel predictors of stent under-expansion regarding calcified coronary lesions assessed by optical coherence tomography.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1473-1481.
    >> Share

  307. WANG M, Liu H, Xu B, Bian X, et al
    Protective ballooning technique for prevention of side branch occlusion in coronary nonleft main true bifurcation lesions: A single-center study.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1418-1423.
    >> Share

  308. HE J, Zhang D, Zhang R, Wang H, et al
    Validation of the V-RESOLVE (Visual Estimation for Risk prEdiction of Side Branch OccLusion in Coronary Bifurcation interVEntion) score system in unprotected left main bifurcation.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1465-1472.
    >> Share

  309. GUAN C, Geng L, Zhang R, You J, et al
    Long-term prognostic value of dynamic function assessment of intermediate coronary lesion with computational physiology.
    Catheter Cardiovasc Interv. 2022;99 Suppl 1:1386-1394.
    >> Share

  310. LEE A, Kimmelstiel C
    Stretching and cutting after drilling. Vessel preparation following rotational atherectomy.
    Catheter Cardiovasc Interv. 2022;99:1750-1751.
    >> Share

  311. PATEL N, Bandyopadhyay D, Agarwal G, Chakraborty S, et al
    Outcomes of rotational atherectomy followed by cutting balloon versus plain balloon before drug-eluting stent implantation for calcified coronary lesions: A meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1741-1749.
    >> Share

  312. BEOHAR N, Stone GW, Martinsen BJ, Parise H, et al
    Coronary orbital atherectomy treatment of Hispanic and Latino patients: A real-world comparative analysis.
    Catheter Cardiovasc Interv. 2022;99:1752-1757.
    >> Share

  313. DALEN M, Settergren M, Kastengren M, Ullstrom P, et al
    Percutaneous decannulation of extracorporeal membrane oxygenation using a plug-based closure device.
    Catheter Cardiovasc Interv. 2022;99:1945-1952.
    >> Share

    April 2022
  314. SALEM H, Mintz GS, Matsumura M, Zhang M, et al
    Reasons for lesion uncrossability as assessed by intravascular ultrasound.
    Catheter Cardiovasc Interv. 2022 Apr 14. doi: 10.1002/ccd.30202.
    >> Share

  315. MOTIWALA A, Jneid H
    Reflections on the association of thrombocytopenia with adverse outcomes after PCI.
    Catheter Cardiovasc Interv. 2022;99:1498-1499.
    >> Share

  316. FABRIS E, Menzio S, Gregorio C, Pezzato A, et al
    Effect of prehospital treatment in STEMI patients undergoing primary PCI.
    Catheter Cardiovasc Interv. 2022;99:1500-1508.
    >> Share

  317. GROOT JEBBINK E, van Wijck I, Holewijn S, Iida O, et al
    Individual patient data meta-analysis of patients treated with a heparin-bonded Viabahn in the femoropopliteal artery for chronic limb-threatening ischemia.
    Catheter Cardiovasc Interv. 2022;99:1714-1722.
    >> Share

  318. RIVERO F, Marco V, Biccire FG, Budassi S, et al
    The double injection technique to improve visualization of severe coronary lesions with optical coherence tomography.
    Catheter Cardiovasc Interv. 2022;99:1511-1517.
    >> Share

  319. SONCK J, Mizukami T, Johnson NP, Nagumo S, et al
    Development, validation, and reproducibility of the pullback pressure gradient (PPG) derived from manual fractional flow reserve pullbacks.
    Catheter Cardiovasc Interv. 2022;99:1518-1525.
    >> Share

  320. KHOKHAR AA, Zelias A, Zlahoda-Huzior A, Dudek D, et al
    Complication during robotic-PCI: Iatrogenic guiding catheter dissection.
    Catheter Cardiovasc Interv. 2022;99:1526-1528.
    >> Share

    March 2022
  321. SIMSEK B, Kostantinis S, Karacsonyi J, Hall A, et al
    International percutaneous coronary intervention complication survey.
    Catheter Cardiovasc Interv. 2022 Mar 29. doi: 10.1002/ccd.30173.
    >> Share

  322. SUMMERS MR, Lavigne PM, Mahoney PD
    Completion peripheral angiography in single-access, Impella-assisted, high-risk PCI: Using a buddy microcatheter sheath after MANTA closure for imaging and potential bailout.
    Catheter Cardiovasc Interv. 2022 Mar 29. doi: 10.1002/ccd.30145.
    >> Share

  323. JANUSZEK R, Siudak Z, Malinowski KP, Wanha W, et al
    Annual operator volume among patients treated using percutaneous coronary interventions with rotational atherectomy and procedural outcomes: Analysis based on a large national registry.
    Catheter Cardiovasc Interv. 2022 Mar 22. doi: 10.1002/ccd.30155.
    >> Share

  324. SANZ-SANCHEZ J, Mashayekhi K, Agostoni P, Egred M, et al
    Device entrapment during percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Mar 21. doi: 10.1002/ccd.30160.
    >> Share

  325. VALLURUPALLI S, Hess E, Plomondon ME, Park K, et al
    Impact of severity of baseline thrombocytopenia on outcomes after percutaneous coronary interventions: Analysis from the Veterans Affairs Clinical Assessment, Reporting, and Tracking (VA CART) Program.
    Catheter Cardiovasc Interv. 2022 Mar 7. doi: 10.1002/ccd.30142.
    >> Share

  326. TARANTINI G, Cardaioli F
    Bioresorbable scaffolds: zebras are not striped horses.
    Catheter Cardiovasc Interv. 2022;99:1084-1085.
    >> Share

  327. WINSCOTT JG, Hillegass WB
    Successfully treating the common femoral artery "no go zone" with directional atherectomy plus antirestenotic therapy (DAART).
    Catheter Cardiovasc Interv. 2022;99:1317-1318.
    >> Share

  328. PATEL NJ, Heuser RR
    Physiologic liquid plumber: A novel treatment to facilitate crossing of chronic total occlusions.
    Catheter Cardiovasc Interv. 2022;99:1074.
    >> Share

  329. DROSOU ME, Gray WA
    Clipping costs.
    Catheter Cardiovasc Interv. 2022;99:1257-1258.
    >> Share

  330. GRINES CL, Marshall JJ
    Step back to see the complete picture: Complete versus incomplete revascularization of multivessel coronary disease.
    Catheter Cardiovasc Interv. 2022;99:968-969.
    >> Share

  331. KUMAR A, Huded CP, Kassis N, Martin J, et al
    Feasibility of transradial primary percutaneous coronary intervention for STEMI complicated by cardiac arrest.
    Catheter Cardiovasc Interv. 2022;99:1363-1365.
    >> Share

  332. DANGAS G, Garg A
    Double kissing crush stenting: No pain, no gain?
    Catheter Cardiovasc Interv. 2022;99:1045-1046.
    >> Share

  333. SIMSEK B, Kostantinis S, Karacsonyi J, Vemmou E, et al
    Challenges and outcomes of the double kissing crush stenting technique: Insights from the PROGRESS-BIFURCATION registry.
    Catheter Cardiovasc Interv. 2022;99:1038-1044.
    >> Share

  334. BISCAGLIA S, Erriquez A, Serenelli M, D'Ascenzo F, et al
    Complete versus culprit-only strategy in older MI patients with multivessel disease.
    Catheter Cardiovasc Interv. 2022;99:970-978.
    >> Share

  335. MURASATO Y, Watanabe Y, Yamawaki M, Kinoshita Y, et al
    Effect of proximal optimization technique on coronary bifurcation stent failure: Insights from the multicenter randomized PROPOT trial.
    Catheter Cardiovasc Interv. 2022;99:1047-1058.
    >> Share

  336. KARIM AM, Li J, Panhwar MS, Arshad S, et al
    Impact of malnutrition and frailty on mortality and major amputation in patients with CLTI.
    Catheter Cardiovasc Interv. 2022;99:1300-1309.
    >> Share

  337. TOMA C, Bunte MC, Cho KH, Jaber WA, et al
    Percutaneous mechanical thrombectomy in a real-world pulmonary embolism population: Interim results of the FLASH registry.
    Catheter Cardiovasc Interv. 2022;99:1345-1355.
    >> Share

  338. TAKAHASHI T, Nishi T, Zimmermann FM, Granada JF, et al
    Clinical validation of a novel simplified offline tool for SYNTAX score calculation.
    Catheter Cardiovasc Interv. 2022;99:1366-1368.
    >> Share

  339. GRAHAM JJ, Bagai A, Wijeysundera H, Weisz G, et al
    Collagenase to facilitate guidewire crossing in chronic total occlusion PCI-The Total Occlusion Study in Coronary Arteries-5 (TOSCA-5) trial.
    Catheter Cardiovasc Interv. 2022;99:1065-1073.
    >> Share

  340. SINGH N, Ding L, Magee GA, Shavelle DM, et al
    Contemporary treatment of below-the-knee peripheral arterial disease in patients with chronic limb threatening ischemia: Observations from the Vascular Quality Initiative.
    Catheter Cardiovasc Interv. 2022;99:1289-1299.
    >> Share

  341. NAN TIE E, Fernando H, Nehme Z, Dinh D, et al
    Sex differences in prehospital analgesia in patients presenting with acute coronary syndromes and their association with clinical outcomes.
    Catheter Cardiovasc Interv. 2022;99:989-995.
    >> Share

  342. ULLAH W, Zghouzi M, Sattar Z, Ahmad B, et al
    Safety and efficacy of drug-coated balloon for peripheral artery revascularization-A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022;99:1319-1326.
    >> Share

  343. HANSEN KN, Maeng M, Raungaard B, Engstrom T, et al
    Impact of diabetes on 1-year clinical outcome in patients undergoing revascularization with the BioFreedom stents or the Orsiro stents from the SORT OUT IX trial.
    Catheter Cardiovasc Interv. 2022;99:1095-1103.
    >> Share

  344. PARK JH, Rha SW
    Early-onset persistent type IIIb endoleak following incraft stent graft implantation in an abdominal aortic aneurysm patient.
    Catheter Cardiovasc Interv. 2022;99:1358-1362.
    >> Share

  345. BARKHOLT TO, Neghabat O, Holck EN, Andreasen LN, et al
    Bioresorbable magnesium scaffold in the treatment of simple coronary bifurcation lesions: The BIFSORB pilot II study.
    Catheter Cardiovasc Interv. 2022;99:1075-1083.
    >> Share

  346. WILLIAMS T, Mittal A, Karageorgiev D, Iniguez Romo A, et al
    Complete revascularization optimizes patient outcomes in multivessel coronary artery disease: Data from the e-Ultimaster registry.
    Catheter Cardiovasc Interv. 2022;99:961-967.
    >> Share

  347. CIOPPA A, Franzese M, Gerardi D, Pucciarelli A, et al
    Three-year outcome of directional atherectomy and drug coated balloon for the treatment of common femoral artery steno-occlusive lesions.
    Catheter Cardiovasc Interv. 2022;99:1310-1316.
    >> Share

  348. PRASAD A, Amin AP, Ryan MP, Gunnarsson C, et al
    Use of iso-osmolar contrast media during endovascular revascularization is associated with a lower incidence of major adverse renal, cardiac, or limb events.
    Catheter Cardiovasc Interv. 2022;99:1335-1342.
    >> Share

    February 2022
  349. ARCHILLETTI F, Giuliani L, Dangas GD, Ricci F, et al
    Timing of mechanical circulatory support during primary angioplasty in acute myocardial infarction and cardiogenic shock: Systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Feb 19. doi: 10.1002/ccd.30137.
    >> Share

  350. HANNA EB, Rossen J, Eustes AS, Dayal S, et al
    Heavy lone coronary artery thrombosis treated by stent retriever, in the setting of COVID-19 infection.
    Catheter Cardiovasc Interv. 2022;99:457-461.
    >> Share

  351. KITE TA, Ladwiniec A, Owens CG, Chase A, et al
    Outcomes following PCI in CABG candidates during the COVID-19 pandemic: The prospective multicentre UK-ReVasc registry.
    Catheter Cardiovasc Interv. 2022;99:305-313.
    >> Share

  352. ALASNAG M
    Sound and light editorial: The ROCK cohort II study.
    Catheter Cardiovasc Interv. 2022;99:674-675.
    >> Share

  353. TEHRANI DM, Seto AH
    Clinical risk overlaps both bare metal and drug-eluting stents.
    Catheter Cardiovasc Interv. 2022;99:552-553.
    >> Share

  354. VARBELLA F, Cerrato E, Rolfo C, Quadri G, et al
    Characteristics and outcomes of elderly patients undergoing carotid stenting: Experience of a high-volume interventional cardiology center.
    Catheter Cardiovasc Interv. 2022;99:853-859.
    >> Share

  355. TARANTINI G, Cardaioli F
    Coronary complete revascularization strategy: A puzzle still hard to complete.
    Catheter Cardiovasc Interv. 2022;99:639-640.
    >> Share

  356. GOLDSTEIN JA, Mehta NK
    Extent of coronary atherosclerosis and ischemic myocardium foment sudden cardiac death.
    Catheter Cardiovasc Interv. 2022;99:812-813.
    >> Share

  357. LOW RJB, Khoo DZL, Ong PJL
    Case report: A novel application of the MicroVascular Plug (MVP) in treating distal coronary perforation.
    Catheter Cardiovasc Interv. 2022;99:502-507.
    >> Share

  358. HIDALGO F, Gonzalez-Manzanares R, Ojeda S, Benito-Gonzalez T, et al
    Instantaneous wave-free ratio for guiding treatment of nonculprit lesions in patients with acute coronary syndrome: A retrospective study.
    Catheter Cardiovasc Interv. 2022;99:489-496.
    >> Share

  359. XU R, Shi Y, Chang S, Qin Q, et al
    Outcomes of contemporary versus conventional reverse controlled and antegrade and retrograde subintimal tracking in chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2022;99:226-233.
    >> Share

  360. LEE K, Lee PH, Lee SW, Kwon O, et al
    Primary versus rescue retrograde approach for chronic total coronary occlusion.
    Catheter Cardiovasc Interv. 2022;99:219-225.
    >> Share

  361. PACCHIONI A, Mugnolo A, Sanz Sanchez J, Sgueglia GA, et al
    Radial artery occlusion after conventional and distal radial access: Impact of preserved flow and time-to-hemostasis in a propensity-score matching analysis of 1163 patients.
    Catheter Cardiovasc Interv. 2022;99:827-835.
    >> Share

  362. BOCCHINO PP, Franchin L, Angelini F, D'Ascenzo F, et al
    Outcomes during the first year following spontaneous coronary artery dissection: A systematic timeframe pooled analysis.
    Catheter Cardiovasc Interv. 2022;99:472-479.
    >> Share

  363. KANDZARI DE, Alaswad K, Jaffer FA, Brilakis E, et al
    Safety and efficacy of dedicated guidewire, microcatheter, and guide catheter extension technologies for chronic total coronary occlusion revascularization: Primary results of the Teleflex Chronic Total Occlusion Study.
    Catheter Cardiovasc Interv. 2022;99:263-270.
    >> Share

  364. COUGHLAN JJ, Aytekin A, Koch T, Wiebe J, et al
    Long-term clinical outcomes after drug eluting stent implantation with and without stent overlap.
    Catheter Cardiovasc Interv. 2022;99:541-551.
    >> Share

  365. KANDZARI DE, Kirtane AJ, Mehran R, Price MJ, et al
    Clinical outcomes according to lesion complexity in high bleeding risk patients treated with 1-month dual antiplatelet therapy following PCI: Analysis from the Onyx ONE clear study.
    Catheter Cardiovasc Interv. 2022;99:583-592.
    >> Share

  366. WIEBE J, Hofmann FJ, West N, Baumbach A, et al
    Outcomes of 10,312 patients treated with everolimus-eluting bioresorbable scaffolds during daily clinical practice - results from the European Absorb Consortium.
    Catheter Cardiovasc Interv. 2022;99:533-540.
    >> Share

  367. NOGIC J, Nerlekar N, Soon K, Freeman M, et al
    Diabetes mellitus is independently associated with early stent thrombosis in patients undergoing drug eluting stent implantation: Analysis from the Victorian cardiac outcomes registry.
    Catheter Cardiovasc Interv. 2022;99:554-562.
    >> Share

  368. ERBEN Y, Meschia JF, Heck DV, Shawl FA, et al
    Safety of the transradial approach to carotid stenting.
    Catheter Cardiovasc Interv. 2022;99:814-821.
    >> Share

  369. EBERLI FR, Stoll HP, Urban P, Morice MC, et al
    Polymer-free Biolimus-A9 coated thin strut stents for patients at high bleeding risk 1-year results from the LEADERS FREE III study.
    Catheter Cardiovasc Interv. 2022;99:593-600.
    >> Share

  370. HUSSAIN Y, Gaston S, Kluger J, Shah T, et al
    Long term outcomes of ultrathin versus standard thickness second-generation drug eluting stents: Meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2022;99:563-574.
    >> Share

  371. HAKEEM A, Hou L, Shah K, Agarwal SK, et al
    Derivation and validation of Pd/Pa in the assessment of residual ischemia post-intervention: A prospective all-comer registry.
    Catheter Cardiovasc Interv. 2022;99:714-722.
    >> Share

  372. NOIRCLERC N, Marliere S, Bakhti A, Mangin L, et al
    Impact of a micro-net mesh technology covering stent on coronary microvascular dysfunction in patients with high thrombus burden.
    Catheter Cardiovasc Interv. 2022;99:397-404.
    >> Share

  373. SCARSINI R, Terentes-Printzios D, Shanmuganathan M, Kotronias RA, et al
    Pressure-controlled intermittent coronary sinus occlusion improves the vasodilatory microvascular capacity and reduces myocardial injury in patients with STEMI.
    Catheter Cardiovasc Interv. 2022;99:329-339.
    >> Share

  374. KARMPALIOTIS D, Stoler R, Walsh S, El-Jack S, et al
    Safety and efficacy of Everolimus-Eluting bioabsorbable Polymer-Coated stent in patients with long coronary lesions: The EVOLVE 48 study.
    Catheter Cardiovasc Interv. 2022;99:373-380.
    >> Share

  375. ZAFIROVSKA B, Jovkovski A, Vasilev I, Taravari H, et al
    Ipsilateral transulnar artery approach catheterizations after failure of the radial approach-Are two sheaths in the same arm safe?
    Catheter Cardiovasc Interv. 2022;99:411-417.
    >> Share

  376. OSMAN M, Ghaffar YA, Osman K, Kheiri B, et al
    Gender-based outcomes of coronary bifurcation stenting: A report from the National Readmission Database.
    Catheter Cardiovasc Interv. 2022;99:433-439.
    >> Share

  377. VAN HEMERT ND, Rozemeijer R, Voskuil M, Stein M, et al
    Clinical outcomes after permanent polymer or polymer-free stent implantation in patients with diabetes mellitus: The ReCre8 diabetes substudy.
    Catheter Cardiovasc Interv. 2022;99:366-372.
    >> Share

  378. IQBAL MB, Moore PT, Nadra IJ, Robinson SD, et al
    Complete revascularization in stable multivessel coronary artery disease: A real world analysis from the British Columbia Cardiac Registry.
    Catheter Cardiovasc Interv. 2022;99:627-638.
    >> Share

  379. ANCHAN R, Venturini J, Larsen P, Lee L, et al
    Safe and rapid radial hemostasis achieved using a novel topical hemostatic patch: Results of a first-in-human pilot study using hydrophobically modified polysaccharide-chitosan.
    Catheter Cardiovasc Interv. 2022;99:786-794.
    >> Share

  380. G TOTH G, Ono M, Buschmann E, Wu X, et al
    Usability of Fantom Encore(R) scaffold in non-complex bifurcations-Analysis in bench models.
    Catheter Cardiovasc Interv. 2022;99:424-432.
    >> Share

  381. SAITO Y, Wijns W, Baumbach A, Xu B, et al
    Differential impact of abluminal groove-filled biodegradable-polymer sirolimus-eluting stent versus durable-polymer everolimus-eluting stent on and off dual antiplatelet therapy.
    Catheter Cardiovasc Interv. 2022;99:357-365.
    >> Share

    January 2022
  382. TORABI AJ, Mshelbwala FS, Hugenberg D, Kovacs RJ, et al
    Social deprivation index and ischemic events after percutaneous coronary intervention in patients with diabetes mellitus.
    Catheter Cardiovasc Interv. 2022 Jan 30. doi: 10.1002/ccd.30108.
    >> Share

  383. CHEN S, Li J, Qiu M, Ma S, et al
    Predictors and long-term outcomes of in-hospital switching from clopidogrel to ticagrelor among patients with acute coronary syndrome undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30089.
    >> Share

  384. LI J, Liu X, Ma S, Na K, et al
    Effectiveness and safety of bivalirudin in elderly patients with coronary artery disease undergoing percutaneous coronary intervention: A real-world study.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30099.
    >> Share

  385. HONG XL, Li Y, Fu GS, Zhang WB, et al
    Predictors and clinical significance of periprocedural myocardial infarction following rotational atherectomy.
    Catheter Cardiovasc Interv. 2022 Jan 25. doi: 10.1002/ccd.30095.
    >> Share

  386. SIMSEK B, Kostantinis S, Karacsonyi J, Alaswad K, et al
    Outcomes of chronic total occlusion percutaneous coronary intervention in patients with reduced left ventricular ejection fraction.
    Catheter Cardiovasc Interv. 2022 Jan 23. doi: 10.1002/ccd.30097.
    >> Share

  387. SHAMKHANI W, Kinnaird T, Ludman P, Rashid M, et al
    Sex differences in high-risk but indicated coronary interventions (CHiP): National report from British Cardiovascular Intervention Society Registry.
    Catheter Cardiovasc Interv. 2022 Jan 18. doi: 10.1002/ccd.30081.
    >> Share

  388. LI Y, Li J, Qiu M, Ma S, et al
    Ticagrelor versus clopidogrel in patients with acute coronary syndrome undergoing complex percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2022 Jan 15. doi: 10.1002/ccd.30077.
    >> Share

  389. LI W, Takahashi T, Rios SA, Latib A, et al
    Diagnostic performance and prognostic impact of coronary angiography-based Index of Microcirculatory Resistance assessment: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30076.
    >> Share

  390. MANGIACAPRA F, Paolucci L, Viscusi MM, Mangiacapra R, et al
    Prevalence and clinical impact of high platelet reactivity in patients with chronic kidney disease treated with percutaneous coronary intervention: An updated systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2022 Jan 12. doi: 10.1002/ccd.30071.
    >> Share

  391. SIMSEK B, Brilakis ES
    Chronic total occlusion percutaneous coronary intervention in prior coronary artery bypass graft surgery patients: Caveat Emptor!
    Catheter Cardiovasc Interv. 2022;99:85-87.
    >> Share

  392. LI J, Arora S, Ikeoka K, Smith J, et al
    The utility of geriatric nutritional risk index to predict outcomes in chronic limb-threatening ischemia.
    Catheter Cardiovasc Interv. 2022;99:121-133.
    >> Share

  393. IMPROTA R, Scarparo P, Wilschut J, Wolff Q, et al
    Elastic stent recoil in coronary total occlusions: Comparison of durable-polymer zotarolimus eluting stent and ultrathin strut bioabsorbable-polymer sirolimus eluting stent.
    Catheter Cardiovasc Interv. 2022;99:88-97.
    >> Share

  394. WANG HY, Mo R, Guan CD, Wang Y, et al
    Establishing the optimal duration of DAPT following PCI in high-risk TWILIGHT-like patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2022;99:98-113.
    >> Share

  395. VEMMOU E, Nikolakopoulos I, Xenogiannis I, Karacsonyi J, et al
    Learning and innovation among interventional cardiologists: Insights from an international survey.
    Catheter Cardiovasc Interv. 2022;99:11-16.
    >> Share

  396. NAVARESE EP, Kandzari DE
    REPLY: ITT (intrepret and test to effectively treat) approach for no-reflow.
    Catheter Cardiovasc Interv. 2022;99:E44-E45.
    >> Share

  397. MOVAHED MR
    Distal administration of very high doses of adenosine using over-the-wire balloon or export catheter should be the first choice for treatment of patients with resistant no-reflow.
    Catheter Cardiovasc Interv. 2022;99:E43.
    >> Share

    December 2021
  398. DEMIR OM, Little CD, Jabbour R, Rahman H, et al
    Impact of COVID-19 pandemic on the management of nonculprit lesions in patients presenting with ST-elevation myocardial infarction: Outcomes from the pan-London heart attack centers.
    Catheter Cardiovasc Interv. 2021 Dec 30. doi: 10.1002/ccd.30056.
    >> Share

  399. KIM YH, Her AY, Jeong MH, Kim BK, et al
    Two-year outcomes between ST-elevation and non-ST-elevation myocardial infarction in patients with chronic kidney disease undergoing newer-generation drug-eluting stent implantation.
    Catheter Cardiovasc Interv. 2021 Dec 28. doi: 10.1002/ccd.30049.
    >> Share

  400. GARBO R, Di Russo C, Sciahbasi A, Fedele S, et al
    The last resort during complex retrograde percutaneous coronary chronic total occlusion intervention: Extraplaque intracoronary lithotripsy to externally crush a heavy calcified occluded stent.
    Catheter Cardiovasc Interv. 2021 Dec 23. doi: 10.1002/ccd.30050.
    >> Share

  401. HERNANDEZ-SUAREZ DF, Azzalini L, Moroni F, Tinoco de Paula JE, et al
    Outcomes of chronic total occlusion percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the LATAM CTO registry.
    Catheter Cardiovasc Interv. 2021 Dec 20. doi: 10.1002/ccd.30041.
    >> Share

  402. KORNOWSKI R
    Left main coronary revascularization strategies in the COVID-19 era.
    Catheter Cardiovasc Interv. 2021;98:1262-1263.
    >> Share

  403. VETROVEC GW
    Surgical turndowns are not no option patients.
    Catheter Cardiovasc Interv. 2021;98:1230-1231.
    >> Share

  404. TOPAZ O
    Debulking uncrossable lesions with excimer laser: The interplay between device performance and limitations.
    Catheter Cardiovasc Interv. 2021;98:1250-1251.
    >> Share

  405. KUMAR A, Jneid H
    Predicting mortality after percutaneous coronary intervention: The need for improved risk models.
    Catheter Cardiovasc Interv. 2021;98:1298-1299.
    >> Share

  406. SHUNK KA
    The CathPCI Registry (still) welcomes ambulatory surgical center participation.
    Catheter Cardiovasc Interv. 2021;98:1415.
    >> Share

  407. RAO S, Karuppasamy K, Radhakrishnan K, Fagan TE, et al
    Restriction of congenital portosystemic shunt using the modified microvascular plug.
    Catheter Cardiovasc Interv. 2021;98:1358-1362.
    >> Share

  408. KLEIN LW, Tamis-Holland J, Kirtane AJ, Anderson HV, et al
    The appropriate use criteria: Improvements for its integration into real world clinical practice.
    Catheter Cardiovasc Interv. 2021;98:1349-1357.
    >> Share

  409. CHICHAREON P, van Klaveren D, Modolo R, Kogame N, et al
    Predicting 2-year all-cause mortality after contemporary PCI: Updating the logistic clinical SYNTAX score.
    Catheter Cardiovasc Interv. 2021;98:1287-1297.
    >> Share

  410. VERDOIA M, Rolla R, Pergolini P, Gioscia R, et al
    Low hemoglobin predicts high-platelet reactivity and major cardiovascular ischemic events at long-term follow-up among ACS patients receiving dual antiplatelet therapy with ticagrelor.
    Catheter Cardiovasc Interv. 2021;98:1309-1316.
    >> Share

  411. ABHYANKAR A, Abizaid A, Chamie D, Patel G, et al
    Healing and early stent coverage after ultrathin strut biodegradable polymer-coated sirolimus-eluting stent implantation: SiBi optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:1335-1342.
    >> Share

  412. OJEDA S, Azzalini L, Suarez de Lezo J, Johal GS, et al
    Excimer laser coronary atherectomy for uncrossable coronary lesions. A multicenter registry.
    Catheter Cardiovasc Interv. 2021;98:1241-1249.
    >> Share

  413. KOUTOUZIS M, Liontou C, Xenogiannis I, Tajti P, et al
    Same day discharge after chronic total occlusion interventions: A single center experience.
    Catheter Cardiovasc Interv. 2021;98:1232-1239.
    >> Share

    November 2021
  414. BHARDWAJ B, Gunzburger E, Valle JA, Grunwald GK, et al
    Radial versus femoral access for left main percutaneous coronary intervention: An analysis from the Veterans Affairs Clinical, Reporting, and Tracking Program.
    Catheter Cardiovasc Interv. 2021 Nov 30. doi: 10.1002/ccd.30024.
    >> Share

  415. SHOAIB A, Spratt JC, Curzen N, Wilson S, et al
    Clinical outcomes of percutaneous coronary intervention for chronic total occlusion by treated segment length.
    Catheter Cardiovasc Interv. 2021 Nov 19. doi: 10.1002/ccd.30015.
    >> Share

  416. AKL E, Pinilla-Echeverri N, Garcia-Garcia HM, Mehta SR, et al
    First in-human evaluation of a novel intravascular ultrasound and optical coherence tomography system for intracoronary imaging.
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30001.
    >> Share

  417. KUFNER S, Rai H, Wiebe J, Altevogt F, et al
    A prospective trial of a novel low-dose paclitaxel-coated balloon therapy in patients with restenosis in drug-eluting coronary stents Intracoronary Stenting and Angiographic Results: Optimizing Treatment of Drug Eluting Stent In-stent REstenosis 3A (I
    Catheter Cardiovasc Interv. 2021 Nov 18. doi: 10.1002/ccd.30014.
    >> Share

  418. VALLURUPALLI S, Salehi N, Agarwal S, Hasan R, et al
    Exhaustion of coronary vasodilatory reserve in the resting state: Clinical characteristics and long-term outcomes after intervention.
    Catheter Cardiovasc Interv. 2021;98:1021-1026.
    >> Share

  419. DAVIES RE, Rier JD, McEntegart M, Riley RF, et al
    Subintimal tracking and reentry as a tool in CTO-PCI: Past, present, and future.
    Catheter Cardiovasc Interv. 2021;98:1144-1151.
    >> Share

  420. MEHTA S, Grines CL, Botelho R, Fernandez F, et al
    STEMI telemedicine for 100 million lives.
    Catheter Cardiovasc Interv. 2021;98:1066-1071.
    >> Share

  421. PIAYDA K, Grunwald I, Sievert K, Bertog S, et al
    Acute stroke intervention for acute embolic procedural strokes performed by cardiologists.
    Catheter Cardiovasc Interv. 2021;98:E963-E967.
    >> Share

  422. MARMAGKIOLIS K, Caballero JA, Cilingiroglu M, Iliescu C, et al
    Single-access dual-injection technique (SADIT) for high-risk PCI with Impella CP.
    Catheter Cardiovasc Interv. 2021;98:1138-1140.
    >> Share

  423. ROY S, Choxi R, Wasilewski M, Jovin IS, et al
    Novel oral anticoagulants in the treatment of radial artery occlusion.
    Catheter Cardiovasc Interv. 2021;98:1133-1137.
    >> Share

  424. CERRATO E, Belliggiano D, Quadri G, Erriquez A, et al
    Anatomical and functional healing after resorbable magnesium scaffold implantation in human coronary vessels: A combined optical coherence tomography and quantitative flow ratio analysis.
    Catheter Cardiovasc Interv. 2021;98:1038-1046.
    >> Share

  425. NIKOLAKOPOULOS I, Vemmou E, Xenogiannis I, Karacsonyi J, et al
    Radial versus femoral access in patients with coronary artery bypass surgery: Frequentist and Bayesian meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 14. doi: 10.1002/ccd.30010.
    >> Share

  426. TAMIS-HOLLAND JE, Puvanalingam A, Cigarroa J
    Physician practice patterns in managing severe multivessel disease in acute myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Nov 13. doi: 10.1002/ccd.30004.
    >> Share

  427. KIRRESH A, Candilio L, Stone GW
    Intralesional delivery of glycoprotein IIb/IIIa inhibitors in acute myocardial infarction: Review and recommendations.
    Catheter Cardiovasc Interv. 2021 Nov 12. doi: 10.1002/ccd.30008.
    >> Share

  428. LATIF A, Ahsan MJ, Lateef N, Aurit S, et al
    Impact of sex on outcomes of percutaneous coronary intervention for chronic total occlusion: A meta-analysis.
    Catheter Cardiovasc Interv. 2021 Nov 12. doi: 10.1002/ccd.30017.
    >> Share

  429. KALETA FP, Gilchrist IC
    PRECISE-DAPT: A tool to measure if Afib patients may risk being stretched too thin.
    Catheter Cardiovasc Interv. 2021;98:846-847.
    >> Share

  430. TOELG R, Slagboom T, Waltenberger J, Lefevre T, et al
    Individual patient data analysis of the BIOFLOW study program comparing safety and efficacy of a bioresorbable polymer sirolimus eluting stent to a durable polymer everolimus eluting stent.
    Catheter Cardiovasc Interv. 2021;98:848-856.
    >> Share

  431. FUJIHARA M, Takahara M, Yamaoka T, Iida O, et al
    Clinical outcomes of endovascular procedure using VIABAHN(R) VBX covered stent in complex aortoiliac artery disease: Result from AVOCADO study.
    Catheter Cardiovasc Interv. 2021;98:928-937.
    >> Share

  432. NOGUCHI M, Dohi T, Okazaki S, Matsumura M, et al
    Comparison of 6-month vascular healing response after bioresorbable polymer versus durable polymer drug-eluting stent implantation in patients with acute coronary syndromes: A randomized serial optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:E677-E686.
    >> Share

  433. ZANCA F, Dabin J, Collard C, Alexandre N, et al
    Evaluation of a suspended radiation protection system to reduce operator exposure in cardiology interventional procedures.
    Catheter Cardiovasc Interv. 2021;98:E687-E694.
    >> Share

  434. FAGEL ND, Amoroso G, Rabbering T, Gescher F, et al
    One-year mortality in NSTEMI patients is unaffected by timing of PCI within the first week of admission: Results of a real-world cohort analysis.
    Catheter Cardiovasc Interv. 2021;98:E661-E667.
    >> Share

  435. KHAN AA, Murtaza G, Khalid MF, White CJ, et al
    Outcomes of rotational atherectomy versus orbital atherectomy for the treatment of heavily calcified coronary stenosis: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021;98:884-892.
    >> Share

  436. HERNANDEZ-ENRIQUEZ M, Belle L, Madiot H, Pansieri M, et al
    Use and outcomes of the PK Papyrus covered stent in France: SOS PK Papyrus Registry.
    Catheter Cardiovasc Interv. 2021;98:874-881.
    >> Share

  437. SALINAS P, Sanchez-Casanueva RM, Gonzalo N, A Gil J, et al
    Dose-reducing fluoroscopic system decreases patient but not occupational radiation exposure in chronic total occlusion intervention.
    Catheter Cardiovasc Interv. 2021;98:895-902.
    >> Share

  438. D'ASCENZO F, Saglietto A, Ramakrishna H, Andreis A, et al
    Usefulness of oral anticoagulation in patients with coronary aneurysms: Insights from the CAAR registry.
    Catheter Cardiovasc Interv. 2021;98:864-871.
    >> Share

  439. WIEBE J, Rai H, Kuna C, Cassese S, et al
    Angiographic performance of everolimus-eluting stents for the treatment of coronary in-stent restenosis in daily practice.
    Catheter Cardiovasc Interv. 2021;98:857-862.
    >> Share

    October 2021
  440. SATTAR Y, Abdul Razzack A, Kompella R, Alhajri N, et al
    Outcomes of intravascular ultrasound versus optical coherence tomography guided percutaneous coronary angiography: A meta regression-based analysis.
    Catheter Cardiovasc Interv. 2021 Oct 20. doi: 10.1002/ccd.29976.
    >> Share

  441. DAI N, Zhang R, Hu N, Guan C, et al
    Integrated coronary disease burden and patterns to discriminate vessels benefiting from percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Oct 15. doi: 10.1002/ccd.29983.
    >> Share

  442. HAWAMDEH H, Moliterno DJ
    Finding sideline benefits-Of pandemics and same-day-discharge following rotational atherectomy.
    Catheter Cardiovasc Interv. 2021;98:689-690.
    >> Share

  443. KERN MJ
    Does rotoblation or cutting balloon before provisional stenting of calcified side branches make any difference? Comparing results by OCT and FFR.
    Catheter Cardiovasc Interv. 2021;98:669-670.
    >> Share

  444. KOH JS, Gogas BD, Kumar S, Benham JJ, et al
    Very late vasomotor responses and gene expression with bioresorbable scaffolds and metallic drug-eluting stents.
    Catheter Cardiovasc Interv. 2021;98:723-732.
    >> Share

  445. ZGHOUZI M, Moussa Pacha H, Ullah W, Sattar Y, et al
    In-hospital outcomes of endovascular versus surgical revascularization for chronic total occlusion in peripheral artery disease.
    Catheter Cardiovasc Interv. 2021;98:E586-E593.
    >> Share

  446. BOEDER NF, Kastner J, Mehilli J, Munzel T, et al
    Predictors of scaffold failure and impact of optimized scaffold implantation technique on outcome: Results from the German-Austrian ABSORB RegIstRy.
    Catheter Cardiovasc Interv. 2021;98:E555-E563.
    >> Share

  447. CHUNG YH, Kim JS, Lee SY, Im E, et al
    Safety and usefulness of a novel short track sliding balloon catheter.
    Catheter Cardiovasc Interv. 2021;98:E548-E554.
    >> Share

  448. TROBS M, Achenbach S, Nef HM, Gori T, et al
    Everolimus eluting bioresorbable vascular scaffolds in patients with acute coronary syndromes: Two-year results from the German-Austrian ABSORB registry.
    Catheter Cardiovasc Interv. 2021;98:E564-E570.
    >> Share

  449. IWANCZYK S, Wlodarczak A, Hiczkiewicz J, Faron W, et al
    Feasibility of intravascular lithotripsy for calcific coronary lesions: A multi-institutional experience.
    Catheter Cardiovasc Interv. 2021;98:E540-E547.
    >> Share

  450. ONO M, Kawashima H, Hara H, Gamal A, et al
    External validation of the GRACE risk score 2.0 in the contemporary all-comers GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2021;98:E513-E522.
    >> Share

  451. YELAVARTHY P, Seth M, Pielsticker E, Grines CL, et al
    The DISCO study-Does Interventionalists' Sex impact Coronary Outcomes?
    Catheter Cardiovasc Interv. 2021;98:E531-E539.
    >> Share

  452. MEMON S, George JC, Kalra S, Janzer S, et al
    Antegrade and retrograde in-stent tibial artery chronic total occlusion recanalization with double kiss crush (DK crush) stenting of previous stent.
    Catheter Cardiovasc Interv. 2021;98:743-747.
    >> Share

  453. RAMASAMY A, Bajaj R, Jones DA, Amersey R, et al
    Iatrogenic catheter-induced ostial coronary artery dissections: Prevalence, management, and mortality from a cohort of 55,968 patients over 10 years.
    Catheter Cardiovasc Interv. 2021;98:649-655.
    >> Share

  454. MIDULLA M, Chevallier O, Comby PO, Giordano G, et al
    Endovascular management of the deep venous thrombosis: A new challenging role for the endovascular specialist in 2020.
    Catheter Cardiovasc Interv. 2021;98:748-755.
    >> Share

  455. KERKMEIJER LSM, Tijssen RYG, Hofma SH, van der Schaaf RJ, et al
    Three-year clinical outcomes of the absorb bioresorbable vascular scaffold compared to Xience everolimus-eluting stent in routine PCI in patients with diabetes mellitus-AIDA sub-study.
    Catheter Cardiovasc Interv. 2021;98:713-720.
    >> Share

  456. SAPONTIS J, Hirai T, Patterson C, Gans B, et al
    Intermediate procedural and health status outcomes and the clinical care pathways after chronic total occlusion angioplasty: A report from the OPEN-CTO (outcomes, patient health status, and efficiency in chronic total occlusion hybrid procedures) stud
    Catheter Cardiovasc Interv. 2021;98:626-635.
    >> Share

  457. TAXIARCHI P, Martin GP, Curzen N, Kinnaird T, et al
    Rotational atherectomy and same day discharge: Safety and growth from a national perspective.
    Catheter Cardiovasc Interv. 2021;98:678-688.
    >> Share

  458. AGOSTONI P, Scott B, Budassi S, Verheye S, et al
    A prospective evaluation of a redefined version of the "minimalistic hybrid approach" algorithm for percutaneous coronary chronic total occlusion revascularization.
    Catheter Cardiovasc Interv. 2021;98:617-625.
    >> Share

    September 2021
  459. CORTESE B, de la Torre Hernandez JM, Lanocha M, Ielasi A, et al
    Optical coherence tomography, intravascular ultrasound or angiography guidance for distal left main coronary stenting. The ROCK cohort II study.
    Catheter Cardiovasc Interv. 2021 Sep 28. doi: 10.1002/ccd.29959.
    >> Share

  460. SOOMRO AY, Almaddah N, Lendel V, Agarwal SK, et al
    Elective percutaneous coronary intervention performed during contrast-induced hypotension.
    Catheter Cardiovasc Interv. 2021 Sep 22. doi: 10.1002/ccd.29958.
    >> Share

  461. WATANABE Y, Mitomo S, Naganuma T, Chieffo A, et al
    The importance of proximal optimization technique with intravascular imaging guided for stenting unprotected left main distal bifurcation lesions: The Milan and New-Tokyo registry.
    Catheter Cardiovasc Interv. 2021 Sep 14. doi: 10.1002/ccd.29954.
    >> Share

  462. ULLAH W, Zghouzi M, Ahmad B, Suleiman AM, et al
    Safety and efficacy of the polymer-free and polymer-coated drug-eluting stents in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Sep 12. doi: 10.1002/ccd.29953.
    >> Share

  463. SHEIBAN I, Ge Z, Kan J, Nie S, et al
    Association of peri-procedural myocardial infarction with mortality after stenting true coronary bifurcation lesions: A pooled individual participant data analysis from four randomized controlled trials.
    Catheter Cardiovasc Interv. 2021 Sep 7. doi: 10.1002/ccd.29946.
    >> Share

  464. BEERKENS FJ, Singh R, Cao D, Claessen BE, et al
    Impact of target vessel choice on outcomes following percutaneous coronary intervention in patients with a prior coronary artery bypass graft.
    Catheter Cardiovasc Interv. 2021 Sep 3. doi: 10.1002/ccd.29935.
    >> Share

  465. TARANTINI G, Zuccarelli V
    Percutaneous coronary intervention versus coronary artery bypass graft surgery: The battle rages on.
    Catheter Cardiovasc Interv. 2021;98:434-435.
    >> Share

  466. MUSUMECI G, Colopi M
    Percutaneous coronary intervention outcomes in left main and multivessel disease: Navigating the patent minefield.
    Catheter Cardiovasc Interv. 2021;98:445-446.
    >> Share

  467. OKUYA Y, Moussa ID
    Coronary bypass graft surgery accentuates proximal coronary disease progression!
    Catheter Cardiovasc Interv. 2021;98:492.
    >> Share

  468. STABILE E, Esposito G
    Below the knee percutaneous transluminal angioplasty for claudicants: One vessel is enough to relieve symptoms.
    Catheter Cardiovasc Interv. 2021;98:570-571.
    >> Share

  469. POSTALIAN A, Krajcer Z
    MANTA versus Perclose for large-bore vessel closure: The evidence continues to grow.
    Catheter Cardiovasc Interv. 2021;98:586-587.
    >> Share

  470. COBB H, Spray B, Daily J, Dossey A, et al
    Cutting balloon angioplasty on branch pulmonary artery stenosis in pediatric patients.
    Catheter Cardiovasc Interv. 2021;98:526-532.
    >> Share

  471. ROCHA-SINGH KJ, Sachar R, DeRubertis BG, Nolte-Ernsting CCA, et al
    Directional atherectomy before paclitaxel coated balloon angioplasty in complex femoropopliteal disease: The VIVA REALITY study.
    Catheter Cardiovasc Interv. 2021;98:549-558.
    >> Share

  472. SALAHUDDIN T, Giannopoulos S, Adams G, Armstrong EJ, et al
    Anterior, posterior, or all-vessel infrapopliteal revascularization in patients with moderate-severe claudication: Insights from the LIBERTY 360 study.
    Catheter Cardiovasc Interv. 2021;98:559-569.
    >> Share

  473. KATSUKI T, Yamaji K, Soga Y, Iida O, et al
    New lesion after endovascular therapy of femoropopliteal lesions for intermittent claudication.
    Catheter Cardiovasc Interv. 2021;98:E395-E402.
    >> Share

  474. HARA H, Ono M, Kawashima H, Kogame N, et al
    Impact of stent length and diameter on 10-year mortality in the SYNTAXES trial.
    Catheter Cardiovasc Interv. 2021;98:E379-E387.
    >> Share

  475. MOCCETTI F, Wolfrum M, Bossard M, Attinger-Toller A, et al
    Reduction of MANTA-associated vascular complications after implementation of key insights on failure mechanisms.
    Catheter Cardiovasc Interv. 2021;98:E462-E465.
    >> Share

  476. FOURNIER S, Toth GG, De Bruyne B, Kala P, et al
    Changes in surgical revascularization strategy after fractional flow reserve.
    Catheter Cardiovasc Interv. 2021;98:E351-E355.
    >> Share

  477. CORDERO A, Cid-Alvarez B, Alegria E, Fernandez-Cisnal A, et al
    Multicenter and all-comers validation of a score to select patients for manual thrombectomy, the DDTA score.
    Catheter Cardiovasc Interv. 2021;98:E342-E350.
    >> Share

  478. LHERMUSIER T, Carrie D, Cayla G, Fajadet J, et al
    Three-year clinical outcomes with the ABSORB bioresorbable vascular scaffold in real life: Insights from the France ABSORB registry.
    Catheter Cardiovasc Interv. 2021;98:511-519.
    >> Share

  479. YAGER N, Schulman-Marcus J, Torosoff M
    Coronary anatomy and comorbidities impact on elective PCI outcomes in left main and multivessel coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:436-444.
    >> Share

  480. KERKMEIJER LSM, Chandrasekhar J, Kalkman DN, Woudstra P, et al
    Final five-year results of the REMEDEE Registry: Real-world experience with the dual-therapy COMBO stent.
    Catheter Cardiovasc Interv. 2021;98:503-510.
    >> Share

  481. WOLNY R, Mintz GS, Matsumura M, Kim SY, et al
    Left coronary artery calcification patterns after coronary bypass graft surgery: An in-vivo optical coherence tomography study.
    Catheter Cardiovasc Interv. 2021;98:483-491.
    >> Share

  482. MOHAMED MO, Shoaib A, Gogas B, Patel T, et al
    Trends of repeat revascularization choice in patients with prior coronary artery bypass surgery.
    Catheter Cardiovasc Interv. 2021;98:470-480.
    >> Share

  483. MATSOUKIS IL, Karanasos A, Patsa C, Anousakis-Vlachochristou N, et al
    Long-term clinical outcomes of coronary artery bypass graft surgery compared to those of percutaneous coronary intervention with second generation drug eluting stents in patients with stable angina and an isolated lesion in the proximal left anterior
    Catheter Cardiovasc Interv. 2021;98:447-457.
    >> Share

  484. LEE JH, Kim U, Kim JS, Hong SJ, et al
    Clinical implication of neointimal burden in in-stent restenosis treated with drug-coated balloon.
    Catheter Cardiovasc Interv. 2021;98:493-502.
    >> Share

  485. SHAH R, Labroo A, Davis DA, Le FK, et al
    Increased risk of stent thrombosis with use of a direct oral anticoagulant and a single antiplatelet agent after PCI: A meta-analysis.
    Catheter Cardiovasc Interv. 2021;98:E490-E492.
    >> Share

  486. JANG WJ, Chun WJ, Park IH, Choi KH, et al
    Impact of stent designs of second-generation drug-eluting stents on long-term outcomes in coronary bifurcation lesions.
    Catheter Cardiovasc Interv. 2021;98:458-467.
    >> Share

    August 2021
  487. LICHAA H
    Coronary stent positioning under live IVUS guidance in low contrast percutaneous coronary interventions: The live IVUS stenting technique.
    Catheter Cardiovasc Interv. 2021 Aug 31. doi: 10.1002/ccd.29940.
    >> Share

  488. YAMADA T, Washimi S, Hashimoto S, Taniguchi N, et al
    Feasibility and safety of the successive use of distal transradial access for coronary angiography and intervention in the same arm.
    Catheter Cardiovasc Interv. 2021 Aug 28. doi: 10.1002/ccd.29938.
    >> Share

  489. SAITO A, Dai Z, Ono M, Kanie T, et al
    The relationship between coronary stent strut thickness and the incidences of clinical outcomes after drug-eluting stent implantation: A systematic review and meta-regression analysis.
    Catheter Cardiovasc Interv. 2021 Aug 22. doi: 10.1002/ccd.29922.
    >> Share

  490. MATSUOKA T, Kitahara H, Saito K, Mori N, et al
    Utility of near-infrared spectroscopy to detect the extent of lipid core plaque leading to periprocedural myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Aug 20. doi: 10.1002/ccd.29927.
    >> Share

  491. YIN T, Zhong X, Tao L, Hu T, et al
    Revascularization by percutaneous coronary intervention in a case of left main coronary artery atresia.
    Catheter Cardiovasc Interv. 2021 Aug 19. doi: 10.1002/ccd.29931.
    >> Share

  492. BASIR MB, Lemor A, Gorgis S, Taylor AM, et al
    Vasopressors independently associated with mortality in acute myocardial infarction and cardiogenic shock.
    Catheter Cardiovasc Interv. 2021 Aug 3. doi: 10.1002/ccd.29895.
    >> Share

  493. JIA X, Jneid H
    Practice patterns for patients with ST-elevation myocardial infarction during the early phase of the COVID-19 pandemic-Valuable lessons learned.
    Catheter Cardiovasc Interv. 2021;98:223-224.
    >> Share

  494. GARCIA S, Stanberry L, Schmidt C, Sharkey S, et al
    Impact of COVID-19 pandemic on STEMI care: An expanded analysis from the United States.
    Catheter Cardiovasc Interv. 2021;98:217-222.
    >> Share

  495. CAO D, Dangas GD
    Assessing the risk of acute kidney injury after primary PCI: The simpler the sooner the better.
    Catheter Cardiovasc Interv. 2021;98:206-207.
    >> Share

  496. WINSCOTT JG, Hillegass WB
    Critical limb ischemia in the end stage renal disease patient: Some next steps.
    Catheter Cardiovasc Interv. 2021;98:308-309.
    >> Share

  497. SHROFF GR, Henry TD
    Percutaneous coronary intervention in end-stage kidney disease: Trapped between a rock and a hard place.
    Catheter Cardiovasc Interv. 2021;98:215-216.
    >> Share

  498. GAO W, Chen Y, Yang H, Yao K, et al
    Outcomes of rotational atherectomy for severely calcified coronary lesions: A single center 5-year experience.
    Catheter Cardiovasc Interv. 2021;98:E254-E261.
    >> Share

  499. DAWSON DB, Telles-Garcia NA, Atkins JL, Mina GS, et al
    End-stage renal disease patients undergoing angioplasty and bypass for critical limb ischemia have worse outcomes compared to non-ESRD patients: Systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021;98:297-307.
    >> Share

  500. ZHAO Y, Li J, Ma S, Jiang Z, et al
    Impact of extended dual antiplatelet therapy on long-term prognosis in patients with acute coronary syndrome complicated with anemia: A sub-analysis of the real-world OPT-CAD study.
    Catheter Cardiovasc Interv. 2021;98:E235-E242.
    >> Share

  501. GRIMFJARD P, Bergman E, Buccheri S, Erlinge D, et al
    Outcome of PCI with Xience versus other commonly used modern drug eluting stents: A SCAAR report.
    Catheter Cardiovasc Interv. 2021;98:E197-E204.
    >> Share

  502. PATHAN AZ, Aijaz S, Sheikh S, Sattar S, et al
    Randomized trial comparing radial hemostasis techniques; catechol conjugated chitosan pad (InnoSEAL) versus pneumatic compression band.
    Catheter Cardiovasc Interv. 2021;98:E181-E187.
    >> Share

  503. KABIR R, Vuppala S, Liu Y, Tejani I, et al
    Clinical outcomes of patients with and without chronic kidney disease undergoing endovascular revascularization of infrainguinal peripheral artery disease: Insights from the XLPAD registry.
    Catheter Cardiovasc Interv. 2021;98:310-316.
    >> Share

  504. HERNANDEZ-ENRIQUEZ M, Boudou N, Belle L
    Reply to "what have we learnt from the use of Papyrus covered stent in France and Spain?"
    Catheter Cardiovasc Interv. 2021;98:411-412.
    >> Share

  505. JURADO-ROMAN A, Gonzalvez A, Jimenez-Valero S, Galeote G, et al
    What have we learnt from the use of papyrus covered stent in France and Spain?
    Catheter Cardiovasc Interv. 2021;98:410.
    >> Share

  506. AZIZ A, Bhatia G, Pitt M, Choudhury A, et al
    Intravascular lithotripsy in calcified-coronary lesions: A real-world observational, European multicenter study.
    Catheter Cardiovasc Interv. 2021;98:225-235.
    >> Share

  507. SANZ SANCHEZ J, Garbo R, Gagnor A, Oreglia J, et al
    Management and outcomes of coronary artery perforations treated with the block and deliver technique.
    Catheter Cardiovasc Interv. 2021;98:238-245.
    >> Share

  508. BURATTI S, Crimi G, Somaschini A, Cornara S, et al
    A preprocedural risk score predicts acute kidney injury following primary percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021;98:197-205.
    >> Share

  509. IMAMURA T
    Implication of Impella-supported percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021;98:E324.
    >> Share

  510. DUNN AN, Huded C, Simpfendorfer C, Raymond R, et al
    End-stage renal disease as an independent risk factor for in-hospital mortality after coronary drug-eluting stenting: Understanding and modeling the risk.
    Catheter Cardiovasc Interv. 2021;98:246-254.
    >> Share

    July 2021
  511. BISWAS S, Dinh D, Duffy SJ, Brennan A, et al
    Characteristics and outcomes of unsuccessful percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Jul 31. doi: 10.1002/ccd.29886.
    >> Share

  512. SCHUMACHER SP, Everaars H, Stuijfzand WJ, van Diemen PA, et al
    Viability and functional recovery after chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Jul 30. doi: 10.1002/ccd.29888.
    >> Share

  513. MARCUSOHN E, Zukermann R, Kerner A, Roguin A, et al
    Long-term outcomes of patients with chronic inflammatory diseases after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Jul 14. doi: 10.1002/ccd.29870.
    >> Share

  514. TAVENIER AH, Claassens DMF, Hermanides RS, Vos GJA, et al
    Efficacy and safety of glycoprotein IIb/IIIa inhibitors in addition to P2Y12 inhibitors in ST-segment elevation myocardial infarction: A subanalysis of the POPular Genetics trial.
    Catheter Cardiovasc Interv. 2021 Jul 7. doi: 10.1002/ccd.29861.
    >> Share

  515. HERMILLER JB JR, Gunnarsson CL, Ryan MP, Moore KA, et al
    The need for future coronary access following surgical or transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2021 Jul 6. doi: 10.1002/ccd.29841.
    >> Share

  516. DAI Y, Ge J
    The synergistic effect of coronary artery bifurcations and calcifications on the adverse outcomes after PCI: Is 1+1>1?
    Catheter Cardiovasc Interv. 2021;98:43-44.
    >> Share

  517. ICHIHASHI S, Tamura Y, Maeda S, Kichikawa K, et al
    Percutaneous deep venous arterialization at femoropopliteal segment for unhealed amputated stump ulcer after below the knee amputation.
    Catheter Cardiovasc Interv. 2021;98:E124-E126.
    >> Share

  518. SULIMOV DS, Markuske M, Desch S, Thiele H, et al
    Management of dead space thrombosis during decannulation of peripherally inserted venoarterial extracorporeal membrane oxygenation.
    Catheter Cardiovasc Interv. 2021;98:E122-E123.
    >> Share

  519. AZZALINI L, Carlino M
    A new combined antegrade and retrograde approach for chronic total occlusion recanalization: Facilitated antegrade fenestration and re-entry.
    Catheter Cardiovasc Interv. 2021;98:E85-E90.
    >> Share

  520. LEE HS, Kang J, Park KW, Ki YJ, et al
    Procedural optimization of drug-coated balloons in the treatment of coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E43-E52.
    >> Share

  521. WATANABE Y, Mitomo S, Naganuma T, Takagi K, et al
    Clinical impact of bifurcation angle change between diastole and systole in complex stenting for left main distal bifurcation: The Milan and New-Tokyo (MITO) Registry.
    Catheter Cardiovasc Interv. 2021;98:E24-E34.
    >> Share

  522. SOGABE K, Koide M, Fukui K, Kato Y, et al
    Optical coherence tomography analysis of late lumen enlargement after paclitaxel-coated balloon angioplasty for de-novo coronary artery disease.
    Catheter Cardiovasc Interv. 2021;98:E35-E42.
    >> Share

  523. SREENIVASAN J, Abu-Haniyeh A, Hooda U, Khan MS, et al
    Rate, causes, and predictors of 90-day readmissions and the association with index hospitalization coronary revascularization following non-ST elevation myocardial infarction in the United States.
    Catheter Cardiovasc Interv. 2021;98:12-21.
    >> Share

  524. BEOHAR N, Chen S, Lembo NJ, Banning AP, et al
    Impact of lesion preparation strategies on outcomes of left main PCI: The EXCEL trial.
    Catheter Cardiovasc Interv. 2021;98:24-32.
    >> Share

  525. SANZ SANCHEZ J, Chiarito M, Cortese B, Moretti A, et al
    Drug-Coated balloons vs drug-eluting stents for the treatment of small coronary artery disease: A meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2021;98:66-75.
    >> Share

  526. MAILLARD L, de Labriolle A, Brasselet C, Faurie B, et al
    Evaluation of the safety and efficacy of the Cobra PzF NanoCoated coronary stent in routine, consecutive, prospective, and high-risk patients: The e-Cobra study.
    Catheter Cardiovasc Interv. 2021;98:45-54.
    >> Share

  527. BASAVARAJAIAH S, Athukorala S, Kalogeras K, Panoulas V, et al
    Mid-term clinical outcomes from use of Sirolimus coated balloon in coronary intervention; data from real world population.
    Catheter Cardiovasc Interv. 2021;98:57-65.
    >> Share

    June 2021
  528. OCHIUMI Y, Yamamoto M, Tsuchikane E, Muramatsu T, et al
    Predictors of prolonged guidewire manipulation time for native coronary chronic total occlusion percutaneous coronary intervention via primary antegrade approach.
    Catheter Cardiovasc Interv. 2021 Jun 26. doi: 10.1002/ccd.29844.
    >> Share

  529. SCHUKRAFT S, Arroyo D, Togni M, Goy JJ, et al
    Five-year angiographic, OCT and clinical outcomes of a randomized comparison of everolimus and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds.
    Catheter Cardiovasc Interv. 2021 Jun 26. doi: 10.1002/ccd.29837.
    >> Share

  530. RAHMAN F, Jneid H
    The continuing promise of the radial access for coronary interventions.
    Catheter Cardiovasc Interv. 2021;97:1397-1398.
    >> Share

  531. NAGARAJA V, Rao SV, George S, Mamas M, et al
    Evidence-based arterial access site practice in patients with acute coronary syndromes: Has SAFARI-STEMI changed the landscape?
    Catheter Cardiovasc Interv. 2021;97:1417-1421.
    >> Share

  532. KARROWNI W, Zaeiter H, Mansour S, Nassar P, et al
    Tip fracture of the crown of orbital atherectomy device in angulated left circumflex lesion.
    Catheter Cardiovasc Interv. 2021;97:1399-1401.
    >> Share

  533. BEN-DOR I, Sharma A, Rogers T, Yerasi C, et al
    Micropuncture technique for femoral access is associated with lower vascular complications compared to standard needle.
    Catheter Cardiovasc Interv. 2021;97:1379-1385.
    >> Share

  534. ANDO G, Capodanno D
    Safe femoral access for STEMI patients and mortality in the new decade: Back to the future?
    Catheter Cardiovasc Interv. 2021;97:E1054-E1056.
    >> Share

  535. OKSNES A, McEntegart M
    Intravascular lithotripsy in saphenous vein grafts and graft stent failure: A case series.
    Catheter Cardiovasc Interv. 2021;97:E945-E950.
    >> Share

  536. PATEL NJ, Okamoto N, Murphy J, Vengrenyuk Y, et al
    Management of calcified coronary artery bifurcation lesions.
    Catheter Cardiovasc Interv. 2021;97:1407-1416.
    >> Share

  537. TEHRANI BN, Damluji AA, Sherwood MW, Rosner C, et al
    Transradial access in acute myocardial infarction complicated by cardiogenic shock: Stratified analysis by shock severity.
    Catheter Cardiovasc Interv. 2021;97:1354-1366.
    >> Share

  538. DING PYJ, Webber B, Ormiston J, Webster M, et al
    Proximal to distal Y-stenting for coronary bifurcation lesions using radial access: A modern bifurcation technique.
    Catheter Cardiovasc Interv. 2021;97:E951-E955.
    >> Share

  539. AZZALINI L, Baber U, Johal GS, Farhan S, et al
    One-year outcomes of patients undergoing complex percutaneous coronary intervention with three contemporary drug-eluting stents.
    Catheter Cardiovasc Interv. 2021;97:1341-1351.
    >> Share

  540. KARAMASIS GV, Kalogeropoulos AS, Gamma RA, Clesham GJ, et al
    Effects of stent postdilatation during primary PCI for STEMI: Insights from coronary physiology and optical coherence tomography.
    Catheter Cardiovasc Interv. 2021;97:1309-1317.
    >> Share

  541. KAUL U, Abhyankar A, K Abhaichand R, Bhagwat A, et al
    Serial evaluation of vascular responses after implantation of everolimus-eluting coronary stent by optical coherence tomography.
    Catheter Cardiovasc Interv. 2021 Jun 1. doi: 10.1002/ccd.29794.
    >> Share

    May 2021
  542. LEE KH, Torii S, Oguri M, Miyaji T, et al
    Reduction of door-to-balloon time in patients with ST-elevation myocardial infarction by single-catheter primary percutaneous coronary intervention method.
    Catheter Cardiovasc Interv. 2021 May 31. doi: 10.1002/ccd.29797.
    >> Share

  543. MEDRANDA GA, Case BC, Zhang C, Rappaport H, et al
    Propensity-matched comparison of large-bore access closure in transcatheter aortic valve replacement using MANTA versus Perclose: A real-world experience.
    Catheter Cardiovasc Interv. 2021 May 29. doi: 10.1002/ccd.29786.
    >> Share

  544. O'NEILL BP, Grines C, Moses JW, Ohman EM, et al
    Outcomes of bailout percutaneous ventricular assist device versus prophylactic strategy in patients undergoing nonemergent percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 May 29. doi: 10.1002/ccd.29758.
    >> Share

  545. COSGROVE C, Hanratty CG, Hill JM, Mahadevan K, et al
    Intravascular lithotripsy for treatment of calcific coronary lesions in ST elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2021 May 29. doi: 10.1002/ccd.29801.
    >> Share

  546. ROUMELIOTIS A, Claessen BE, Sartori S, Cao D, et al
    Impact of sex on long-term cardiovascular outcomes of patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2021 May 25. doi: 10.1002/ccd.29754.
    >> Share

  547. ELIA E, Iannaccone M, D'Ascenzo F, Gallone G, et al
    Short term outcomes of Impella circulatory support for high-risk percutaneous coronary intervention a systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021 May 24. doi: 10.1002/ccd.29757.
    >> Share

  548. BALDI C, Silverio A, Esposito L, Di Maio M, et al
    Clinical outcome of patients with ST-elevation myocardial infarction and angiographic evidence of coronary artery ectasia.
    Catheter Cardiovasc Interv. 2021 May 5. doi: 10.1002/ccd.29738.
    >> Share

  549. SHOAIB A, Mohamed M, Curzen N, Ludman P, et al
    Clinical outcomes of percutaneous coronary intervention for chronic total occlusion in prior coronary artery bypass grafting patients.
    Catheter Cardiovasc Interv. 2021 May 4. doi: 10.1002/ccd.29691.
    >> Share

  550. TOPAZ O
    The inconsistency of manual thrombectomy and the role of contemporary thrombus grading in PCI for STEMI.
    Catheter Cardiovasc Interv. 2021;97:1149-1150.
    >> Share

  551. SHAH J, Levy MS
    GRACEfully assessing the timeline for noninfarct-related artery intervention in ST-elevation myocardial infarction patients.
    Catheter Cardiovasc Interv. 2021;97:1160-1161.
    >> Share

  552. SHADMAN S, Heyliger S, Watts C, Aghili N, et al
    Successful impella-assisted suction thrombectomy of right heart thrombus via the AngioVac device: Advantages, limitations, and alternatives.
    Catheter Cardiovasc Interv. 2021;97:1296-1300.
    >> Share

  553. ADUSUMALLI S, Dautov R
    An ultra-low-profile 0.85 mm Nano Hydro balloon to treat wire-crossable balloon-uncrossable lesions: A useful tool in CTO armamentarium.
    Catheter Cardiovasc Interv. 2021;97:1213-1217.
    >> Share

  554. KROON HG, Tonino PAL, Savontaus M, Amoroso G, et al
    Dedicated plug based closure for large bore access -The MARVEL prospective registry.
    Catheter Cardiovasc Interv. 2021;97:1270-1278.
    >> Share

  555. ALLAHWALA UK, Nour D, Bhatia K, Ward MR, et al
    Prognostic impact of collaterals in patients with a coronary chronic total occlusion: A meta-analysis of over 3,000 patients.
    Catheter Cardiovasc Interv. 2021;97:E771-E777.
    >> Share

  556. FUKAGAWA T, Mori S, Hirano K
    Feasibility of the novel proximal superficial femoral artery puncture technique to recanalize chronic total occlusions.
    Catheter Cardiovasc Interv. 2021;97:E852-E856.
    >> Share

  557. KALRA S, Doshi D, Sapontis J, Kosmidou I, et al
    Outcomes of retrograde chronic total occlusion percutaneous coronary intervention: A report from the OPEN-CTO registry.
    Catheter Cardiovasc Interv. 2021;97:1162-1173.
    >> Share

  558. ELRAYES MM, Xenogiannis I, Nikolakopoulos I, Vemmou E, et al
    An algorithmic approach to balloon-uncrossable coronary lesions.
    Catheter Cardiovasc Interv. 2021;97:E817-E825.
    >> Share

  559. TESTI G, Ceccacci T, Maioli F, Grotti S, et al
    Medial-to-lateral plantar loop technique for retrograde transcollateral recanalization of the lateral plantar artery in patients with type 3 plantar arch.
    Catheter Cardiovasc Interv. 2021;97:E842-E846.
    >> Share

  560. ARANZULLA TC, Musumeci G
    Morphological stabilization and regression of carotid plaque following therapy with evolocumab in a high-risk patient.
    Catheter Cardiovasc Interv. 2021;97:E835-E841.
    >> Share

  561. WERNER GS, Yaginuma K, Koch M, Tischer K, et al
    Modulated radiation protocol achieves marked reduction of radiation exposure for chronic total coronary occlusion intervention.
    Catheter Cardiovasc Interv. 2021;97:1196-1206.
    >> Share

  562. CHEN S, David SW, Khan ZA, Metzger DC, et al
    One-year outcomes of supersaturated oxygen therapy in acute anterior myocardial infarction: The IC-HOT study.
    Catheter Cardiovasc Interv. 2021;97:1120-1126.
    >> Share

  563. KIM MC, Bae S, Ahn Y, Sim DS, et al
    Benefit of a staged in-hospital revascularization strategy in hemodynamically stable patients with ST-segment elevation myocardial infarction and multivessel disease: Analyses by risk stratification.
    Catheter Cardiovasc Interv. 2021;97:1151-1159.
    >> Share

  564. PAHUJA M, Ranka S, Chehab O, Mishra T, et al
    Incidence and clinical outcomes of bleeding complications and acute limb ischemia in STEMI and cardiogenic shock.
    Catheter Cardiovasc Interv. 2021;97:1129-1138.
    >> Share

  565. PATTERSON C, Sapontis J, Nicholson WJ, Lombardi W, et al
    Impact of body mass index on outcome and health status after chronic total occlusion percutaneous coronary intervention: Insights from the OPEN-CTO study.
    Catheter Cardiovasc Interv. 2021;97:1186-1193.
    >> Share

  566. GARCIA S, Schmidt CW, Garberich R, Henry TD, et al
    Temporal changes in patient characteristics and outcomes in ST-segment elevation myocardial infarction 2003-2018.
    Catheter Cardiovasc Interv. 2021;97:1109-1117.
    >> Share

  567. KOLK MZH, van Veelen A, Agostoni P, van Houwelingen GK, et al
    Predictors and outcomes of procedural failure of percutaneous coronary intervention of a chronic total occlusion-A subanalysis of the EXPLORE trial.
    Catheter Cardiovasc Interv. 2021;97:1176-1183.
    >> Share

  568. MEIER D, Fournier S, Masci PG, Eeckhout E, et al
    Impact of manual thrombectomy on microvascular obstruction in STEMI patients.
    Catheter Cardiovasc Interv. 2021;97:1141-1148.
    >> Share

  569. CAI X, Tian F, Jing J, Jin Q, et al
    Prognostic value of quantitative flow ratio measured immediately after drug-coated balloon angioplasty for in-stent restenosis.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1048-1054.
    >> Share

  570. HU P, Sun Y, Li CL, Jin R, et al
    A randomized comparison of two paclitaxel-coated balloons for the treatment of in-stent restenosis: The LONGTY ISR China randomized trial (LONGTY DCB vs. SeQuent Please DCB).
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:988-995.
    >> Share

  571. LI X, Qiu M, Na K, Li Y, et al
    Comparison of the efficacy and safety of ticagrelor and clopidogrel in patients with acute coronary syndrome after risk stratification.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1032-1039.
    >> Share

  572. ZHANG J, Qiu M, Na K, Ma S, et al
    Impact of 6- versus 12-month dual antiplatelet therapy on clinical prognosis in patients with high bleeding risk: Insights from the 4-year results of the I LOVE IT 2 study.
    Catheter Cardiovasc Interv. 2021;97 Suppl 2:1025-1031.
    >> Share

    April 2021
  573. DUNN AN, Huded C, Raymond R, Lincoff AM, et al
    Successful modeling of long term outcomes in end-stage renal disease patients undergoing percutaneous coronary intervention with drug-eluting stents.
    Catheter Cardiovasc Interv. 2021 Apr 29. doi: 10.1002/ccd.29707.
    >> Share

  574. ABIZAID A, Campos CM, Guimaraes PO, Costa JR Jr, et al
    Patients with COVID-19 who experience a myocardial infarction have complex coronary morphology and high in-hospital mortality: Primary results of a nationwide angiographic study.
    Catheter Cardiovasc Interv. 2021 Apr 27. doi: 10.1002/ccd.29709.
    >> Share

  575. OBA Y, Inohara T, Takahashi M, Fukutomi M, et al
    In-hospital outcomes and usage of embolic protection devices in percutaneous coronary intervention for coronary artery bypass grafts: Insights from a Japanese nationwide registry.
    Catheter Cardiovasc Interv. 2021 Apr 16. doi: 10.1002/ccd.29695.
    >> Share

  576. KIM M, Park KW, Lee HS, Ki YJ, et al
    The validation of the dual antiplatelet therapy score in East Asians receiving percutaneous coronary intervention with exclusively second generation drug-eluting stents.
    Catheter Cardiovasc Interv. 2021 Apr 5. doi: 10.1002/ccd.29682.
    >> Share

  577. SHARMA SK, Fuster V, Hofstra L, Kini AS, et al
    Lessons learned from reduced acute cardiovascular events and STEMI during Covid-19.
    Catheter Cardiovasc Interv. 2021;97:850-852.
    >> Share

  578. LOPEZ JJ, Ebinger JE, Allen S, Yildiz M, et al
    Adapting STEMI care for the COVID-19 pandemic: The case for low-risk STEMI triage and early discharge.
    Catheter Cardiovasc Interv. 2021;97:847-849.
    >> Share

  579. QUESADA O, Henry TD
    New generation drug eluting stents: Closing the gap in sex disparity in cardiovascular outcomes in women.
    Catheter Cardiovasc Interv. 2021;97:805-806.
    >> Share

  580. FARHAD H, Levy MS
    PCI for left main bifurcation stenting: A treatment paradigm at a crossroads?
    Catheter Cardiovasc Interv. 2021;97:786-787.
    >> Share

  581. NICOLAS J, Mehran R
    Bivalirudin versus heparin in PCI: Is the pendulum swinging again in favor of heparin?
    Catheter Cardiovasc Interv. 2021;97:774-775.
    >> Share

  582. ASHLEY KE, Hillegass WB
    Genotype-guided antiplatelet therapy for acute coronary syndrome percutaneous coronary intervention patients: A new standard of care?
    Catheter Cardiovasc Interv. 2021;97:795-796.
    >> Share

  583. FUKAGAWA T, Hirano K, Mori S, Yamawaki M, et al
    Efficacy of the novel technique HIRANODOME in preventing distal embolization during endovascular treatment of femoropopliteal lesions.
    Catheter Cardiovasc Interv. 2021;97:E697-E703.
    >> Share

  584. VERMA I, Chang EY, Kumar G, Sachdeva R, et al
    Catheter directed embolectomy of right atrial clot in transit-A case series.
    Catheter Cardiovasc Interv. 2021;97:869-873.
    >> Share

  585. CHOI CH, Hall JK, Malaver D, Applegate RJ, et al
    A novel technique for postclosure of large-bore sheaths using two Perclose devices.
    Catheter Cardiovasc Interv. 2021;97:905-909.
    >> Share

  586. MENDELSOHN FO, Holmes DR Jr, Hopkins LN
    Expanding the stroke team to include interventional cardiology.
    Catheter Cardiovasc Interv. 2021;97:874-875.
    >> Share

  587. OSMAN M, Syed M, Abdul Ghaffar Y, Patel B, et al
    Gender-based outcomes of impeller pumps percutaneous ventricular assist devices.
    Catheter Cardiovasc Interv. 2021;97:E627-E635.
    >> Share

  588. MODINE T, Vincent F, Delhaye C, Van Belle E, et al
    A dedicated Y-shaped percutaneous ECMO cannula for femoral 2-in-1 vascular access during high-risk procedures.
    Catheter Cardiovasc Interv. 2021;97:959-961.
    >> Share

  589. PROTTY MB, Hussain HI, Gallagher S, Al-Raisi S, et al
    Excimer laser coronary atherectomy during complex PCI: An analysis of 1,471 laser cases from the British Cardiovascular Intervention Society database.
    Catheter Cardiovasc Interv. 2021;97:E653-E660.
    >> Share

  590. LEE CH, Ahn JM, Kang DY, Han M, et al
    Comparison of simple versus complex stenting in patients with true distal left main bifurcation lesions.
    Catheter Cardiovasc Interv. 2021;97:776-785.
    >> Share

  591. SHAIK A, Mosleh W, Dahal K, Pickett C, et al
    The absence of evidence is not the evidence of absence: A case report on the challenges in diagnosing ostial left main stenosis.
    Catheter Cardiovasc Interv. 2021;97:836-840.
    >> Share

  592. KITANI S, Igarashi Y, Tsuchikane E, Nakamura S, et al
    Efficacy of drug-coated balloon angioplasty after directional coronary atherectomy for coronary bifurcation lesions (DCA/DCB registry).
    Catheter Cardiovasc Interv. 2021;97:E614-E623.
    >> Share

  593. FABBIOCCHI F, Calligaris G, Bartorelli AL
    Progressive growth of coronary aneurysms after bioresorbable vascular scaffold implantation: Successful treatment with OCT-guided exclusion using covered stents.
    Catheter Cardiovasc Interv. 2021;97:E676-E679.
    >> Share

  594. NAZIR S, Ahuja KR, Virk HUH, Elzanaty A, et al
    A meta-analysis of efficacy and safety of genotype-guided versus standard of care treatment strategies in selecting antiplatelet therapy in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021;97:788-794.
    >> Share

  595. TARANTINI G, Masiero G, Burzotta F, Pazzanese V, et al
    Timing of Impella implantation and outcomes in cardiogenic shock or high-risk percutaneous coronary revascularization.
    Catheter Cardiovasc Interv. 2021 Apr 1. doi: 10.1002/ccd.29674.
    >> Share

    March 2021
  596. LIU ZY, Yin ZH, Liang CY, He J, et al
    Zero contrast optical coherence tomography-guided percutaneous coronary intervention in patients with non-ST segment elevation myocardial infarction and chronic kidney disease.
    Catheter Cardiovasc Interv. 2021 Mar 25. doi: 10.1002/ccd.29655.
    >> Share

  597. MOHAMED MO, Curzen N, de Belder M, Goodwin AT, et al
    Revascularisation strategies in patients with significant left main coronary disease during the COVID-19 pandemic.
    Catheter Cardiovasc Interv. 2021 Mar 25. doi: 10.1002/ccd.29663.
    >> Share

  598. HU X, Qiao S, Guan C, Guo C, et al
    Angiographic characteristics and long-term outcomes of single-vessel chronic total occlusion percutaneous coronary intervention in patients with and without previous myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Mar 24. doi: 10.1002/ccd.29651.
    >> Share

  599. SHAH AM, Siddiqui E, Cuenca C, Drotar P, et al
    Trends in the utilization and reimbursement of coronary revascularization in the United States Medicare population from 2010 to 2018.
    Catheter Cardiovasc Interv. 2021 Mar 24. doi: 10.1002/ccd.29649.
    >> Share

  600. OTSUKA T, Ueki Y, Kavaliauskaite R, Zanchin T, et al
    Single antiplatelet therapy with use of prasugrel in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 22. doi: 10.1002/ccd.29650.
    >> Share

  601. WANG H, Wang HY, Yin D, Feng L, et al
    Early radial artery occlusion following the use of a transradial 7-French sheath for complex coronary interventions in Chinese patients.
    Catheter Cardiovasc Interv. 2021 Mar 22. doi: 10.1002/ccd.29653.
    >> Share

  602. PLOUMEN EH, Buiten RA, Zocca P, Doggen CJM, et al
    Acute myocardial infarction treated with novel Resolute Onyx and Orsiro stents in the randomized BIONYX trial.
    Catheter Cardiovasc Interv. 2021 Mar 10. doi: 10.1002/ccd.29594.
    >> Share

  603. GAO L, Gao Z, Song Y, Guan C, et al
    Long-term clinical outcomes in transradial versus transfemoral access for left main percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 10. doi: 10.1002/ccd.29586.
    >> Share

  604. WANG T, Guan H, Tian T, Guan C, et al
    Thirty-day and 5-year results of percutaneous coronary intervention for in-stent restenotic chronic total occlusion lesions: Data from 2,659 consecutive patients.
    Catheter Cardiovasc Interv. 2021 Mar 5. doi: 10.1002/ccd.29585.
    >> Share

  605. SONG L, Qiao S, Guan C, Bai Y, et al
    Association of symptom status, myocardial viability, and clinical/anatomic risk on long-term outcomes after chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Mar 2. doi: 10.1002/ccd.29577.
    >> Share

  606. SMALLING RW
    Pre-transfer/PCI with ticagrelor and heparin administration in STEMI patients may be beneficial but should we do more?
    Catheter Cardiovasc Interv. 2021;97:600-601.
    >> Share

  607. AGARWAL SK, Uretsky BF
    Is it time for a "functional" hybrid algorithm to optimize interventional results in chronic total occlusion?
    Catheter Cardiovasc Interv. 2021;97:656-657.
    >> Share

  608. ASHLEY KE, Hillegass WB
    Antiplatelet therapy regimen and duration after percutaneous coronary intervention: Combining prediction scores with clinical judgment.
    Catheter Cardiovasc Interv. 2021;97:579-580.
    >> Share

  609. PATEL NJ, Heuser RR
    "PROGRESS is our most important product": Adventures in CTO intervention.
    Catheter Cardiovasc Interv. 2021;97:668-669.
    >> Share

  610. CASE BC, Satler LF
    The challenges of coronary no-reflow phenomenon.
    Catheter Cardiovasc Interv. 2021;97:612-613.
    >> Share

  611. AREGULLIN EO, Mohammad Nijres B, Al-Khatib Y, Vettukattil J, et al
    Transcatheter Fontan completion using novel balloon and stent system.
    Catheter Cardiovasc Interv. 2021;97:679-684.
    >> Share

  612. N'DANDU Z, Bonilla J, Yousef GM, White CJ, et al
    Percutaneous deep vein arterialization: An emerging technique for no-option chronic limb-threatening ischemia patients.
    Catheter Cardiovasc Interv. 2021;97:685-690.
    >> Share

  613. MIHATOV N, Secemsky EA, Kereiakes DJ, Steg G, et al
    Utility of the dual antiplatelet therapy score to guide antiplatelet therapy: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2021;97:569-578.
    >> Share

  614. AL NASEF M, Oslizlok P, Walsh KP
    Percutaneous transcatheter occlusion of left atrioventricular valve in a patient with single ventricle and severe atrioventricular valve regurgitation.
    Catheter Cardiovasc Interv. 2021;97:E510-E513.
    >> Share

  615. ENOMOTO Y, Egashira Y, Iwama T
    What's happening in carotid stent? A case report of prominent plaque protrusion after carotid artery stenting observed on angioscopy.
    Catheter Cardiovasc Interv. 2021;97:E532-E535.
    >> Share

  616. JOSHI FR, Lonborg J, Sadjadieh G, Helqvist S, et al
    The benefit of complete revascularization after primary PCI for STEMI is attenuated by increasing age: Results from the DANAMI-3-PRIMULTI randomized study.
    Catheter Cardiovasc Interv. 2021;97:E467-E474.
    >> Share

  617. NAVARESE EP, Frediani L, Kandzari DE, Caiazzo G, et al
    Efficacy and safety of intracoronary epinephrine versus conventional treatments alone in STEMI patients with refractory coronary no-reflow during primary PCI: The RESTORE observational study.
    Catheter Cardiovasc Interv. 2021;97:602-611.
    >> Share

  618. LEE SH, Choi KH, Lee JM, Shin D, et al
    Residual functional SYNTAX score by quantitative flow ratio and improvement of exercise capacity after revascularization.
    Catheter Cardiovasc Interv. 2021;97:E454-E466.
    >> Share

  619. WHITBECK MG, Chambers JW
    Single-access during Impella hemodynamic support utilizing the Railway system.
    Catheter Cardiovasc Interv. 2021;97:675-678.
    >> Share

  620. KAYAERT P, Coeman M, Drieghe B, Bennett J, et al
    iFR uncovers profound but mostly reversible ischemia in CTOs and helps to optimize PCI results.
    Catheter Cardiovasc Interv. 2021;97:646-655.
    >> Share

  621. NAKAJIMA A, Araki M, Kurihara O, Minami Y, et al
    Comparison of post-stent optical coherence tomography findings among three subtypes of calcified culprit plaques in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021;97:634-645.
    >> Share

    February 2021
  622. TAO L, Li Z, Yin Z, Lin W, et al
    Nine-month angiographic and 2-year clinical outcomes of the RECOVERY trial: A randomized study of the biodegradable polymer sirolimus-eluting COMBO dual-therapy stent versus a polymer-free sirolimus-eluting stent in Chinese patients.
    Catheter Cardiovasc Interv. 2021 Feb 19. doi: 10.1002/ccd.29553.
    >> Share

  623. ALEJANDRO GB, Gheorghe LL, Camacho Freire S, Silva E, et al
    Long-term clinical, angiographic, and optical coherence tomography findings of Mg-based bioresorbable scaffold in patients with acute coronary syndrome.
    Catheter Cardiovasc Interv. 2021 Feb 18. doi: 10.1002/ccd.29557.
    >> Share

  624. REILLY JP, Parikh PB
    PCI in TAVR patients: Timing isn't everything.
    Catheter Cardiovasc Interv. 2021;97:540-541.
    >> Share

  625. RAZZOUK L, Jneid H
    Revascularization in patients with diabetes and chronic total occlusion: The journey or the destination?
    Catheter Cardiovasc Interv. 2021;97:384-385.
    >> Share

  626. ALQAHTANI F, Osman M, Harris AH, Hohmann SF, et al
    Mortality and functional outcomes of endovascular stroke therapy in the United States.
    Catheter Cardiovasc Interv. 2021;97:470-474.
    >> Share

  627. ZHANG Y, Xiang D, Lu Q, Wu M, et al
    A systematic review and meta-analysis of the performance of flow-diverting stents in the treatment of peripheral and visceral artery aneurysms.
    Catheter Cardiovasc Interv. 2021;97:461-469.
    >> Share

  628. KUMAR A, Sammour Y, Reginauld S, Sato K, et al
    Adverse clinical outcomes in patients undergoing both PCI and TAVR: Analysis from a pooled multi-center registry.
    Catheter Cardiovasc Interv. 2021;97:529-539.
    >> Share

  629. CHIABRANDO JG, Lombardi M, Vescovo GM, Wohlford GF, et al
    Stenting techniques for coronary bifurcation lesions: Evidence from a network meta-analysis of randomized clinical trials.
    Catheter Cardiovasc Interv. 2021;97:E306-E318.
    >> Share

  630. MADDER RD, VanOosterhout S, Parker J, Sconzert K, et al
    Robotic telestenting performance in transcontinental and regional pre-clinical models.
    Catheter Cardiovasc Interv. 2021;97:E327-E332.
    >> Share

  631. YASUMURA K, Benhuri B, Vengrenyuk Y, Petrov A, et al
    Procedural and 1-year clinical outcomes of orbital atherectomy for treatment of coronary in-stent restenosis: A single-center, retrospective study.
    Catheter Cardiovasc Interv. 2021;97:E280-E287.
    >> Share

  632. OSHEROV AB, Qiang B, Butany J, Wright GA, et al
    A calcified chronic total occlusion preclinical model.
    Catheter Cardiovasc Interv. 2021;97:437-442.
    >> Share

  633. ABHYANKAR A, Abizaid A, Chamie D, Rathod M, et al
    Comparison of neointimal coverage between ultrathin biodegradable polymer-coated sirolimus-eluting stents and durable polymer-coated everolimus-eluting stents: 6 months optical coherence tomography follow-up from the TAXCO study.
    Catheter Cardiovasc Interv. 2021;97:423-430.
    >> Share

  634. FLORES-UMANZOR EJ, Cepas-Guillen PL, Vazquez S, Fernandez-Valledor A, et al
    Survival benefit of revascularization versus optimal medical therapy alone for chronic total occlusion management in patients with diabetes.
    Catheter Cardiovasc Interv. 2021;97:376-383.
    >> Share

  635. SAITO Y, Cristea E, Bouras G, Abizaid A, et al
    Long-term serial functional evaluation after implantation of the Fantom sirolimus-eluting bioresorbable coronary scaffold.
    Catheter Cardiovasc Interv. 2021;97:431-436.
    >> Share

  636. YA'QOUB L, Gad M, Saad AM, Elgendy IY, et al
    National trends of utilization and readmission rates with intravascular ultrasound use for ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Feb 11. doi: 10.1002/ccd.29524.
    >> Share

  637. ALAOUR B, Onwordi E, Khan A, Menexi C, et al
    Outcome of left main stem percutaneous coronary intervention in a UK nonsurgical center: A 5-year clinical experience.
    Catheter Cardiovasc Interv. 2021 Feb 11. doi: 10.1002/ccd.29530.
    >> Share

  638. KINNAIRD T, Anderson R, Gallagher S, Sharp ASP, et al
    Vascular complications associated with intraaortic balloon pump supported percutaneous coronary intervention (PCI) and clinical outcomes from the British Cardiovascular Intervention Society National PCI Database.
    Catheter Cardiovasc Interv. 2021 Feb 8. doi: 10.1002/ccd.29549.
    >> Share

  639. BRUNO F, De Filippo O, Conrotto F, D'Ascenzo F, et al
    Response to: Angiography versus FFR-guided coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2021 Feb 7. doi: 10.1002/ccd.29542.
    >> Share

  640. LEE SH, Choi J, Chang YJ, Shin ES, et al
    Sex difference in long-term clinical outcomes after percutaneous coronary intervention: A propensity-matched analysis of National Health Insurance data in Republic of Korea.
    Catheter Cardiovasc Interv. 2021 Feb 6. doi: 10.1002/ccd.29511.
    >> Share

  641. CHANGAL K
    Angiography versus fractional flow rate-guided coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2021 Feb 4. doi: 10.1002/ccd.29540.
    >> Share

  642. VAN WIECHEN MP, Kroon H, Hokken TW, Ooms JF, et al
    Vascular complications with a plug-based vascular closure device after transcatheter aortic valve replacement: Predictors and bail-outs.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29506.
    >> Share

  643. SHIELDS MC, Ouellette M, Kiefer N, Kohan L, et al
    Characteristics and outcomes of surgically ineligible patients with multivessel disease treated with percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2021 Feb 3. doi: 10.1002/ccd.29508.
    >> Share

  644. KAYANI WT, Jneid H
    Increasing stroke events in patients with ST elevation myocardial infraction and cardiogenic shock: A cause for concern.
    Catheter Cardiovasc Interv. 2021;97:226-227.
    >> Share

  645. AGARWAL SK, Uretsky BF
    Toward a more perfect coronary intervention....
    Catheter Cardiovasc Interv. 2021;97:245-246.
    >> Share

  646. KERN MJ, Seto AH
    How strong is the warranty of a negative FFR? Comment on long-term outcome after deferred revascularization due to negative fractional flow reserve in intermediate coronary lesions by Weerts et al.
    Catheter Cardiovasc Interv. 2021;97:257-258.
    >> Share

  647. BUTMAN SM
    Hybrid revascularization procedures for multivessel disease: 2021.
    Catheter Cardiovasc Interv. 2021;97:265-266.
    >> Share

  648. CELIK O, Guner A, Kalcik M, Guler A, et al
    The predictive value of CHADS2 score for subclinical cerebral ischemia after carotid artery stenting (from the PREVENT-CAS trial).
    Catheter Cardiovasc Interv. 2021;97:301-309.
    >> Share

  649. BARRETT C, Warsavage T, Kovach C, McGuinn E, et al
    Comparison of rotational and orbital atherectomy for the treatment of calcific coronary lesions: Insights from the VA clinical assessment reporting and tracking (CART) program.
    Catheter Cardiovasc Interv. 2021;97:E219-E226.
    >> Share

  650. GALLONE G, D'Ascenzo F, Conrotto F, Costa F, et al
    Accuracy of the PARIS score and PCI complexity to predict ischemic events in patients treated with very thin stents in unprotected left main or coronary bifurcations.
    Catheter Cardiovasc Interv. 2021;97:E227-E236.
    >> Share

  651. TAMARU H, Fujii K, Otsuji S, Takiuchi S, et al
    Short- and mid-term influence of drug-coated stent implantation on structural and functional vascular healing response: An optical coherence tomography and acetylcholine testing study.
    Catheter Cardiovasc Interv. 2021;97:E186-E193.
    >> Share

  652. WATANABE Y, Mitomo S, Naganuma T, Kawamoto H, et al
    Clinical outcomes of double stent strategy for unprotected left main distal bifurcation lesions using current generation drug eluting stent comparing to early generation drug eluting stent; The Milan and New Tokyo (MITO) registry.
    Catheter Cardiovasc Interv. 2021;97:E198-E208.
    >> Share

  653. HUSSAIN HI, Protty MB, Gallagher S, Al-Raisi S, et al
    The impact of coronary perforation in percutaneous interventions involving the left main stem coronary artery in the United Kingdom 2007-2014: Insights from the British Cardiovascular Intervention Society database.
    Catheter Cardiovasc Interv. 2021;97:E179-E185.
    >> Share

  654. SHARMA RK, Poulin MF, Tamez-Aguilar H, Pinto DS, et al
    Post hoc closure of large bore vascular access using the MANTA closure device.
    Catheter Cardiovasc Interv. 2021;97:282-286.
    >> Share

    January 2021
  655. CHIARITO M, Cao D, Nicolas J, Roumeliotis A, et al
    Radial versus femoral access for coronary interventions: An updated systematic review and meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2021 Jan 28. doi: 10.1002/ccd.29486.
    >> Share

  656. HIRAI T, Grantham JA, Sapontis J, Nicholson WJ, et al
    Development and validation of a prediction model for angiographic perforation during chronic total occlusion percutaneous coronary intervention: OPEN-CLEAN perforation score.
    Catheter Cardiovasc Interv. 2021 Jan 13. doi: 10.1002/ccd.29466.
    >> Share

  657. MCKENZIE A, Zhou C, Svendsen C, Anketell R, et al
    Ability of a novel shock index that incorporates invasive hemodynamics to predict mortality in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2021 Jan 9. doi: 10.1002/ccd.29460.
    >> Share

  658. TARANTINI G, Fraccaro C
    Twilight-specific light cues.
    Catheter Cardiovasc Interv. 2021;97:72-73.
    >> Share

  659. KRAJCER Z, Costello B
    Clinical impact of calcified nodules in patients with heavily calcified lesions requiring rotational atherectomy.
    Catheter Cardiovasc Interv. 2021;97:20-21.
    >> Share

  660. RODRIGUEZ-PAZ E, Heuser R
    "Back to the future: Beta radiation to treat recurrent in-stent restenosis".
    Catheter Cardiovasc Interv. 2021;97:47.
    >> Share

  661. SMITH T, Henry TD
    Spontaneous coronary artery dissection with cardiogenic shock: How frequent is it? How should we treat it?
    Catheter Cardiovasc Interv. 2021;97:78-79.
    >> Share

  662. GRINES CL, Yen A
    Between a rock and a hard place: Orbital atherectomy for under-expanded stents.
    Catheter Cardiovasc Interv. 2021;97:8-9.
    >> Share

  663. CHUGH Y, Brilakis ES
    Intravascular lithotripsy for stent under-expansion: Panacea or Pandora's box?
    Catheter Cardiovasc Interv. 2021;97:30-31.
    >> Share

  664. KERN MJ
    Is stealing still a crime? Comment on left internal mammary artery side branch intervention in the management of coronary steal syndrome following coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2021;97:105-107.
    >> Share

  665. MAESTAS CM, Blankenship JC
    Interventional economics provide a roadmap to better patient care.
    Catheter Cardiovasc Interv. 2021;97:94-96.
    >> Share

  666. FAN LM, Tong D, Mintz GS, Mamas MA, et al
    Breaking the deadlock of calcified coronary artery lesions: A contemporary review.
    Catheter Cardiovasc Interv. 2021;97:108-120.
    >> Share

  667. DI MARCO A, Anguera I, Nombela-Franco L, Oloriz T, et al
    Revascularization of coronary chronic total occlusions in an infarct-related artery and recurrence of ventricular arrhythmias among patients with secondary prevention implantable cardioverter defibrillator.
    Catheter Cardiovasc Interv. 2021;97:E1-E11.
    >> Share

  668. MCQUILLAN C, Jackson MWP, Brilakis ES, Egred M, et al
    Uncrossable and undilatable lesions-A practical approach to optimizing outcomes in PCI.
    Catheter Cardiovasc Interv. 2021;97:121-126.
    >> Share

  669. BABER U, Chandiramani R, Mehta SR, Sartori S, et al
    Safety and efficacy of the bioabsorbable polymer everolimus-eluting stent versus durable polymer drug-eluting stents in high-risk patients undergoing PCI: TWILIGHT-SYNERGY.
    Catheter Cardiovasc Interv. 2021;97:63-71.
    >> Share

  670. KUME T, Murasato Y, Yamada R, Koyama T, et al
    Effect of proximal balloon edge dilation technique for opening a side branch ostium in repetitive-proximal optimizing technique sequence.
    Catheter Cardiovasc Interv. 2021;97:E12-E18.
    >> Share

  671. CHEN K, Scridon T, Chait R
    Inadvertent aortocoronary arteriovenous fistula after CABG: Systematic review of case reports.
    Catheter Cardiovasc Interv. 2021;97:E19-E25.
    >> Share

  672. AZZALINI L, Alaswad K, Uretsky BF, Agostoni P, et al
    Multicenter experience with the antegrade fenestration and reentry technique for chronic total occlusion recanalization.
    Catheter Cardiovasc Interv. 2021;97:E40-E50.
    >> Share

  673. LAMELAS P, Padilla L, Abud M, Cigalini I, et al
    In-stent chronic total occlusion angioplasty in the LATAM-CTO registry.
    Catheter Cardiovasc Interv. 2021;97:E34-E39.
    >> Share

  674. MOROFUJI T, Kuramitsu S, Shinozaki T, Jinnouchi H, et al
    Clinical impact of calcified nodule in patients with heavily calcified lesions requiring rotational atherectomy.
    Catheter Cardiovasc Interv. 2021;97:10-19.
    >> Share

  675. WIEBE J, Hofmann FJ, Dorr O, Bauer T, et al
    Five-year follow-up of patients who underwent everolimus-eluting bioresorbable scaffold implantation.
    Catheter Cardiovasc Interv. 2021;97:56-62.
    >> Share

  676. NEUPANE S, Basir M, Tan C, Sultan A, et al
    Feasibility and safety of orbital atherectomy for the treatment of in-stent restenosis secondary to stent under-expansion.
    Catheter Cardiovasc Interv. 2021;97:2-7.
    >> Share

    December 2020
  677. SCOTTI A, Godino C, Munafo A, Pivato CA, et al
    Cardiac and sudden death after chronic total occlusion percutaneous coronary intervention: Prognostic role of the target vessel.
    Catheter Cardiovasc Interv. 2020 Dec 17. doi: 10.1002/ccd.29425.
    >> Share

  678. BLOOM JE, Dinh DT, Noaman S, Martin C, et al
    Adverse impact of chronic kidney disease on clinical outcomes following percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Dec 16. doi: 10.1002/ccd.29436.
    >> Share

  679. BRUNO F, D'Ascenzo F, Marengo G, Manfredi R, et al
    Fractional flow reserve guided versus angiographic guided surgical revascularization: A meta-analysis.
    Catheter Cardiovasc Interv. 2020 Dec 14. doi: 10.1002/ccd.29427.
    >> Share

  680. TOKUDA T, Mori S, Oba Y, Koshida R, et al
    Comparison of ultrasound-guided versus angiography-guided endovascular treatment for femoropopliteal artery occlusive disease.
    Catheter Cardiovasc Interv. 2020 Dec 12. doi: 10.1002/ccd.29437.
    >> Share

  681. ASIF A, Sezer A, Thoma F, Toma C, et al
    Relationship between predicting bleeding complication in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score and mortality among patients with atrial fibrillation undergoing percutaneous coronary interv
    Catheter Cardiovasc Interv. 2020 Dec 9. doi: 10.1002/ccd.29399.
    >> Share

  682. COCKBURN J, Kemp T, Ludman P, Kinnaird T, et al
    Percutaneous coronary intervention in octogenarians: A risk scoring system to predict 30-day outcomes in the elderly.
    Catheter Cardiovasc Interv. 2020 Dec 6. doi: 10.1002/ccd.29406.
    >> Share

  683. ABIZAID A, Kedev S, Ali RBM, Santoso T, et al
    Imaging and 2-year clinical outcomes of thin strut sirolimus-eluting bioresorbable vascular scaffold: The MeRes-1 extend trial.
    Catheter Cardiovasc Interv. 2020 Dec 2. doi: 10.1002/ccd.29396.
    >> Share

  684. LAZKANI M, Tripathi B, Dattilo P
    Impact of intracoronary imaging on in-hospital mortality and 30-day readmission rates following percutaneous coronary intervention: A nationwide readmissions database analysis.
    Catheter Cardiovasc Interv. 2020 Dec 2. doi: 10.1002/ccd.29394.
    >> Share

    November 2020
  685. GIFFT K, Omran J, Ghrair F, Allaham H, et al
    Impact of preexisting coronary arterial disease in patients undergoing percutaneous mitral valve repair (MitraClip).
    Catheter Cardiovasc Interv. 2020 Nov 28. doi: 10.1002/ccd.29404.
    >> Share

  686. LABIN JE, Saggar R, Yang EH, Lluri G, et al
    Left main coronary artery compression in pulmonary hypertension.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29401.
    >> Share

  687. BLUM M, Cao D, Chandiramani R, Goel R, et al
    Prevalence and prognostic impact of hsCRP elevation are age-dependent in women but not in men undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Nov 25. doi: 10.1002/ccd.29402.
    >> Share

  688. AHSAN MJ, Lateef N, Latif A, Malik SU, et al
    A systematic review and meta-analysis of impact of baseline thrombocytopenia on cardiovascular outcomes and mortality in patients undergoing percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Nov 24. doi: 10.1002/ccd.29405.
    >> Share

  689. PROTTY MB, Gallagher S, Farooq V, Sharp AS, et al
    Combined use of rotational and excimer lASER coronary atherectomy (RASER) during complex coronary angioplasty-An analysis of cases (2006-2016) from the British Cardiovascular Intervention Society database.
    Catheter Cardiovasc Interv. 2020 Nov 17. doi: 10.1002/ccd.29377.
    >> Share

  690. KAWASHIMA H, Hara H, Wang R, Ono M, et al
    Usefulness of updated logistic clinical SYNTAX score based on MI-SYNTAX score in patients with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Nov 11. doi: 10.1002/ccd.29383.
    >> Share

  691. TARANTINI G, Fraccaro C
    Aortic valve replacement plus revascularization: The battle of surgical versus transcatheter approach still rages.
    Catheter Cardiovasc Interv. 2020;96:1126-1127.
    >> Share

  692. POSTALIAN A, Krajcer Z
    Chronic total occlusion percutaneous coronary intervention: The Latin American experience.
    Catheter Cardiovasc Interv. 2020;96:1056-1057.
    >> Share

    October 2020
  693. GARG A, Rout A, Raheja H, Hakeem H, et al
    Long-term follow-up of percutaneous coronary intervention versus coronary artery bypass grafting in left main coronary artery disease: A systematic review and meta-analysis.
    Catheter Cardiovasc Interv. 2020 Oct 26. doi: 10.1002/ccd.29338.
    >> Share

  694. SOGA Y, Takahara M, Ito N, Katsuki T, et al
    Clinical impact of intravascular ultrasound-guided balloon angioplasty in patients with chronic limb threatening ischemia for isolated infrapopliteal lesion.
    Catheter Cardiovasc Interv. 2020 Oct 21. doi: 10.1002/ccd.29347.
    >> Share

  695. YAMAMOTO K, Shiomi H, Morimoto T, Takeji Y, et al
    Ischemic and bleeding risk after complex percutaneous coronary intervention in patients with or without high bleeding risk.
    Catheter Cardiovasc Interv. 2020 Oct 16. doi: 10.1002/ccd.29335.
    >> Share

  696. SEPULVEDA P, Hameau R, Backhouse C, Charme G, et al
    Mid-term follow-up of balloon pulmonary angioplasty for inoperable chronic thromboembolic pulmonary hypertension: An experience in Latin America.
    Catheter Cardiovasc Interv. 2020 Oct 15. doi: 10.1002/ccd.29322.
    >> Share

  697. GOEL R, Cao D, Chandiramani R, Roumeliotis A, et al
    Comparative influence of bleeding and ischemic risk factors on diabetic patients undergoing percutaneous coronary intervention with everolimus-eluting stents.
    Catheter Cardiovasc Interv. 2020 Oct 10. doi: 10.1002/ccd.29314.
    >> Share

  698. MASDJEDI K, van Zandvoort LJ, Balbi MM, Nuis RJ, et al
    Validation of novel 3-dimensional quantitative coronary angiography based software to calculate fractional flow reserve post stenting.
    Catheter Cardiovasc Interv. 2020 Oct 6. doi: 10.1002/ccd.29311.
    >> Share

  699. PAJJURU VS, Thandra A, Guddeti RR, Kothapalli SR, et al
    ST-elevation myocardial infarction in nonagenarians: A nationwide analysis of trends and outcomes in the United States.
    Catheter Cardiovasc Interv. 2020 Oct 3. doi: 10.1002/ccd.29313.
    >> Share

    September 2020
  700. LUNARDI M, Franzese I, Faggian G, Ribichini FL, et al
    Hybrid treatment of aortic aneurism, type-A dissection, and aortic valve stenosis.
    Catheter Cardiovasc Interv. 2020 Sep 26. doi: 10.1002/ccd.29303.
    >> Share

  701. KUNO T, Takagi H, Ando T, Kodaira M, et al
    Safety and efficacy of mechanical circulatory support with Impella or intra-aortic balloon pump for high-risk percutaneous coronary intervention and/or cardiogenic shock: Insights from a network meta-analysis of randomized trials.
    Catheter Cardiovasc Interv. 2020 Sep 7. doi: 10.1002/ccd.29236.
    >> Share

  702. LOPERA JE, Jen S
    Superior vena cava filter placement over existing central venous lines: Is line removal necessary?
    Catheter Cardiovasc Interv. 2020;96:651-656.
    >> Share

  703. TANNOUS P, Popescu A, Forbess L, Nugent A, et al
    Transcatheter biventricular conversion in an adult patient with a 1.5 ventricle Glenn palliation and superior vena cava syndrome.
    Catheter Cardiovasc Interv. 2020;96:633-637.
    >> Share

  704. MATHIS C, Romans R, Divekar A
    Variation in the outer diameter of vascular sheaths commonly used in infant cardiac catheterization.
    Catheter Cardiovasc Interv. 2020;96:620-625.
    >> Share

  705. ZILBERSZAC R, Chandiramani R, Hengstenberg C, Sartori S, et al
    Clinical outcomes after TAVR with heparin or bivalirudin as periprocedural anticoagulation in patients with and without peripheral arterial disease: Results from the BRAVO-3 randomized trial.
    Catheter Cardiovasc Interv. 2020;96:E377-E386.
    >> Share

  706. ARANZULLA TC
    One, two, three ... breakdance and twist.
    Catheter Cardiovasc Interv. 2020;96:601-608.
    >> Share

  707. TOVAR FORERO MN, Van Mieghem NM, Daemen J
    Stent underexpansion due to heavy coronary calcification resistant to rotational atherectomy: A case for coronary lithoplasty?
    Catheter Cardiovasc Interv. 2020;96:598-600.
    >> Share

  708. ABU SHARAR H, Helfert S, Vafaie M, Pleger ST, et al
    Identification of patients at higher risk for myocardial injury following elective coronary artery intervention.
    Catheter Cardiovasc Interv. 2020;96:578-585.
    >> Share

  709. KANDZARI DE, Lembo NJ, Carlson HD, Kalynych A, et al
    Procedural, clinical, and health status outcomes in chronic total coronary occlusion revascularization: Results from the PERSPECTIVE study.
    Catheter Cardiovasc Interv. 2020;96:567-576.
    >> Share

  710. PARR CJ, Sharma R, Arora RC, Singal R, et al
    Outcomes of extracorporeal membrane oxygenation support in the cardiac catheterization laboratory.
    Catheter Cardiovasc Interv. 2020;96:547-555.
    >> Share

  711. DE ROECK F, Tijskens M, Segers VFM
    Coronary-subclavian steal syndrome, an easily overlooked entity in interventional cardiology.
    Catheter Cardiovasc Interv. 2020;96:614-619.
    >> Share

  712. PROMPHAN W, Han Siang K, Prachasilchai P, Jarutach J, et al
    Feasibility and early outcomes of aortic coarctation treatments with BeGraft Aortic stent.
    Catheter Cardiovasc Interv. 2020;96:E310-E316.
    >> Share

  713. NOAMAN S, Andrianopoulos N, Brennan AL, Dinh D, et al
    Outcomes of cardiogenic shock complicating acute coronary syndromes.
    Catheter Cardiovasc Interv. 2020;96:E257-E267.
    >> Share

  714. GALLONE G, D'Ascenzo F, Boccuzzi G, Cortese B, et al
    Real-world reasons and outcomes for 1-month versus longer dual antiplatelet therapy strategies with a polymer-free BIOLIMUS A9-coated stent.
    Catheter Cardiovasc Interv. 2020;96:E248-E256.
    >> Share

  715. KOREN O, Abu Rajab Saaida R, Rozner E, Turgeman Y, et al
    Outcomes and safety of concurrent coronary and peripheral catheterization (REVascularization in concomitant PERIpheral artery disease and coronary artery disease REV-PERICAD Study).
    Catheter Cardiovasc Interv. 2020;96:E317-E323.
    >> Share

  716. SONCK J, Collet C, Mizukami T, Vandeloo B, et al
    Motorized fractional flow reserve pullback: Accuracy and reproducibility.
    Catheter Cardiovasc Interv. 2020;96:E230-E237.
    >> Share

  717. HASEGAWA K, Yamamoto W, Nakabayashi S, Otsuji S, et al
    Streamlined reverse wire technique for the treatment of complex bifurcated lesions.
    Catheter Cardiovasc Interv. 2020;96:E287-E291.
    >> Share

  718. RADHOE SP, Schuurman AS, Ligthart JM, Witberg K, et al
    Two decades after coronary radiation therapy: A single center longitudinal clinical study.
    Catheter Cardiovasc Interv. 2020;96:E204-E212.
    >> Share

  719. FEMIA G, Faour A, Assad J, Sharma L, et al
    Comparing the clinical and prognostic impact of proximal versus nonproximal lesions in dominant right coronary artery ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Sep 1. doi: 10.1002/ccd.29245.
    >> Share

    August 2020
  720. D'ENTREMONT MA, Laferriere C, Berube S, Couture EL, et al
    The effect of ASA, ticagrelor, and heparin in ST-segment myocardial infarction patients with prolonged transport times to primary percutaneous intervention.
    Catheter Cardiovasc Interv. 2020 Aug 29. doi: 10.1002/ccd.29144.
    >> Share

  721. FEGHALY J, Muskula P, Kumar S, Helmy T, et al
    Percutaneous coronary interventions on vein graft bifurcation lesions presenting as an acute coronary syndrome.
    Catheter Cardiovasc Interv. 2020 Aug 26. doi: 10.1002/ccd.29218.
    >> Share

  722. BOM MJ, Schumacher SP, Driessen RS, van Diemen PA, et al
    Non-invasive procedural planning using computed tomography-derived fractional flow reserve.
    Catheter Cardiovasc Interv. 2020 Aug 26. doi: 10.1002/ccd.29210.
    >> Share

  723. NAIDU SS, Coylewright M, Hawkins BM, Meraj P, et al
    Hot topics in interventional cardiology: Proceedings from the society for cardiovascular angiography and interventions 2020 think tank.
    Catheter Cardiovasc Interv. 2020 Aug 25. doi: 10.1002/ccd.29197.
    >> Share

  724. SHAH H, Patel S, Solanki S, Wudexi I, et al
    Clinical characteristics and in hospital outcomes of heart transplant recipients undergoing percutaneous coronary intervention: Insights from the National Inpatient Sample.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29184.
    >> Share

  725. SAGLIETTO A, D'Ascenzo F, Errigo D, Leonardi S, et al
    Antithrombotic strategies in patients needing oral anticoagulation undergoing percutaneous coronary intervention: A network meta-analysis.
    Catheter Cardiovasc Interv. 2020 Aug 13. doi: 10.1002/ccd.29192.
    >> Share

  726. LAFONT A, Sinnaeve PR, Cuisset T, Cook S, et al
    Two-year outcomes after percutaneous coronary intervention with drug-eluting stents or bare-metal stents in elderly patients with coronary artery disease.
    Catheter Cardiovasc Interv. 2020 Aug 6. doi: 10.1002/ccd.29159.
    >> Share

  727. GEORGE JC, Tabaza L, Janzer S
    Robotic-assisted balloon angioplasty and stent placement with distal embolic protection device for severe carotid artery stenosis in a high-risk surgical patient.
    Catheter Cardiovasc Interv. 2020;96:410-412.
    >> Share

  728. QIU Z, Liu J, Huang R, Liu D, et al
    Incidence, risk, and treatment of binary restenosis after vertebral artery stenting.
    Catheter Cardiovasc Interv. 2020;96:404-409.
    >> Share

  729. YAN C, Wan L, Li L, Li H, et al
    Transfemoral transcatheter puncture of interventricular septum in a swine model: A novel transfemoral-venous access to left ventricle with the assistance of arterio-venous circuit.
    Catheter Cardiovasc Interv. 2020;96:488-496.
    >> Share

  730. BUNCH F, Nair P, Aggarwala G, Dippel E, et al
    A universal drug delivery catheter for the treatment of infrapopliteal arterial disease using liquid therapy.
    Catheter Cardiovasc Interv. 2020;96:393-401.
    >> Share

  731. SIVAKUMAR K, Anantharaj A, Raghuram P, Krishna Kumar R, et al
    First in man study of a new semi-open cell design Zephyr cobalt-chromium stent in large vessels and conduits.
    Catheter Cardiovasc Interv. 2020;96:367-375.
    >> Share

  732. BARBASH IM, Kornowski R, Berkovitch A, Assali A, et al
    Percutaneous nitinol-based vascular closure device for large bore arterial access hemostasis: Results of a prospective multicenter study.
    Catheter Cardiovasc Interv. 2020;96:473-478.
    >> Share

  733. GUREVICH S, Prins KW
    The evolving role of interventional cardiology in the treatment of pulmonary hypertension.
    Catheter Cardiovasc Interv. 2020 Aug 1. doi: 10.1002/ccd.29146.
    >> Share

    July 2020
  734. SHAH H, Ramineni G, Varghese R, Thwe EE, et al
    Outcomes of percutaneous coronary interventions in patients with liver transplant.
    Catheter Cardiovasc Interv. 2020 Jul 29. doi: 10.1002/ccd.29168.
    >> Share

  735. KOTRONIAS RA, Bray JH, Scarsini R, Rajasundaram S, et al
    Transcatheter aortic valve replacement and percutaneous coronary intervention versus surgical aortic valve replacement and coronary artery bypass grafting in patients with severe aortic stenosis and concomitant coronary artery disease: A systematic re
    Catheter Cardiovasc Interv. 2020 Jul 14. doi: 10.1002/ccd.29110.
    >> Share

  736. CHIEW KLX, Lim PO
    Three-year outcome with drug-coated balloon percutaneous coronary intervention in coronary Takayasu arteritis: A case review.
    Catheter Cardiovasc Interv. 2020 Jul 4. doi: 10.1002/ccd.29099.
    >> Share

    June 2020
  737. NIKOLAKOPOULOS I, Choi JW, Alaswad K, Khatri JJ, et al
    Equipment utilization in chronic total occlusion percutaneous coronary interventions: Insights from the PROGRESS-CTO registry.
    Catheter Cardiovasc Interv. 2020 Jun 29. doi: 10.1002/ccd.29106.
    >> Share

  738. YOUNG L, Kapadia S, Khatri J
    Optimizing complex, high-risk indicated percutaneous coronary interventions: The future of interventional cardiology.
    Catheter Cardiovasc Interv. 2020 Jun 27. doi: 10.1002/ccd.29127.
    >> Share

  739. KAPUR NK, Hirst CS, Davila CD, Garcia R, et al
    Single stick access using a VA-ECMO arterial return cannula for coronary intervention in cardiogenic shock.
    Catheter Cardiovasc Interv. 2020 Jun 25. doi: 10.1002/ccd.29073.
    >> Share

  740. SAITO S, Ikeda N, Toi S, Nakamura M, et al
    Gadolinium contrast balloon pulmonary angioplasty for a patient with chronic thromboembolic pulmonary hypertension and severe iodine allergy.
    Catheter Cardiovasc Interv. 2020 Jun 1. doi: 10.1002/ccd.29004.
    >> Share

  741. CONROTTO F, D'Ascenzo F, Piroli F, Franze A, et al
    Percutaneous coronary intervention of unprotected left main and bifurcation in octogenarians: Subanalysis from RAIN (veRy thin stents for patients with left mAIn or bifurcatioN in real life).
    Catheter Cardiovasc Interv. 2020 Jun 1. doi: 10.1002/ccd.29048.
    >> Share

    May 2020
  742. SEIF S, Ayuna A, Kumar A, Macdonald J, et al
    Massive coronary thrombosis caused primary percutaneous coronary intervention to fail in a COVID-19 patient with ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 May 30. doi: 10.1002/ccd.29050.
    >> Share

  743. ELEID MF, Zheng PP, Gulati R, Bergman P, et al
    Remote robotic percutaneous coronary intervention: An animal feasibility study.
    Catheter Cardiovasc Interv. 2020 May 22. doi: 10.1002/ccd.28978.
    >> Share

  744. SAMMOUR Y, Kadri AN, Gajulapalli RD, Kaur M, et al
    Comparison of acute recoil after valve deployment and after post-dilation in patients undergoing transfemoral-transcatheter aortic valve replacement with SAPIEN-3 valve.
    Catheter Cardiovasc Interv. 2020 May 19. doi: 10.1002/ccd.28968.
    >> Share

  745. EFFOE VS, Kumar G, Sachdeva R
    Intravascular ultrasound-guided pulmonary artery embolectomy for saddle pulmonary embolism.
    Catheter Cardiovasc Interv. 2020 May 19. doi: 10.1002/ccd.28985.
    >> Share

  746. RILEY RF, Henry TD, Mahmud E, Kirtane AJ, et al
    SCAI Position Statement on Optimal Percutaneous Coronary Interventional Therapy for Complex Coronary Artery Disease.
    Catheter Cardiovasc Interv. 2020 May 14. doi: 10.1002/ccd.28994.
    >> Share

  747. BOX LC, Blankenship JC, Henry TD, Messenger JC, et al
    SCAI Position Statement on the Performance of Percutaneous Coronary Intervention in Ambulatory Surgical Centers.
    Catheter Cardiovasc Interv. 2020 May 14. doi: 10.1002/ccd.28991.
    >> Share

  748. HIGUCHI S, Kabeya Y, Nishina Y, Miura Y, et al
    Feasibility and safety of noncontrast percutaneous coronary intervention in patients with complicated acute coronary syndrome.
    Catheter Cardiovasc Interv. 2020 May 8. doi: 10.1002/ccd.28958.
    >> Share

  749. FERLINI M, Musumeci G, Grieco N, Trabattoni D, et al
    Follow-up strategies and individual risk profile after percutaneous coronary intervention: The prospective post percutaneous coronary intervention registry.
    Catheter Cardiovasc Interv. 2020 May 8. doi: 10.1002/ccd.28964.
    >> Share

  750. BUDASSI S, Zivelonghi C, Dens J, Bagnall AJ, et al
    Impact of prior coronary artery bypass grafting in patients undergoing chronic total occlusion-percutaneous coronary intervention: Procedural and clinical outcomes from the REgistry of Crossboss and Hybrid procedures in FrAnce, the NetheRlands, BelGiu
    Catheter Cardiovasc Interv. 2020 May 5. doi: 10.1002/ccd.28954.
    >> Share

    April 2020
  751. AZZALINI L, Johal GS, Baber U, Bander J, et al
    Outcomes of Impella-supported high-risk nonemergent percutaneous coronary intervention in a large single-center registry.
    Catheter Cardiovasc Interv. 2020 Apr 25. doi: 10.1002/ccd.28931.
    >> Share

  752. HARA H, Kogame N, Takahashi K, Modolo R, et al
    Usefulness of the updated logistic clinical SYNTAX score after percutaneous coronary intervention in patients with prior coronary artery bypass graft surgery: Insights from the GLOBAL LEADERS trial.
    Catheter Cardiovasc Interv. 2020 Apr 15. doi: 10.1002/ccd.28898.
    >> Share

  753. THOMSON VS, Varghese MJ, Chacko ST, Varghese L, et al
    Coronary artery disease management and cost implications with fractional flow reserve guided coronary intervention in Indian patients with stable ischemic coronary artery disease.
    Catheter Cardiovasc Interv. 2020 Apr 15. doi: 10.1002/ccd.28897.
    >> Share

  754. YAP J, Chen S, Smith TWR, Rogers JH, et al
    Transjugular mitral valve repair with the MitraClip: A step-by-step guide.
    Catheter Cardiovasc Interv. 2020 Apr 7. doi: 10.1002/ccd.28902.
    >> Share

    March 2020
  755. YOUNG L, Harb SC, Puri R, Khatri J, et al
    Percutaneous coronary intervention of an anomalous coronary chronic total occlusion: The added value of three-dimensional printing.
    Catheter Cardiovasc Interv. 2020 Mar 31. doi: 10.1002/ccd.28625.
    >> Share

  756. GIANNINI F, Pagnesi M, Campo G, Donahue M, et al
    Italian Multicenter Registry of Bare Metal Stent Use in Modern Percutaneous Coronary Intervention Era (AMARCORD): A multicenter observational study.
    Catheter Cardiovasc Interv. 2020 Mar 21. doi: 10.1002/ccd.28798.
    >> Share

  757. CHANDRASEKHAR J, Kerkmeijer LS, Kalkman DN, Sartori S, et al
    Sex differences in 1-year clinical outcomes after percutaneous coronary intervention with COMBO stents: From the COMBO collaboration.
    Catheter Cardiovasc Interv. 2020 Mar 21. doi: 10.1002/ccd.28853.
    >> Share

  758. BRENER SJ, Lembo NJ, Kandzari DE, Sabate M, et al
    Antithrombotic regimens for percutaneous coronary intervention of the left main coronary artery: The EXCEL trial.
    Catheter Cardiovasc Interv. 2020 Mar 17. doi: 10.1002/ccd.28858.
    >> Share

  759. LEISTNER DM, Dietrich S, Erbay A, Steiner J, et al
    Association of left ventricular end-diastolic pressure with mortality in patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Catheter Cardiovasc Interv. 2020 Mar 6. doi: 10.1002/ccd.28839.
    >> Share

  760. BAWAMIA BR, Egred M, Jackson M, Purcell I, et al
    Percutaneous coronary intervention for left main stem disease: Impact of diabetes mellitus on mortality.
    Catheter Cardiovasc Interv. 2020 Mar 5. doi: 10.1002/ccd.28818.
    >> Share

  761. PRASAD A, Rosenthal NA, Kartashov A, Knish K, et al
    Contemporary trend of acute kidney injury incidence and incremental costs among US patients undergoing percutaneous coronary procedures.
    Catheter Cardiovasc Interv. 2020 Mar 4. doi: 10.1002/ccd.28824.
    >> Share

    February 2020
  762. KWOK CS, Chatterjee S, Bagur R, Sharma K, et al
    Multiple unplanned readmissions after discharge for an admission with percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Feb 28. doi: 10.1002/ccd.28797.
    >> Share

  763. KHEIRI B, Rao SV, Osman M, Simpson TF, et al
    Meta-analysis of bivalirudin versus heparin in transradial coronary interventions.
    Catheter Cardiovasc Interv. 2020 Feb 24. doi: 10.1002/ccd.28800.
    >> Share

  764. AOI S, Baber U, Kovacic JC, Mehran R, et al
    Combined and independent impact of coronary artery calcification and inflammation on risk for adverse cardiovascular events after percutaneous coronary intervention: Results from a large single-center registry.
    Catheter Cardiovasc Interv. 2020 Feb 22. doi: 10.1002/ccd.28784.
    >> Share

  765. NOAMAN S, O'Brien J, Andrianopoulos N, Brennan AL, et al
    Clinical outcomes following ST-elevation myocardial infarction secondary to stent thrombosis treated by percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Feb 22. doi: 10.1002/ccd.28802.
    >> Share

  766. SHAH SR, Kiemeneij F, Khuddus MA
    Distal arteriovenous fistula formation after percutaneous coronary intervention: An old complication of a new access site.
    Catheter Cardiovasc Interv. 2020 Feb 7. doi: 10.1002/ccd.28772.
    >> Share

  767. VEROUHIS D, Sorensson P, Gourine A, Henareh L, et al
    Long-term effect of remote ischemic conditioning on infarct size and clinical outcomes in patients with anterior ST-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2020 Feb 7. doi: 10.1002/ccd.28760.
    >> Share

    January 2020
  768. QUADROS A, Belli KC, de Paula JET, de Magalhaes Campos CAH, et al
    Chronic total occlusion percutaneous coronary intervention in Latin America.
    Catheter Cardiovasc Interv. 2020 Jan 28. doi: 10.1002/ccd.28744.
    >> Share

  769. BUGANI G, Ponticelli F, Giannini F, Gallo F, et al
    Practical guide to prevention of contrast-induced acute kidney injury after percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2020 Jan 22. doi: 10.1002/ccd.28740.
    >> Share

  770. ALAWAMI M, Thirunavukarasu S, Ahmed J, El-Omar M, et al
    Intravascular lithotripsy to treat an underexpanded coronary stent: 4-Month angiographic and OCT follow-up.
    Catheter Cardiovasc Interv. 2020 Jan 20. doi: 10.1002/ccd.28738.
    >> Share

  771. XU MX, Ruddy TD, Schoenhagen P, Bartel T, et al
    The CatLet score and outcome prediction in acute myocardial infarction for patients undergoing primary percutaneous intervention: A proof-of-concept study.
    Catheter Cardiovasc Interv. 2020 Jan 14. doi: 10.1002/ccd.28724.
    >> Share

  772. BURZOTTA F, Aurigemma C, Romagnoli E, Shoeib O, et al
    A less-invasive totally-endovascular (LITE) technique for trans-femoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 11. doi: 10.1002/ccd.28697.
    >> Share

  773. ESTEVES V, Oliveira MAP, Feitosa FS, Mariani J Jr, et al
    Late clinical outcomes of myocardial hybrid revascularization versus coronary artery bypass grafting for complex triple-vessel disease: Long-term follow-up of the randomized MERGING clinical trial.
    Catheter Cardiovasc Interv. 2020 Jan 10. doi: 10.1002/ccd.28710.
    >> Share

  774. NAI FOVINO L, Scotti A, Massussi M, Fabris T, et al
    Incidence and feasibility of coronary access after transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28720.
    >> Share

  775. PRANATA R, Tondas AE, Vania R, Toruan MPL, et al
    Remote ischemic preconditioning reduces the incidence of contrast-induced nephropathy in patients undergoing coronary angiography/intervention: Systematic review and meta-analysis of randomized controlled trials.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28709.
    >> Share

  776. COSTANTINI CR, Denk MA, De Macedo RM, Tarbine SG, et al
    Absorb bioresorbable vascular scaffold outcomes following implantation with routine intravascular imaging guidance.
    Catheter Cardiovasc Interv. 2020 Jan 8. doi: 10.1002/ccd.28699.
    >> Share

    December 2019
  777. GARCIA-GARCIA HM, Adamo M, Soud M, Yacob O, et al
    Assessment of residual thrombus burden in patients with ST-segment elevation myocardial infarction undergoing bivalirudin versus unfractionated heparin infusion: The MATRIX (minimizing adverse hemorrhagic events by transradial access site and angioX)
    Catheter Cardiovasc Interv. 2019 Dec 28. doi: 10.1002/ccd.28661.
    >> Share

  778. KWOK CS, Amin AP, Shah B, Kinnaird T, et al
    Cost of coronary syndrome treated with percutaneous coronary intervention and 30-day unplanned readmission in the United States.
    Catheter Cardiovasc Interv. 2019 Dec 26. doi: 10.1002/ccd.28660.
    >> Share

  779. YBARRA LF, Dandona S, Daneault B, Rinfret S, et al
    Drug-coated balloon after subintimal plaque modification in failed coronary chronic total occlusion percutaneous coronary intervention: A novel concept.
    Catheter Cardiovasc Interv. 2019 Dec 23. doi: 10.1002/ccd.28663.
    >> Share

  780. YAP J, Teo TY, Foong P, Binte Hussin N, et al
    A randomized controlled trial on the effectiveness of a portable patient education video prior to coronary angiography and angioplasty.
    Catheter Cardiovasc Interv. 2019 Dec 22. doi: 10.1002/ccd.28655.
    >> Share

  781. NAGARAJA V, Schwarz K, Moss S, Kwok CS, et al
    Outcomes of patients who undergo percutaneous coronary intervention with covered stents for coronary perforation: A systematic review and pooled analysis of data.
    Catheter Cardiovasc Interv. 2019 Dec 18. doi: 10.1002/ccd.28646.
    >> Share

  782. HONDA Y, Araki M, Yamawaki M, Hirano K, et al
    The ARAHKEY technique: A novel method for the management of access site bleeding during percutaneous transfemoral transcatheter aortic valve replacement.
    Catheter Cardiovasc Interv. 2019 Dec 9. doi: 10.1002/ccd.28610.
    >> Share

  783. XENOGIANNIS I, Choi JW, Alaswad K, Khatri JJ, et al
    Outcomes of subintimal plaque modification in chronic total occlusion percutaneous coronary intervention.
    Catheter Cardiovasc Interv. 2019 Dec 4. doi: 10.1002/ccd.28614.
    >> Share

  784. HODSON RW, Jin R, Ring ME, Gafoor S, et al
    Intrathoracic complications associated with trans-femoral transcatheter aortic valve replacement: Implications for emergency surgical preparedness.
    Catheter Cardiovasc Interv. 2019 Dec 3. doi: 10.1002/ccd.28620.
    >> Share

    November 2019
  785. MANGELS D, Penny W, Reeves R
    Left internal mammary artery side branch intervention in the management of coronary steal syndrome following coronary artery bypass grafting.
    Catheter Cardiovasc Interv. 2019 Nov 29. doi: 10.1002/ccd.28630.
    >> Share

  786. AMR BS, Lippmann M, Tobbia P, Isom N, et al
    Impact of short term oral steroid use for intravenous contrast media hypersensitivity prophylaxis in diabetic patients undergoing nonemergent coronary angiography or interventions.
    Catheter Cardiovasc Interv. 2019 Nov 26. doi: 10.1002/ccd.28618.
    >> Share

  787. ALSANJARI O, Chouari T, Williams T, Myat A, et al
    Angiographically visible coronary artery collateral circulation improves prognosis in patients presenting with acute ST segment-elevation myocardial infarction.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28532.
    >> Share

  788. BAZARBASHI N, Ahuja K, Gad MM, Sammour YM, et al
    The utilization of single versus double Perclose devices for transfemoral aortic valve replacement access site closure: Insights from Cleveland Clinic Aortic Valve Center.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28585.
    >> Share

  789. ALQAHTANI F, Balla S, AlHajji M, Chaudhary F, et al
    Temporal trends in the utilization and outcomes of percutaneous coronary interventions in patients with liver cirrhosis.
    Catheter Cardiovasc Interv. 2019 Nov 12. doi: 10.1002/ccd.28593.
    >> Share

  790. RUSSO JJ, Prasad M, Doshi D, Karmpaliotis D, et al
    Improvement in left ventricular function following higher-risk percutaneous coronary intervention in patients with ischemic cardiomyopathy.
    Catheter Cardiovasc Interv. 2019 Nov 6. doi: 10.1002/ccd.28557.
    >> Share

    October 2019
  791. HANNAN EL, Zhong Y, Ling FSK, Tamis-Holland J, et al
    Assessment of repeat target lesion percutaneous coronary intervention as a quality measure for public reporting and general quality assessment for PCIs.
    Catheter Cardiovasc Interv. 2019 Oct 23. doi: 10.1002/ccd.28526.
    >> Share

  792. ALRAIES MC, Kaki A, Kajy M, Blank N, et al
    Sex-related difference in the use of percutaneous left ventricular assist device in patients undergoing complex high-risk percutaneous coronary intervention: Insight from the cVAD registry.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28509.
    >> Share

  793. RAJKUMAR CA, Cook C, Shalhoub J, Chukwuemeka A, et al
    Facilitating right-sided axillary artery access for transcatheter aortic valve replacement using the Edwards Sapien 3 and ultra valves: Technical considerations.
    Catheter Cardiovasc Interv. 2019 Oct 21. doi: 10.1002/ccd.28558.
    >> Share

  794. CANTOR WJ, Lavi S, Dzavik V, Cairns J, et al
    Upstream anticoagulation for patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: Insights from the TOTAL trial.
    Catheter Cardiovasc Interv. 2019 Oct 15. doi: 10.1002/ccd.28540.
    >> Share

    September 2019
  795. PLITT A, Claessen BE, Sartori S, Baber U, et al
    Impact of stent diameter on outcomes following percutaneous coronary intervention with second-generation drug-eluting stents: Results from a large single-center registry.
    Catheter Cardiovasc Interv. 2019 Sep 6. doi: 10.1002/ccd.28488.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016